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ABSTRACT 
 
Research on long noncoding RNAs (lncRNAs) has increased significantly over 
the past few decades. However, investigation of lncRNA continues to lag behind that of 
other noncoding RNAs species like microRNA (miRNA). One subject receiving limited 
consideration to date is how teratogens impact the expression patterns and functions of 
lncRNAs as well as their interactions with other noncoding RNAs. To that end, research 
was undertaken to determine how six lncRNAs present in the developing nervous system 
are affected by ethanol and nicotine exposure. 
After identifying Malat1, Cyrano, Sox2ot, TUNA, Emx2os, and MIAT as 
neurodevelopmentally-regulated transcripts, initial experiments probed the expression 
patterns of each lncRNA in mouse fetal cortical neurosphere cultures treated with 
ethanol, nicotine, and ethanol and nicotine in combination. While expression of the 
transcripts of interest was not significantly impacted by ethanol exposure, nicotine 
treatment reduced expression of TUNA, MIAT, Cyrano, and Malat1.  Treatment with 
both ethanol and nicotine also yielded reduced expression of Cyrano, TUNA, and MIAT. 
Experimentation progressed to investigations of the potential for interactions between 
miRNAs, TUNA, MIAT, and Emx2os. These studies focused on whether such 
associations were mediated by the Argonaute 2 (Ago2) protein, if they were disrupted by 
ethanol and nicotine treatment, and where these interactions localized within cells. 
Although bioinformatics tools predicted multiple binding sites between ethanol- and 
nicotine-sensitive miRNAs and the six lncRNAs of interest, there was no evidence of 
 iii 
 
Ago2-mediated interactions in either treated or untreated mouse fetal neurosphere 
cultures. As such, there was also no evidence of disrupted localization of these 
complexes. However, RNA immunoprecipitation (RIP) experiments with Ago2 did 
provide insight into the miRNAs actively associated with the RNA-induced silencing 
complex (RISC) and the compartmentalization patterns of these miRNAs within cells of 
the developing cortex. Ultimately, this work expands knowledge on the expression 
patterns of several lncRNAs in the developing brain and serves as the first report 
detailing the impacts of ethanol and nicotine on lncRNAs in this developmental context. 
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
I.1  Long Noncoding RNA 
 
For several decades the scientific community puzzled over the fact that over 80% 
of the human genome produces non-protein coding RNA molecules (Ender and Meister, 
2010, Guennewig and Cooper, 2014). These molecules were collectively deemed “junk 
RNA” and mostly ignored. Despite the fact that ribosomal RNA and transfer RNA were 
discovered in the 1950s, it took nearly 40 years for researchers to revisit these “junk” 
transcripts, ultimately concluding that much of the non-protein coding RNA was indeed 
functional (Palazzo and Lee, 2015, Gomes et al., 2013). Study of the newly termed 
noncoding RNAs (ncRNAs) provided evidence for the existence of several classes of 
small ncRNAs including miRNAs, piwi-interacting RNAs (piRNAs), and small 
nucleolar RNAs (snoRNAs); all distinguished by their relative lengths and molecular 
functions (Lee et al., 1993, Ender and Meister, 2010, Guennewig and Cooper, 2014). 
While investigations of these small ncRNAs exploded from the early 1990s through the 
2000s, research slowly accumulated on another class of ncRNA initially identified in the 
mid-1980s and called long noncoding RNA (Lee et al., 1993, Gomes et al., 2013, 
Palazzo and Lee, 2015). Pioneering studies of lncRNAs characterized H19 (Pachnis et 
al., 1984, Pachnis et al., 1988, Brannan et al., 1990) and Xist (Brockdorff et al., 1991, 
Borsani et al., 1991, Brockdorff et al., 1992, Brown et al., 1992), revealing their roles in 
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genomic imprinting and X chromosome inactivation, respectively. It was not until the 
past decade and a half that research on lncRNAs truly began in earnest, however. In 
particular, the discovery of roles for some lncRNAs in cancer development and 
metastasis has been a major driver in the recent surge of investigation (Gupta et al., 
2010, Gutschner and Diederichs, 2012, Tano and Akimitsu, 2012). 
As the name suggests, the major characteristic that distinguishes lncRNAs from 
their smaller noncoding counterparts is their size. In general, any ncRNA sequence 
longer than 200 base pairs is classified as an lncRNA (Mercer et al., 2009, Geisler and 
Coller, 2013, Fatica and Bozzoni, 2014). Members of this category can additionally be 
divided into four groups according to their location within the genome relative to protein 
coding genes. These groups include sense, antisense, intronic, and intergenic noncoding 
RNAs (Mercer et al., 2009, Ponting et al., 2009, Ma et al., 2013). Sense lncRNAs are 
transcribed from genomic regions on the same strand as exons of protein-coding genes 
and may overlap or entirely encompass these exons (Ponting et al., 2009, Ma et al., 
2013). Conversely, antisense lncRNAs are transcribed from genomic regions on the 
strand opposite coding exons (Mercer et al., 2009, Ma et al., 2013). Intronic lncRNAs 
are transcribed from regions within the introns of protein-coding genes while intergenic 
lncRNAs are transcribed from genomic regions between coding genes (Mercer et al., 
2009, Ponting et al., 2009, Ma et al., 2013). 
While lncRNA sequence length and genomic locations are varied, they do share 
some things in common with mRNA. For instance, they are transcribed by RNA 
polymerase II and the majority of lncRNAs are 5’ capped, undergo splicing, and exhibit 
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3’ polyadenylation (Krishnan and Mishra, 2014). However, unlike mRNA, sequence 
conservation tends to be limited between species, except for a few highly conserved 
regions (Mercer et al., 2009, Ponting et al., 2009, Diederichs, 2014, Johnsson et al., 
2014). While this lack of sequence conservation led many to hypothesize that these 
sequences had limited functionality compared with the other ncRNA classes, others have 
more recently suggested that conservation in lncRNAs is most predominant in a 
transcript’s secondary structure; thus, the specific interactions between lncRNAs and 
their targets should also be conserved (Diederichs, 2014, Fatica and Bozzoni, 2014, 
Johnsson et al., 2014, Krishnan and Mishra, 2014). With regard to secondary structure, 
lncRNAs are a rather diverse noncoding RNA class, which seems to explain the variety 
of functional roles attributed to them. These include regulation of chromatin structure 
(Malecova and Morris, 2010, Tsai et al., 2010, Saxena and Carninci, 2011), formation 
and maintenance of nuclear bodies and molecular scaffolding complexes (Clemson et al., 
2009, Wang and Chang, 2011), gene regulation mediated by lncRNA transcription 
(Kornienko et al., 2013), splicing of target molecules (Hutchinson et al., 2007, Anko and 
Neugebauer, 2010, Tsuiji et al., 2011), and regulation of protein and transcription factor 
activity (Wilusz et al., 2009, Geisler and Coller, 2013, Bergmann and Spector, 2014), 
among others.  
Since lncRNAs have not been the focus of intense research for as long as the 
various small noncoding RNAs, there are many basic research questions that remain to 
be answered about this category of ncRNA. One such subject requiring additional 
investigation is how lncRNAs and the other ncRNA classes may interact and what 
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purpose these interactions serve. Evidence from the primary literature suggests lncRNAs 
and other noncoding RNAs make up complex regulatory networks (Cesana et al., 2011, 
Hansen et al., 2013, Wang et al., 2013). Many of these interactions appear to follow the 
pattern of miRNA-mediated RNA-induced silencing often observed between miRNAs 
and their targets (Leucci et al., 2013, Wang et al., 2015). More recently, however, some 
researchers have described lncRNAs that appear to function as miRNA regulators and 
sequestration molecules (Cesana et al., 2011, Wang et al., 2013, Zhou et al., 2014, Liu et 
al., 2014). Such transcripts have been termed competing endogenous RNAs (ceRNAs) or 
miRNA sponges (Cesana and Daley, 2013, Hansen et al., 2013, Tay et al., 2014). For 
example, two separate studies have identified the lncRNA linc-RNA-RoR as an effective 
miRNA sponge for miR-145. Wang et al. (2013) observed that by binding miR-145-
activated RISC complexes, linc-RNA-RoR served to limit the miRNA-mediated 
degradation of Oct4, Sox2, and Nanog in human embryonic stem cells; thereby, 
positively impacting stem cell maintenance. Zhou et al. (2014) further characterized this 
interaction between miR-145 and linc-RNA-RoR in cancer stem cells. Yet, with only a 
few hundred of the thousands of known and predicted long noncoding RNA transcripts 
having undergone much study, there remain a multitude of potential undiscovered 
lncRNA/small ncRNA interactions to be described. 
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I.2  Noncoding RNAs and Neural Development: Effects of Teratogens 
 
I.2.1  Alcohol and Development 
 
 Alcohol is one of the most commonly abused substances in the world and has 
been used by humans for thousands of years (Global Status Report On Alcohol And 
Health 2014, Weiss and Porrino, 2002, Alfonso-Loeches and Guerri, 2011). In 2014, an 
estimated 139.7 million Americans aged 12 years and older were current alcohol users 
(Center for Behavioral Health Statistics and Quality, 2014). Worldwide 3.3 million 
deaths are attributable to the consumption and misuse of alcohol annually (Global Status 
Report On Alcohol And Health 2014). Aside from fatalities, alcohol use has short-term 
risks such as alcohol poisoning and bodily injury as well as long-term risks like the 
development of chronic diseases and alcoholism (Global Status Report On Alcohol And 
Health 2014, CDC - Fact Sheets-Alcohol Use and Health - Alcohol). However, research 
has indicated that some of the starkest effects of alcohol use stem from its impacts on the 
central nervous system. Chronic alcohol use is associated with a variety of structural, 
cellular, and molecular changes in the (Harper, 1998, Bleich et al., 2003, Yadav et al., 
2011, Kryger et al., 2012, Most et al., 2014, Wu et al., 2014, de la Monte and Kril, 2014, 
Pleil et al., 2015). Such effects result in brain damage and reduced brain mass, which in 
turn lead to cognitive and motor deficits, dysfunction of the cholinergic system, and 
dementia (Arendt, 1994, Harper and Matsumoto, 2005, Yadav et al., 2011, de la Monte 
and Kril, 2014). Although mediated by other factors like nutritional state and genetics, 
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the severity of alcohol’s neurotoxic effects is dose and frequency dependent; heavy 
drinkers run the greatest risk of developing adverse outcomes (Vengeliene et al., 2008, 
de la Monte and Kril, 2014). 
While the effects of alcohol use during adulthood are severe, exposure during 
prenatal development is especially damaging. Despite widespread campaigns to curb 
alcohol consumption during pregnancy, such behavior persists. According to results of 
the 2013 National Survey on Drug Use and Health, an annual average of 9.4% of 
pregnant American women aged 15-44 years reported current use of alcohol within one 
month of taking the survey (Center for Behavioral Health Statistics and Quality, 2014). 
Drinking during pregnancy can result in negative outcomes including miscarriage, 
stillbirth, and a suite of disabilities collectively referred to as fetal alcohol spectrum 
disorders (FASDs) (CDC - Fact Sheets-Alcohol Use and Health – Alcohol, Haycock, 
2009, Laufer et al., 2013). FASD-associated disabilities commonly include facial 
dysmorphologies, microcephaly, growth retardation, poor coordination, hyperactivity 
and attention issues, poor memory, learning disabilities, cognitive disabilities, vision or 
hearing issues, and cardiac and skeletal abnormalities (CDC - Fact Sheets-Alcohol Use 
and Health – Alcohol, Haycock, 2009, Ramsay, 2010, Alfonoso-Loeches and Guerri, 
2011). 
Echoing results observed in adults, research has determined that the risk of 
alcohol-related effects and the nature of such effects depend greatly on the timing, 
frequency, and dose encountered (Alfonso-Loeches and Guerri, 2011, de la Monte and 
Kril, 2014). Additionally, neurotoxicity caused by developmental alcohol exposure is 
 7 
 
associated with structural, cellular, and molecular changes; the same types of changes 
linked to alcohol-related neurotoxicity in adults (Haycock, 2009, Soares et al., 2012, 
Carnahan et al., 2013, Tingling et al., 2013, Ungerer et al., 2013, Qi et al., 2014). For 
example, Camarillo et al. (2008) observed that alcohol exposure disrupted normal 
cellular migration patterns in the developing cortex, dysregulated the expression of 
migration-related mRNAs, and reduced neurite branching in differentiating neurons. 
Similarly, abnormal cellular migration, changes in cytoskeletal structures, and increased 
apoptotic cell death have been reported in neural crest cells of alcohol-exposed chick 
embryos (Rovasio and Battiato, 2002). Such mechanisms have ultimately been shown to 
give rise to agenesis of and abnormalities in various regions of the CNS including the 
cerebellum, brainstem, corpus callosum, optic nerve, pituitary, neural tube, cortex, 
hippocampus, olfactory bulb, basal ganglia, and diencephalon (Roebuck et al., 1998, 
Guerri, 2010, Alfonso-Loeches and Guerri, 2011). 
 
I.2.2  Nicotine and Development 
 
 Tobacco products are used widely throughout the world. According to the 2013 
NSDUH, 25.5% of the U.S. population aged 12 years and older were current users of 
tobacco products with 21.3% smoking cigarettes or cigars (Center for Behavioral Health 
Statistics and Quality, 2015). Smoking tobacco allows for quick and efficient delivery of 
nicotine directly to the brain (Research Report Series: Tobacco/Nicotine, WHO Report 
On The Global Tobacco Epidemic, 2008: The MPOWER Package). Each puff of a 
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cigarette delivers one to two milligrams of nicotine (Research Report Series: 
Tobacco/Nicotine). With the average smoker taking ten puffs per cigarette, each one 
provides approximately 10 milligrams of this highly addictive substance (Research 
Report Series: Tobacco/Nicotine). As with alcohol, smoking—and, therefore, indirectly 
nicotine—leads to a multitude of adverse health consequences; the most serious being 
death. It is the leading cause of preventable deaths in the U.S. and results in 6 million 
fatalities worldwide (WHO Report On The Global Tobacco Epidemic, 2011: Warning 
About the Dangers of Tobacco, Research Report Series: Tobacco/Nicotine). Other 
negative outcomes associated with smoking include higher risk of developing cancer, 
heart disease, chronic obstructive pulmonary diseases, and emphysema as well as higher 
risk of suffering a stroke or heart attack (Research Report Series: Tobacco/Nicotine). 
Other impacts on the brain and nervous system are observed at the cellular and 
molecular levels and have been shown to mediate nicotine addiction and withdrawal 
(Benowitz, 2009, Lingford-Hughes et al., 2010, Yu et al., 2012, Ng et al., 2013, Bavarva 
et al., 2013). 
 In part due to nicotine’s highly addictive nature, some women continue smoking 
during pregnancy despite warnings about the dangers it poses to the unborn child. In 
2013, 15.4% of gestating American women aged 15-44 years self-reported as current 
smokers (Center for Behavioral Health Statistics and Quality, 2014). Of these women, 
19.9% smoked during the first trimester, 13.4% continued into the second trimester, and 
12.8% smoked through to the third trimester (Center for Behavioral Health Statistics and 
Quality, 2014). Due to the nature of nicotine metabolism and transfer through the 
 9 
 
placenta, concentrations experienced by the fetus can be up to 15% higher than levels 
observed in the mother (Maccani and Knopik, 2012, Duncan et al., 2015). In utero 
exposure to nicotine and tobacco smoke is associated with growth retardation, dose-
dependent low birth weight, disrupted blood flow to and oxygenation of the fetus, and 
tissue damage to the developing lungs and brain (Slotkin, 1998, Atluri et al., 2001, Mick 
et al., 2002, Roza et al., 2007, Cents et al., 2012). Smoking during pregnancy also 
increases the risk of spontaneous abortion, pre-term birth, stillbirth, and Sudden Infant 
Death Syndrome (SIDS) as well as the likelihood that a child will suffer from respiratory 
problems, behavioral issues, and nicotine addiction later on (Slotkin, 1998, Atluri et al., 
2001, Mick et al., 2002, Takarada et al., 2012, Lee et al., 2014). 
 Investigation into the impacts of developmental nicotine exposure on the central 
nervous system has revealed that it exerts its neurotoxic effects through the disruption of 
structural, cellular, and molecular processes. In general, such disruptions are attributed to 
nicotine’s role as a nicotinic acetylcholine receptor (nAChR) agonist (Benowitz, 2009, 
Fagerstrom, 2014). Acetylcholine is the endogenous agonist of nAChRs and its 
regulation in the developing brain is critical for proper cholinergic control of 
neurogenesis (Slotkin, 1998, Slotkin, 2004, Dwyer et al., 2008). Therefore, in utero 
nicotine exposure causes overstimulation and inappropriately timed stimulation of the 
cholinergic system resulting in molecular, cellular, and structural abnormalities (Slotkin, 
2004, Dwyer et al., 2008). The most common of these effects are impaired 
synaptogenesis and axonogenesis, reduced cell proliferation, and increased cell death 
(Slotkin, 1998, Slotkin, 2004, Slikker et al., 2005, Slotkin et al., 2007, Lee et al., 2014, 
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Aoyama et al., 2016). For example, Roy et al. (1998) observed significant cell death in 
neural tubes of mouse embryos exposed to one, 10, and 100 µM nicotine. A study by 
Takarada et al. (2012) revealed that exposure to nicotine inhibited the proliferation of 
neural progenitors and lead to altered expression of MAP2 and GFAP in neurons 
differentiated from these neural progenitors. In addition to these outcomes, research also 
indicates that in utero nicotine exposure may impact the expression of nAChRs based on 
subunit type and alter DNA methylation in offspring (Markunas et al., 2014, Duncan et 
al., 2015). 
  
I.2.3  Ethanol, Nicotine, and ncRNAs in Neural Development 
 
Recently investigations into the molecular mechanisms of alcohol- and nicotine-
related developmental defects have begun to focus on noncoding RNAs. Multiple 
research teams have reported the existence of miRNAs which are dysregulated following 
alcohol and/or nicotine exposure (Sathyan et al., 2007, Wang et al., 2008, Huang and Li, 
2009, Yadav et al., 2011, Guo et al., 2012, Maccani and Knopik, 2012, Soares et al., 
2012, Takahashi et al., 2013, Yokoi and Nakajima, 2013). In a paper by Taki et al. 
(2014), researchers observed dose-dependent changes in the expression profiles of 40 
miRNAs in C. elegans individuals exposed to 20 µM or 20 mM nicotine. Another report 
by Tal et al. (2012) described altered expression of 35 miRNAs in D. rerio embryos 
exposed to ethanol from four to 24 hpf. 
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Interestingly, although toxicology and teratology are major research foci in 
developmental biology, few studies on long noncoding RNA have considered the effects 
of developmental exposure to environmental compounds on these transcripts. Of the 
publications detailing such effects, several explored the impacts of toxic compounds like 
dioxin and azacytidine on methylation patterns at the H19 imprint control region and 
expression of H19 in embryos (Wu et al., 2004, Haycock and Ramsay, 2009, Zhao et al., 
2012). One group of researchers reported that expression of Xist was significantly 
reduced in the cerebrums of female mouse pups following bisphenol-A exposure in 
utero (Kumamoto and Oshio, 2013). However, to date, no studies have considered how 
ethanol or nicotine might affect lncRNAs in the developing nervous system. In fact, a 
recent search of the primary literature turned up no papers concerning the role of long 
noncoding RNAs in the etiology of FASDs. As such, this constitutes a major knowledge 
gap in the developmental toxicology literature. 
 
I.3  Argonaute Proteins and Noncoding RNA 
 
Argonaute (Ago) proteins are a family of highly conserved RNA binding proteins 
that can be divided into two subfamilies, Ago proteins and Piwi proteins (Patel et al., 
2006, Ender and Meister, 2010, Derrien and Genschik, 2014). Piwi protein expression is 
mainly restricted to the germ line, while Ago subgroup members are expressed in a 
variety of tissues (Hammell, 2008, Ender and Meister, 2010).  Due to this expression 
pattern, Ago proteins are of greater interest when studying the brain. In mammals, the 
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Ago subfamily is comprised of four different proteins: Ago1, Ago2, Ago3, and Ago4 
(Hutvagner and Simard, 2008, Ender and Meister, 2010). In general, these proteins have 
a molecular weight of approximately 100 kDa and contain a Piwi-Argonaute-Zwille 
(PAZ) domain that allows for binding of small RNAs (Patel et al., 2006, Gagnon and 
Corey, 2012, Gurtan and Sharp, 2013). 
Functionally, Ago proteins are key components of the RISC, which facilitates the 
regulation of RNA, DNA, and protein targets of small noncoding RNAs in cells 
(Hutvagner and Simard, 2008, Gagnon and Corey, 2012, Ohrt et al., 2012). This is 
accomplished when a small ncRNA molecule binds to an Ago protein and proceeds to 
direct the associated RISC to targets with sequences complementary to itself (Hammell, 
2008, Gurtan and Sharp, 2013, Meister, 2013). For miRNAs, variable complementarity 
between an eight base pair seed region and sequences in a target dictates RISC binding 
as well as the mechanism of RNA induced silencing (Ender and Meister, 2010, Ohrt et 
al., 2012). Some common mechanisms include cleavage of the target, altered stability of 
the target, and altered translation of the target. While any of the four types of Ago 
proteins can be recruited to RISC for interaction with small ncRNAs, only Ago2 is 
capable of carrying out direct cleavage of small ncRNA target molecules on its own 
(Morita et al., 2007, Hutvagner and Simard, 2008, Ender and Meister, 2010). This 
independent splicing functionality and evidence that it is required for successful early 
embryonic development have made Ago2 popular for study, especially in developmental 
contexts (Morita et al., 2007, Lykke-Andersen et al., 2008). 
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Initial research indicated that Ago proteins and RISC complexes were localized 
in the cytoplasm (Ohrt et al., 2012, Gomes et al., 2013). This was in large part due to the 
discovery of cytoplasmic sub-compartments, such as cytoplasmic processing bodies and 
stress granules, where miRNA-bound Ago proteins and miRNA target molecules 
aggregate (Hammell, 2008, Hutvagner and Simard, 2008). However, evidence from a 
growing number of studies has described the localization of Ago proteins/RISC 
complexes and associated RNA to the nucleus in a variety of organisms (Morita et al., 
2007, Hammell, 2008, Gagnon and Corey, 2012, Meister, 2013). Indeed, it appears that 
active RISC complexes are shuttled between the cytoplasm and nucleus following RISC 
complex loading in the cytoplasm (Ohrt et al., 2012, Gomes et al., 2013). 
As was briefly mentioned above, evidence indicates that lncRNAs and miRNAs 
interact and regulate one another’s transcription, cellular functions, etc. (Cesana et al., 
2011, Hansen et al., 2013, Wang et al., 2013). As such, it is likely that Ago proteins are 
involved in such interactions. Indeed, evidence of lncRNAs interacting with 
Ago/miRNA complexes has been reported (Ulitsky et al., 2011, Jalali et al., 2013, Juan 
et al., 2013).  Most of these studies have found such interactions via in silico analysis of 
sequencing datasets generated from Argonaute pull downs. However, only one such 
publication has assessed Ago-mediated miRNA interactions in the developing brain. 
While Chi et al. (2009) did probe such associations in the post-natal mouse cortex, the 
investigators did not consider interactions between miRNAs and other ncRNAs, only 
between miRNAs and mRNA targets found in Ago pull downs. Therefore, there is little 
to no information available regarding potential miRNA/lncRNA interactions in the brain. 
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Furthermore, at this time there appears to be nothing in the primary literature that 
investigates how environmental contaminants or drugs of abuse may change the 
Ago/ncRNA interactions observed in cells. 
 
I.4  lncRNAs of Interest and Specific Aims 
 
I.1.2  lncRNAs of Interest 
 
Toward the aim of expanding the body of research on lncRNAs, seven transcripts 
will be considered in this thesis including Malat1, Cyrano, Sox2ot, Megamind, Emx2os, 
MIAT, and GM7854. The first six of these seven lncRNAs were selected by searching 
the lncRNA Database (Amaral et al., 2011) for sequences with evidence supporting 
expression in the nervous system, developmental regulation, conservation from at least 
mouse to human, and association with the adoption of neural cell fate or maintenance of 
stem cell character. The final lncRNA of interest, GM7854, was selected because a 
colleague’s work indicated potential regulation of this transcript via miRNA 
dysregulation. Further, a primary literature search confirmed that none of these lncRNAs 
have been assessed for effects of ethanol and/or nicotine exposure in a 
neurodevelopmental context.  
A brief summary of what is currently known about each transcript with a focus 
on why it was selected for this thesis is presented below. Additional information can be 
found in Table 1. 
 15 
 
Table 1. Long Noncoding RNAs of Interest 
 
 
lncRNA 
Name 
 
 
 
Additional 
Names 
 
 
NCBI 
Accession 
Number(s) 
 
 
 
NCBI PubMed 
Publication 
Number 
 
 
 
 
Reasons for Consideration 
 
 
Selected 
Publications 
 
Malat1 
 
 
Neat2 
 
NR_002847.2 
 
166 
 
Highly expressed in the brain 
especially NSCs and early 
differentiated neurons and 
glia; regulated in various 
cancers; roles in cell 
migration, mitosis, and cell 
death 
 
Mercer et al., 
2010; Tano et 
al., 2010; 
Tripathi et al., 
2010 
Cyrano 
 
linc-oip5 
linc-1510 
linc-NUSAP1-1 
OIP5-AS1 
 
NR_027832.1 
NR_015473.1 
1 Expressed in the brain and eye 
of D. rerio embryos; brain and 
eye defects with knockdown; 
knockdown inhibited neural 
differentiation and neural cell 
fate maintenance 
 
Ulitsky et al., 
2011 
Sox2ot Sox2dot NR_015580.2 
NR_015580.1 
 
12 
 
Expressed in embryonic stem 
cells and cultured 
neurospheres; suggested role 
in ocular defects; possible 
interaction with Sox2 
 
Mercer et al., 
2008; Amaral et 
al., 2009 
TUNA 
 
TUNA 
BX093813 
linc-birc6 
linc-hhipll 
 
NR_045047.1 2 Expressed in the brain and eye 
of D. rerio embryos; brain and 
eye defects with knockdown; 
knockdown inhibited mESC 
pluripotency and neural 
differentiation 
 
Ulitsky et al., 
2011; Lin et al., 
2014 
Emx2os 
 
N/A NR_002863.2 2 Expressed in cells of the 
developing periventricular 
proliferative layers and 
cortical plate of the 
telencephalon; knockdown 
downregulated Emx2 
 
Noonan et al., 
2003; Spigoni 
et al., 2010 
MIAT 
 
gomafu 
RNCR2 
 
NR_033657.1 
NR_003718.2 
14 Expressed in the developing 
retina and in differentiating 
NSCs; possible Oct4 target; 
may regulate splicing factor 1 
splicing efficiency 
Dinger et al., 
2008; Mercer et 
al., 2010; 
Rapicavoli et 
al., 2010; Sheik 
Mohamed et al., 
2010 
 
GM7854 
 
N/A NR_028417.1 0 Expression induced in fetal 
NSCs overexpressing miR-
153 
 
N/A 
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I.1.2.1  Malat1 
 
Metastasis associated lung adenocarcinoma transcript 1 (Malat1) is a 6983 base 
pair (bp) lncRNA located on chromosome 19 in mice (Amaral et al., 2011, Kersey et al., 
2012). It consists of a single exon and contains a 61 bp region near the 3’ end that is 
conserved from zebrafish (Danio rerio) to therian mammals (Amaral et al., 2011, Kersey 
et al., 2012, Zhang et al., 2013). Malat1 was first described by Ji et al. (2003) in cells of 
primary lung tumors from patients with early stage non-small cell lung cancer. Since its 
discovery Malat1 has been the focus of intense study, the majority of which has focused 
on its expression in a variety of cancers (Lin et al., 2007, Guffanti et al., 2009, Lai et al., 
2012, Han et al., 2013, Ozgur et al., 2013, Ren et al., 2013, Fan et al., 2014, Kuo et al., 
2013, Mohamadkhani, 2014, Wang et al., 2014). Malat1 is also highly expressed in cells 
of the adult and developing nervous system. Researchers have reported the presence of 
the lncRNA in adult mouse cortex and hippocampus, adult human cerebellum and 
hippocampus, neural stem cells, and early differentiated neurons and glia (Mercer et al., 
2010, Tano et al., 2010, Tripathi et al., 2010, Kryger et al., 2012, Nakagawa et al., 2012, 
Zhang et al., 2012). In both cancerous and neural cell types, Malat1 is most commonly 
found localized to the nucleus where it is enriched in nuclear speckle structures 
(Clemson et al., 2009, Bernard et al., 2010, Mercer et al., 2010, Nakagawa et al., 2012). 
Functionally, it has been determined that upregulation of Malat1 in cancerous tissue is 
associated with cancer promotion, increased metastatic nature of tumors, and lower 
survival rates among patients (Ji et al., 2003, Yamada et al., 2006, Schmidt et al., 2011, 
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Lai et al., 2012, Gutschner et al., 2013, Liu et al., 2013, Fan et al., 2014). Similarly, 
Malat1 is believed to play a role in cell migration, mitosis, and cell death in other tissues 
(Mercer et al., 2010, Tano et al., 2010, Tripathi et al., 2010, Amaral et al., 2011). Several 
researchers have also determined that this transcript modulates splicing factor levels and 
distribution; thereby, controlling alternative splicing (Tripathi et al., 2010, Wang et al., 
2014). 
  
I.1.2.3  Cyrano, TUNA, and GM7854 
 
Unlike Malat1, the majority of lncRNAs have been the subject of limited study. 
Of the lncRNAs considered in the scope of this thesis, the least is known about GM7854. 
Indeed, ENSEMBL and the lncRNA Database either do not contain a record of it at all 
or simply indicate that it is a predicted lncRNA (Amaral et al., 2011, Kersey et al., 
2012). At this time, no publications have investigated this transcript. However, in 
personal communication with Dr. Pai Chi Tsai it was revealed that during the course of 
his research GM7854 expression was induced in neural stem cells (NSCs) 
overexpressing miR-153. 
Although more is understood about Cyrano than GM7854, this transcript has still 
received limited attention. Located on chromosome 2 in M. musculus, this lncRNA 
consists of three exons and has two transcript variants (RefSeq Accession NR_027832.1) 
(Amaral et al., 2011, Kersey et al., 2012). Within each sequence there is a 67 bp region 
that is conserved between zebrafish, mice, and humans and may contain a binding site 
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for miR-7 (RefSeq Accession NR_027832.1) (Ulitsky et al., 2011). At this time, only a 
single paper has investigated Cyrano expression and functions. This research was 
performed in zebrafish embryos and found evidence for the transcript’s expression in the 
developing brain and notochord (Amaral et al., 2011, Ulitsky et al., 2011) Knockdown 
of the transcript led to a variety of nervous system abnormalities including fetuses with 
small heads and eyes, short curly tails, defects in neural tube opening, loss of Neuro-D 
positive neurons in the retina and tectum, and enlarged nasal placodes (Ulitsky et al., 
2011). When zebrafish, mouse, and human Cyrano transcripts were reintroduced into 
knockdown embryos, the abnormal phenotypes were rescued (Ulitsky et al., 2011). 
Cyrano is sometimes referred to as linc-oip5 or OIP-AS1 because it is antisense to the 
coding region for the OIP5 gene (Amaral et al., 2011). This is potentially significant 
since OIP5 is associated with chromatin organization and cell cycle control (Naetar et 
al., 2007). 
The lncRNA referred to as TUNA (Tcl1 upstream nuclear associated transcript), 
or Megamind, is approximately 3303 bps in length and composed of three exons 
(RefSeq Accession NR_045047.1) (Amaral et al., 2011, Kersey et al., 2012). Although 
there are multiple orthologs in humans and zebrafish, only one transcript exists in mice. 
The TUNA gene is located on chromosome 12 in mice with the major region of 
sequence conservation between humans, zebrafish, and mice consisting of a stretch of 93 
bp (RefSeq Accession NR_045047.1) (Amaral et al., 2011, Kersey et al., 2012). 
Research in D. rerio shows that, like Cyrano, this lncRNA is expressed in the developing 
brain and eye. Some evidence also exists suggesting that orthologs are found in the 
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brains of humans and mice (Amaral et al., 2011, Ulitsky et al., 2011). Functionally, 
TUNA is required for normal development of the brain and eye in zebrafish. Following 
knockout in zebrafish embryos, resultant fetuses had smaller heads and eyes, enlarged 
brain ventricles, and loss of Neuro-D positive cells in the retina and tectum (Ulitsky et 
al., 2011). More recently, Lin et al. (2014) reported the expression of TUNA in mouse 
embryonic stem cells. The researchers suggest a role for TUNA in the maintenance of 
pluripotency and control of neural cell fate commitment in these cells. Evidence is also 
provided for localization of TUNA to both the nucleus and cytoplasm, regulation of the 
transcript in the brains of Huntington’s patients, and a possible regulatory connection 
between TUNA and Sox2 (Lin et al., 2014). 
 
I.1.2.4  Sox2ot 
 
Sox2ot, or Sox2 overlapping transcript, is an lncRNA located on mouse 
chromosome 3 and partially overlapping the region from which Sox2 is transcribed 
(Amaral et al., 2011, Kersey et al., 2012). It has seven highly conserved regions in its 
sequence that are associated with promoters. Sox2ot consists of five exons and has 
multiple isoforms in mice, humans, amphibians, fish, and other organisms (Amaral et al., 
2011). In total, there are sixteen Sox2ot isoforms in M. musculus, some of which contain 
a sequence corresponding to mir-1897 (Kersey et al., 2012). Total length of the Sox2ot 
sequence considered in these experiments is roughly 2971 bp (RefSeq Accession 
NR_015580.1) (Amaral et al., 2011). 
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This lncRNA is expressed in a variety of tissues and cell types including mouse 
embryonic stem cells, cultured neurospheres, the developing and adult CNS, developing 
zebrafish and chicken neural tissues, and in the human CNS (Mercer et al., 2008, Amaral 
et al., 2009, Mandalos et al., 2012, Boraska et al., 2014, Hou et al., 2014). At this time 
the function of Sox2ot is not fully understood. However, most research on this ncRNA 
species points toward a role in ocular development and defects. In particular, it appears 
to be associated with myopia (Amaral et al., 2009). It is also believed that Sox2ot 
interacts with Sox2. In part this is predicted because of the overlapping nature of the 
coding regions for each transcript. However, there is some experimental evidence of 
such an interaction as well (Amaral et al., 2009, Amaral et al., 2011). This is potentially 
meaningful since Sox2 is critical for early embryogenesis and stem cell pluripotency, 
especially in the CNS (Amaral et al., 2009). At this time, little is known about the 
localization of Sox2ot as the author was unable to find publications that explored this. 
Like the four transcripts of interest already described, the effects of nicotine and ethanol 
on Sox2ot expression has also not been investigated in any cell or tissue type. 
 
I.1.2.5  Emx2os 
 
Similar to Sox2ot, the coding region for Emx2 opposite strand transcript 
(Emx2os) is situated nearby that of Emx2 on chromosome 19 in mice (Amaral et al., 
2011, Kersey et al., 2012). As the name suggests, these coding regions are on the strand 
of DNA opposite that of Emx2. The 5023 bp transcript is made up of four exons (RefSeq 
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Accession NR_002863.2) (Amaral et al., 2011). Unlike the other lncRNAs with multiple 
exons that are considered in this experiment, only one transcript variant is known 
(RefSeq Accession NR_002863.2) (Kersey et al., 2012). Also, unlike the other lncRNAs, 
orthologs of Emx2os in mice and humans maintain conservation of function and 
genomic location but do not maintain any sequence conservation (Amaral et al., 2011). 
There is evidence for Emx2os expression in the developing telencephalon (specifically, 
the periventricular proliferative layers/cortical plate) as well as in periventricular 
precursor cells in which Emx2 is also expressed (Spigoni et al., 2010). Functionally, 
knockdown of this ncRNA has been shown to post-transcriptionally down-regulate 
Emx2 in these cells; ultimately, this suggests a regulatory loop with this transcription 
factor since a similar effect on Emx2os is observed with Emx2 knockdown (Spigoni et 
al., 2010). As with Sox2ot and Sox2, it appears that proximity of genomic coding 
regions yields transcripts that interact closely with one another (Noonan et al., 2003). 
This proposed relationship is important because the homeobox transcription factor Emx2 
is critical for neural development and is believed to contribute to the patterning of the 
neocortex (Boncinelli et al., 1995, Bishop et al., 2000). 
 
I.1.2.6  MIAT 
 
MIAT, or myocardial infarction associated transcript, is conserved in mice, 
humans, chickens, and amphibians. In mice the transcript is roughly 8760 bp long and 
consists of seven exons (RefSeq Accession NR_033657.1; RefSeq Accession 
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NR_003718.2) (Amaral et al., 2011, Kersey et al., 2012). The coding region for this 
transcript is located on chromosome 5 in mice (RefSeq Accession NR_033657.1; 
RefSeq Accession NR_003718.2) (Amaral et al., 2011). Like Emx2os, there only 
appears to be evidence for a single transcript variant despite MIAT having such a long 
sequence and multiple exons (Kersey et al., 2012). MIAT was first described by Ishii et 
al. (2006) when they discovered that dysregulation of this transcript correlated strongly 
with risk of myocardial infarction. However, it is mostly expressed in the nervous 
system with strong evidence for its regulation during retinal development, neural stem 
cell differentiation leading to oligodendrocyte development, and during mouse 
embryonic stem cell differentiation (Blackshaw et al., 2004, Sone et al., 2007, 
Rapicavoli et al., 2010, Aprea et al., 2013, Barry et al., 2013). Within these cells, MIAT 
has been shown to localize to the nucleus (Blackshaw et al., 2004, Mercer et al., 2010, 
Tsuiji et al., 2011, Ishizuka et al., 2014). Functionally, two major pathways have been 
described for MIAT. The first involves its interaction with splicing factor 1 (SF1). SF1 
can bind with UACUAAC repeat sequences found in the transcript; thus, allowing 
MIAT to regulate slicing efficiency by inhibiting spliceosomal complex formation 
(Aprea et al., 2013, Barry et al., 2013, Ishizuka et al., 2014, Shahryari et al., 2014). The 
second suggests that MIAT is involved in a feedback loop with Oct4 in mouse 
embryonic stem cells. Its expression may maintain Oct4 expression and ultimately 
pluripotency (Sheik Mohamed et al., 2010, Shahryari et al., 2014). 
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I.1.2  Specific Aims 
 
In this thesis work, attempts were made to answer the following questions:  1) 
What are the expression levels of the lncRNAs of interest in developing NSCs?  2) How 
is their expression impacted by treatment with ethanol and/or nicotine?  3) Do these 
lncRNAs interact with Ago2 and, by proxy, miRNAs?  4) Do these interactions change 
as a result of exposure to ethanol and/or nicotine?  5) Is the location of lncRNAs and/or 
lncRNA/Ago2 complexes within the nuclear or cytoplasmic compartments of NSCs 
affected by treatment with ethanol and/or nicotine? 
 
  
 24 
 
CHAPTER II 
MATERIALS AND METHODS 
 
II.1  General Methods 
 
II.1.1  Mouse Fetal Cortical Neural Stem Cell Line 
 
Non-adherent neurosphere cultures derived from neural stem cells/neural 
precursor cells (NSCs/NPCs) of the dorsal telencephalic vesicle epithelium of 
gestational day (GD) 12.5 CB57BL/6 mouse fetuses were employed as the model 
system. All cultures were maintained in serum-free Type II C medium consisting of the 
following: DMEM/F12 (1:1; Invitrogen/Life Technologies, Carlsbad, CA), EGF (20 
ng/ml; PeproTech, Rocky Hill, NJ), bFGF (20 ng/ml; Corning Life Sciences, 
Tewksbury, MA), ITS-X (1X; Invitrogen/Life Technologies), heparin (5 µg/ml; Sigma-
Aldrich, St. Louis, MO), LIF (0.15 ng/ml; Alomone, Jerusalem, Israel), progesterone 
(0.02 µM; Sigma-Aldrich), and pen-strep (1%; Invitrogen/Life Technologies). This 
model system was previously published (Santillano et al., 2005, Miranda et al., 2008) 
and closely approximates the conditions encountered by NSCs/NPCs in vivo at this stage 
of development. All neurosphere cultures used in this work were generated from a cryo-
preserved cerebral cortical NSC/NPC line previously established in the laboratory. 
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II.1.2  Neurosphere Culture Generation and Treatment 
 
NSCs were cultured as suspended neurospheres in T-75 plastic tissue culture 
flasks (Corning Life Sciences) in 15-20 ml serum-free Type II C medium following 
previously published procedures (Santillano et al., 2005, Miranda et al., 2008). Cultures 
were passaged no more than 12 times prior to use and were allowed to reach 80-90% 
confluency within a flask before they were passaged or used in an experiment. 
Treatments followed a five day static renewal model wherein 15-20 ml fresh Type II C 
medium doped with the appropriate concentration of the experimental compound of 
interest was added to each flask on the first and third days of the treatment period. 
Incubation occurred at 37 ̊ C and 5% CO2. 
 
II.1.3  Primer Design and Selection 
 
Primers were designed for each lncRNA by obtaining their cDNA sequences 
from NCBI Nucleotide (Benson et al., 2013) and using NCBI PrimerBLAST (Ye et al., 
2012) to generate primer pairs conforming to the following parameters: high target 
specificity; melting temperatures between 67 and 71  ̊C, but within 3  ̊C of one another 
for each primer pair; GC content between 40 and 65%; minimal homo- and hetero-dimer 
formation; minimal hairpin formation; amplicon length between 150 and 350 base pairs 
and primer lengths less than 26 base pairs. Primers were also designed to include the 
most highly conserved regions of the lncRNA sequences of interest in the resulting 
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amplicon. These regions were determined by alignment of mouse, human and zebrafish 
cDNA sequences from NCBI Nucleotide via NCBI BLAST (McGinnis and Madden, 
2004). Finally, PrimerBLAST was set to eliminate any primer pairs showing specificity 
to mouse RefSeq sequences other than the sequence of interest. 
 
 
 
Table 2. Primer Pairs 
 
Target 
 
 
Forward Primer 
 
Reverse Primer 
 
Malat1 
 
 
GGTGGGAATGTAGGAAGTCGGATGAA 
 
AGTGCCAGCCACCAGCGTCTTT 
Cyrano 
 
TGTGCCTCCTCCCTTCTCCATGTAA TTTCTCCTATCCGCAGGGAGACTATCA 
Sox2ot 
 
TCGACAACTCTGCCCTCTCCCTGA TCAGCAAATGCTGTCGTCTCTGGCTA 
TUNA 
 
GCAACCAAGATGGTAATCACGAGTGG ACCCTTGTCTCGTGGCCATCCT 
Emx2os 
 
TTGAAGCCGTTTCCATCCACCAGT CTAGGCAGATGAAGGCAATAGCATGT 
MIAT 
 
GGAGCTCCAAGACCCACAGCCTAGAA TAGGACATGCTCGGGCCAGGTTAGT 
GM7854 
 
CCTGCCCTTGTGGGGTTGGAGGT AGTCACCTCTTTGGGCTGCCAGCTA 
GAPDH 
 
AGTATGTCGTGGAGTCTACTG TGGCAGCACCAGTGGATGCAG 
HPRT1 
 
AAGACTTGCTCGAGATGTCATGAA ATCCAGCAGGTCAGCAAAGAA 
PPIA 
 
CGCGTCTCCTTCGAGCTGTTTG TGTAAAGTCACCACCCTGGCACAT 
 
 
 
 
Once primers had been tailored in PrimerBLAST, the candidate primer pairs 
were also evaluated via Primer3 (Untergasser et al., 2012), IDT Oligo Analyzer 
(Integrated DNA Technologies, Coralville, IA) and OligoPerfect Designer (Life 
Technologies). Primer pairs most closely corresponding to the above criteria were 
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ordered for qPCR. Primers for normalization standards were GAPDH (Kedmi and Orr-
Urtreger, 2007), HPRT1 (Caldwell et al., 2008) and PPIA (Mamo et al., 2007, Carnahan 
et al., 2013). A full list of primers generated for the lncRNAs of interest as well as those 
used as normalization standards can be found in Table 2. 
 
II.1.4  RNA Extraction and Quantification 
 
After the completion of the 5 day treatment period, the contents of each flask 
were pelleted and the medium removed. Following two washes with 1X DPBS (Life 
Technologies), a mirVana miRNA Isolation Kit (Life Technologies) was used to lyse 
cells and extract total RNA according to the manufacturer’s instructions. Briefly, the 
provided lysis buffer was added to pellets and the solutions vortexed to further disrupt 
cell membranes. For organic extraction, a provided miRNA homogenate additive was 
added followed by vortexing and incubation. Then, acid-phenol:chloroform was added 
in a volume equal to that of the sample. The resultant solution was vortexed and 
centrifuged to separate the aqueous and organic phases. The aqueous phase was 
transferred to a new tube and eluted in nuclease free H2O via spin column following two 
washes with provided wash buffers. Total RNA extracts were then assessed for RNA 
content and purity using the A260/280 functionality of a Nanodrop 2000 spectrophotometer 
(Thermo Scientific, Waltham, MA). 
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II.1.5  cDNA Synthesis 
 
qScript cDNA Synthesis kits (Quanta Biosciences, Gaithersburg, MD) were used 
to synthesize cDNA for all qPCR reactions according the manufacturer’s instructions. 
Starting total RNA template concentrations for each cDNA synthesis reaction was 250 
ng/µl. The appropriate volume needed to reach this RNA concentration for each sample 
was combined with 4 µl qScript reaction mix, 1 µl qScript reverse transcriptase and 
enough nuclease free H2O to bring the total solution volume to 20 µl. Cycling was 
performed in a thermal cycler with parameters as follows: 25 ̊ C for 5 min., 42 ̊ C for 30 
min., 85 ̊ C for 5 min. and a hold at 4 ̊ C. The cDNA underwent a 1:16 dilution with 
nuclease free water prior to use in qPCR reactions. Both diluted and undiluted cDNA 
was stored at -20 ̊ C. 
 
II.1.6  qPCR 
 
All qPCR reactions were run using PerfeCTa SYBR Green Fastmix kits with 
ROX (Quanta Biosciences). Reaction volumes were 10 µl (5 µl SYBR Green reaction 
mix, 2 µl nuclease free water, 0.5 µl forward primer, 0.5 µl reverse primer and 2 µl 
cDNA template) and each sample was run in triplicate on a 384-well microplate. Primer 
solutions used for qPCR reactions were working solutions consisting of 1:10 dilutions of 
stock solutions prepared from lyophilized oligo nucleotides (100 µM; IDT and Life 
Technologies). All qPCR was performed on an ABI 7900 HT Real-Time PCR System 
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(Life Technologies) set for ‘Standard Curve (ΔA)’ analysis. Cycling parameters were as 
follows: 50 ̊ C for 2 minutes; 95 ̊ C for 10 minutes; 40 cycles of  95 ̊ C for 15 s, 57 ̊ C for 
30 s, 65 ̊ C for 30 s; a melting/dissociation curve step. 
 
II.1.7  New Primer Validation 
 
To ensure amplification of the intended targets, the products of qPCR reactions 
with whole cell, untreated control templates for each lncRNA primer pair were analyzed 
via Southern Blot and DNA sequencing. For Southern Blotting, 7 µl inputs (6 µl qPCR 
reaction product, 1 µl Laemmeli buffer) were run on 1.5% agarose gels (1.5 g agarose 
(Bio-Rad, Hercules, CA) in 100 mL 1X TBE buffer (Life Technologies)) with ethidium 
bromide (2 µl of 10mg/mL ethidium bromide per 100 mL agarose gel) and 5 µl DNA 
ladder (Invitrogen). The gels were run in 1X TBE running buffer at 90 V for 2 hours 
before visualization under UV light. Bands were excised and purified using a Gel/PCR 
DNA Fragments Extraction kit (IBI Scientific, Peosta, IA). Sequencing was performed 
by the Gene Technologies Laboratory of the Texas A&M University Institute of 
Developmental and Molecular Biology. All purified qPCR reaction products underwent 
sequencing with 8 pmol of primer (lncRNA specific primers as described above; 4 pmol 
forward, 4 pmol reverse) and ABI Big Dye Reaction Mix (PerkinElmer) on an ABI 
PRISM® 3100 Genetic Analyzer (Life Technologies). Product identity was assessed via 
NCBI BLAST (McGinnis and Madden, 2004). 
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II.1.8  Data Analysis 
 
All qPCR data was reported as a Ct value corresponding to each well on a 384-
well microplate. The three Cts produced for each sample (run in triplicate) were used to 
generate a single averaged Ct value for a sample in combination with a given primer 
pair. For the potential normalization standard primer pairs considered, these averaged Ct 
values were input in to the EST Database of Cotton Reference Gene Expression Tool 
and assessed via BestKeeper (Pfaffl et al., 2004), NormFinder (Andersen et al., 2004), 
Genorm (Vandesompele et al., 2002), and the comparative delta-Ct method (Silver et al., 
2006). The two ‘best’ reference genes indicated by Genorm were checked against the 
results of the other three evaluation methods to ensure that their standard deviations were 
below 1.0. Provided these requirements were met, the geometric mean of the two ‘best’ 
reference genes was calculated for each sample. Effect of treatment was then evaluated 
for these geometric mean values using an Independent Samples T-Test or ANOVA. 
Having met these requirements, these geometric mean values were used as the 
normalization values. If these requirements were not met, the geometric mean per 
sample of all potential normalization standards was calculated and assessed for an effect 
of treatment. Again, if the requirements were fulfilled, the geometric mean values of all 
potential reference genes were used as the normalization standard. Normalization 
standard values were then subtracted from the averaged Cts for each sample/lncRNA 
primer pair combination. The resultant normalized Ct values were used to calculate a 2-
ΔΔCt value for each sample that ultimately underwent statistical analysis. 
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SPSS Statistics 22 (IBM, Armonk, NY) was used to conduct all statistical 
analyses. As appropriate, One-way ANOVA (with post hoc Fisher’s LSD tests) and 
Independent Samples T-tests were performed to determine statistical significance of fold 
changes in lncRNA expression resulting from treatment. Grubbs Outlier Tests were 
performed before application of these tests to ensure elimination of outliers in the data. 
 
II.2  lncRNA Expression in Untreated and Ethanol-Treated Neurospheres 
 
Treatment groups for this experiment consisted of twenty untreated control 
samples and twenty samples treated with 320 mg/dl ethanol. Each sample corresponded 
to one treated or untreated T-75 culture flasks. All details of cell culture generation and 
treatment, RNA extraction and quantification, cDNA synthesis and qPCR followed the 
procedures outlined in the ‘General Methods’ section above. Data generated were non-
normally distributed and positively skewed. A logarithmic transformation was 
performed prior to statistical analysis via an Independent Samples T-Test. The 
transcripts used to generate the normalization standard for this experiment were HPRT1 
and PPIA. 
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II.3  lncRNA Expression in Neurospheres Treated with Ethanol, Nicotine and  
Ethanol & Nicotine in Combination 
 
Treatment groups for this experiment are presented in Table 3. Each treatment 
group consisted of four samples corresponding to each of four treated or untreated T-75 
culture flasks. All details of cell culture generation and treatment, RNA extraction and 
quantification, cDNA synthesis, qPCR and data analysis followed the procedures 
outlined in the ‘General Methods’ section above. Transcripts used to generate 
normalization standards for this experiment were GAPDH, HPRT1 and PPIA. 
 
II.4  Prediction of lncRNA and miRNA Interactions 
 
II.4.1  miRBase and NCBI Nucleotide 
 
miRBase (Griffiths-Jones, 2004, Griffiths-Jones et al., 2006, Griffiths-Jones et 
al., 2008, Kozomara and Griffiths-Jones, 2011, Kozomara and Griffiths-Jones, 2014) 
sequences for ethanol-sensitive miRNAs and miRNAs amplified in the Human miRNA 
Array Panels were used along with the sequences obtained from NCBI Nucleotide for 
each lncRNA in order to predict lncRNA/miRNA interactions. 
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Table 3. Ethanol and Nicotine Treatment Groups and Samples Generated 
 
Treatment Group 
 
 
Sample Size (T-75 flask) 
Untreated 4 
320 mg/dl EtOH 4 
 
1 µM Nicotine 4 
320 mg/dl EtOH + 1 µM Nicotine 4 
 
 
 
II.4.2  RNA Hybrid and in silico Analysis of lncRNA/miRNA Interactions 
 
RNA Hybrid Version 2.1 (Rehmsmeier et al., 2004) was used to detect possible 
binding sites of ethanol-sensitive and nicotine-sensitive miRNAs (Sathyan et al., 2007, 
Balaraman et al., 2012) with all six lncRNAs of interest. RNA Hybrid Version 2.2 was 
used to detect possible binding sites of miRNAs amplified in Human miRNA Array 
Panels (Exiqon, Woburn, MA) run to determine possible primer pairs for normalization 
standards in Argonaute RNA immunoprecipitation (RIP) experiments. Binding affinity 
of these miRNAs with TUNA, Emx2os and MIAT (the three lncRNAs assessed in the 
nuclear and cytoplasmic RIP samples) was assessed. In both cases, only those predicted 
binding sites with mfe ≤ -21.0 and conforming to general miRNA target binding rules 
outlined in Grimson et al. (2007), specifically 7mer or 8mer binding with the miRNA 
seed region, were reported as likely interactions. 
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II.5  Ago2 RNA Immunoprecipitation (RIP) 
 
II.5.1  Treatment Groups 
 
Treatment groups in this experiment were identical to those for the ethanol & 
nicotine treatment sample set described in Table 3. An additional set of four untreated 
control samples (0 mg/dl EtOH + 0 µM Nicotine) that did not undergo nuclear and 
cytoplasmic fractionation or RNA immunoprecipitation was also included in analysis for 
this experiment. 
 
II.5.2  Formaldehyde Crosslinking 
 
Each neurosphere culture underwent formaldehyde crosslinking according to a 
previously published procedure (Moran et al., 2012). In brief, neurosphere cultures were 
pelleted following completion of treatment. These pellets were re-suspended in 10 ml 1X 
DPBS (Life Technologies) supplemented with 20% paraformaldehyde solution (Electron 
Microscopy Sciences, Hatfield, PA) to produce a final concentration of 0.3% 
paraformaldehyde. The mixture was incubated at room temperature with gentle rotation 
for 10 minutes. Crosslinking was quenched via the addition of 2M glycine (Sigma-
Aldrich) to produce a final concentration of 0.125 M glycine. Incubation lasted 5 
minutes at room temperature followed by two washes with 1X DPBS. The pellet then 
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either immediately underwent nuclear and cytoplasmic fractionation or was stored at      
-80 ̊ C until fractionation could be performed. 
 
 
 
Table 4. Immunoprecipitation and Fractionation Samples Generated 
  
Fractionation 
 
 
Immunoprecipitation 
U
nt
re
at
ed
 4 Nuclear Fractions 
 
4 Nuclear Supernatants 
4 Nuclear RIPs 
4 Cytoplasmic Fractions 
4 Cytoplasmic Supernatants 
4 Cytoplasmic RIPs 
 
32
0 
m
g/
dl
 
E
tO
H
 4 Nuclear Fractions 
 
4 Nuclear Supernatants 
4 Nuclear RIPs 
4 Cytoplasmic Fractions 
4 Cytoplasmic Supernatants 
4 Cytoplasmic RIPs 
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II.5.3  Nuclear and Cytoplasmic Fractionation 
 
Nuclear and cytoplasmic fractionation was performed on each crosslinked 
sample using the NE-PER Nuclear and Cytoplasmic Extraction kit (Thermo Scientific) 
according to the manufacturer’s instructions. In brief, cell pellets were resuspended in 
100 µl CER I solution and incubated for 10 min. on ice. 5.5 µl CER II solution was 
added prior to a 1 min. incubation on ice and a 5 min. centrifugation at maximum speed. 
The resulting supernatants containing the cytoplasmic fractions from each pellet were 
removed and placed into new centrifuge tubes. The remaining pellets (nuclei-rich) were 
resuspended in 50 µl NER solution and incubated on ice for 40 min. with vortexing 
every 10 min. All samples were centrifuged at maximum speed for ten minutes and the 
supernatants containing the nuclear fraction for each sample removed and placed in new 
tubes. These fractions then either immediately underwent Ago2 RNA 
immunoprecipitation or were stored at -80 ̊ C until immunoprecipitation could be 
performed. Both the CER I and the NER solutions were supplemented with Halt 
protease and phosphatase inhibitor (Thermo Scientific) at a ratio of 10 µl protease 
inhibitor to 1 ml solution. All samples were supplemented with 2.5 µl RNaseOUT 
recombinant ribonuclease inhibitor (Life Technologies) upon addition of CER I solution. 
The samples generated during this step are detailed in Table 4. 
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II.5.4  Ago2 RNA Immunoprecipitation (RIP) 
 
Immunoprecipitation with 50 µl Dynabeads Protein G (Invitrogen/Life 
Technologies) and 5 µl anti-Ago2 antibody (Abcam, Cambridge, MA) was performed on 
all fractions produced during nuclear and cytoplasmic fractionation. One untreated 
control sample (nuclear and cytoplasmic fractions) underwent immunoprecipitation with 
50 µl Dynabeads Protein G and 5 µl anti-alpha tubulin antibody (Sigma Aldrich) to 
serve as a control for Western blotting. All RIPs were performed following the 
Dynabeads Protein G instructions supplemented with steps from Moran et al. (2012). 
Briefly, each nuclear or cytoplasmic fraction was incubated with antibody at 4 ̊ C for 1 
hour and 10 minutes with rotation. Immediately following, the sample/antibody 
solutions were incubated with 50 µl Dynabeads Protein G at 4 ̊ C with rotation for 1 
hour. The Dynabeads were pelleted using a magnetic stand and the supernatants 
transferred to new tubes. The Dynabeads were then washed two times with 200 µl 0.05% 
Tween 20 (Sigma Aldrich) in 1X DPBS and once in 200 µl 0.02 % Tween 20 in 1X 
DPBS. Finally, 100 µl 0.02% Tween 20 in 1X DPBS was added to each supernatant 
sample and used to resuspended each Dynabeads (RIP) sample. A 15 µl aliquot of each 
Dynabeads sample was then taken and stored to be used as inputs for Western blotting. 
The supernatants and the remaining Dynabeads samples (with antibody and associated 
proteins, etc. attached) then either immediately underwent proteinase K 
digestion/uncrosslinking or were stored at -80 ̊ C until these steps could be performed. 
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The 15 µl aliquots of Dynabeads were also stored at -80 ̊ C until Western blotting could 
be performed. The samples generated during this step are summarized in Table 4. 
 
II.5.5  Western Blotting 
 
Western blotting was performed using the Dynabeads aliquots retained at the end 
of the RIP step. This was undertaken in order to validate the success of the 
immunoprecipitation. For each sample, 10 µl of each 15 µl aliquot was combined with 4 
µl Laemmeli buffer and incubated in a 95 ̊ C heat block for 5 min. Samples were then 
loaded with 10 µl Kaleidoscope Prestained Standard protein ladder (Bio-Rad) into two 
17-well NuPAGE Novex 4-12% Bis-Tris Protein Gels (Life Technologies), one with all 
16 nuclear fraction RIP samples and one with all 16 cytoplasmic RIP samples. An XCell 
SureFit electrophoresis chamber (Life Technologies) was used to run the gels with 
MOPS buffer (Teknova, Hollister, CA) for 60 min. at 200 Volts. An iBlot transfer 
system (Life Technologies) was used to transfer proteins to a PVDF membrane (7 min. 
transfer period). The anti-Ago2 antibody used for RIP was used as the primary antibody 
for Western blotting at a ratio of 1:1000. A goat anti-mouse-HRP secondary antibody 
(Santa Cruz Biotechnology, Dallas, TX) was used at a ratio of 1:2500 in conjunction 
with a Western Lightning Plus ECL kit (PerkinElmer, Waltham, MA) and a FluorChem 
Q imaging system (4.19 Megapixels CCD camera, 50 mm, f/0.95 fixed/manual lens; 
ProteinSimple, Santa Clara, CA) for protein detection and quantification. All images 
were captured with an aperture setting of 2.8, a setting of 2.5 and an exposure time of 1 
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min. Each membrane was then stripped with Restore Western Blot Stripping Reagent 
(Life Technologies) and re-probed with anti-alpha tubulin antibody as a control. 
An additional Western blot was run to confirm detection of Ago2. The remaining 
5 µl of the Dynabeads for one sample from each treatment group/fraction combination 
(each with 5 µl Laemmeli buffer) was assessed along with the corresponding tubulin RIP 
samples. All other aspects of the Western blotting process were identical to those 
described above. Gel setups for the Western blots are detailed in Figure 1. Image 
processing was performed using ImageJ (Schneider et al., 2012) and Microsoft 
PowerPoint. Processing with ImageJ included color inversion, auto-adjustment of 
brightness/contrast, smoothing and/or sharpening, despeckling and horizontal flipping. 
The extent of processing performed in PowerPoint was straightening and cropping 
images. 
 
II.5.6  Proteinase K Digestion and Uncrosslinking 
 
All supernatants and Dynabeads/antibody/protein solutions from the nuclear and 
cytoplasmic fractions of each sample underwent proteinase K digestion at 42 ̊ C for 30 
minutes with occasional vortexing. A total volume of 150 µl Proteinase K buffer (117 µl 
0.02% Tween 20 in 1X DPBS, 15 µl 10% SDS in nuclease free H2O, 18 µl proteinase K 
(Sigma Aldrich)) was added to each supernatant and RIP sample prior to incubation. 
Uncrosslinking was then performed on a heat block at 65 ̊ C for four hours with 
vortexing every hour. Supernatants were removed from each RIP sample and placed in 
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new tubes. All samples then either immediately underwent RNA extraction or were 
stored at -80 ̊ C until extraction could be performed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Western Blot Gel Loading Schemes 
 
(a) Original individual nuclear and cytoplasmic RIP blot setup, (b) Follow up blot setup with 
treatment group representative samples from  both nuclear and cytoplasmic RIPs. 
 
 
 
II.5.7  RNA Extraction and Quantification 
 
TRIzol® Reagent (Life Technologies) was used to extract total RNA from each 
nuclear RIP, nuclear supernatant, cytoplasmic RIP and cytoplasmic supernatant sample 
according to the manufacturer’s instructions. Briefly, 500 µl TRIzol® Reagent was added 
to each supernatant and RIP sample prior to incubation at room temperature for 5 min. 
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100 µl chloroform was then added to the supernatant and RIP samples and the contents 
of each tube shaken for 15 seconds. All samples were incubated 2-3 min. and 
centrifuged for 15 min. at 4 ̊ C to separate the aqueous and organic phases. The aqueous 
layers containing RNA were then transferred to new tubes. Due to the relatively small 
sample volumes, 1 µl GlycoBlue carrier (Life Technologies) was added to the aqueous 
phase prior to RNA precipitation. 250 µl 100% isopropanol was added to each 
supernatant and RIP aqueous phase. All samples were incubated at room temperature for 
10 minutes and then centrifuged for 10 min. at 4 ̊ C. Supernatants were removed and the 
pelleted RNA washed with 500 µl 75% ethanol for each supernatant and RIP sample. All 
samples were vortexed and centrifuged for 5 min. at 4 ̊ C followed by air drying of the 
RNA pellets for 10 min. Finally, each RNA pellet was resuspended in nuclease free H2O 
via gentle pipetting and then incubated in a 60 ̊ C heat block for 10 min. Supernatant 
samples were resuspended in 50 µl nuclease free H2O and RIP samples were 
resuspended in 40 µl nuclease free H2O. All total RNA samples were then either 
immediately assessed for RNA content or stored at -80 ̊ C until said analysis could be 
performed. Total RNA content and purity were assessed by A260/280 ratio on a Nanodrop 
2000 spectrophotometer (Thermo Scientific). 
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II.5.8  miRNA Array Panels and Ago2 RNA Immunoprecipitation Normalization 
Standard Selection 
 
Candidate normalization standards were determined for use in qPCR with the 
nuclear and cytoplasmic RIP samples. To find potential standards, a composite nuclear 
RIP sample and a composite cytoplasmic RIP sample were generated (~60-70 ng total 
RNA from each nuclear or cytoplasmic RIP sample) and run on Human miRNA Array 
Panels (Exiqon) to assess which miRNAs were most highly expressed. Expression levels 
were determined by normalizing Ct values of amplified products from each fraction to 
Ct values for each of the products from the Human miRNA Array Panels run with whole 
cell lysate from untreated fetal cortical neurospheres. Commercially available primers 
(Exiqon) were then ordered for the most promising candidates. Primer pairs ordered are 
outlined in Table 5. 
 
II.5.9  cDNA Synthesis, qPCR and Data Analysis 
 
Following cDNA synthesis, each cDNA sample was diluted 1:4 with nuclease 
free H2O prior to use in qPCR. In order to detect even low levels of amplified product, 
50 cycles were run during qPCR instead of 40-45 as previously outlined. All other 
details of cDNA synthesis, qPCR and data analysis followed those described in the 
‘General Methods’ section above. 
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Table 5. Commercial Primer Pairs Assessed as RIP Normalization Standards 
 
Target 
 
 
Catalog Number 
 
mirBase ID 
 
Fraction 
 
hsa-mir-490-3p 
 
205875 
 
MIMAT0002806 
 
Both 
 
mmu-mir-346 
 
205158 
 
MIMAT0000597 
 
Nuclear 
 
hsa-mir-30a* 
 
204457 
 
MIMAT0000088 
 
Both 
 
mmu-mir-9* 
 
204620 
 
MIMAT0000442 
 
Cytoplasmic 
 
SNORD49A 
 
 
203904 
 
N/A 
 
Nuclear 
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CHAPTER III 
EXPERIMENTAL RESULTS 
 
III.1  Primer Validation 
 
 In order to assess expression levels of Malat1, Cyrano, Sox2ot, TUNA, Emx2os, 
MIAT, and GM7854 via qPCR, transcript-specific primer pairs were required. After 
searching the primary literature and commercially available primer sets it was 
determined that primers would need to be designed and analyzed for specificity. 
Following qPCR on cDNA from untreated neurosphere cultures, Northern blotting and 
DNA sequencing were performed on reaction products for each primer pair generated. 
All but one of these primer sets successfully amplified the target transcript when 
sequences were assessed for identity matches to the RefSeq database using NCBI 
BLAST (McGinnis and Madden, 2004). 
Primer pairs for Malat1, TUNA, Emx2os, and MIAT all yielded amplification 
products with the highest sequence cover and identity matches corresponding to the 
NCBI accession number and sequence used to design them. Sequence cover matches and 
sequence identity matches for these lncRNAs and primers were as follows: Malat1, 
cover = 70%, identity = 97%; TUNA, cover = 96%, identity = 99%; Emx2os, cover = 
98%, identity = 99%; MIAT, cover = 98%, identity = 85%. While it did not yield an 
amplicon with a hit to the RefSeq database or the NCBI accession number used to design 
the primer set, the primer pair for Cyrano did result in a product with high sequence 
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cover and identity matches to several closely associated transcripts. The M. musculus 
RIKEN cDNA 1700020I14 clone:M5C1004K09 (AK147270.1), M. musculus RIKEN 
cDNA 1700020I14 clone:5031400H20 (AK030275.1), M. musculus RIKEN cDNA 
1700020I14 clone:4732497J20 (AK029148.1), and M. musculus RP23-22A15.2 gene 
(HG978614.1) all yielded a 92% cover match and a 100% identity match with the 
product. BLAST comparison of these transcripts with the transcript used to design the 
Cyrano primer set (NR_027832.1) resulted in the following sequence cover and identity 
matches: AK147270.1, cover = 97%, identity = 100%; AK030275.1, cover = 96%, 
identity = 99%; AK029148.1, cover = 96%, identity = 100%; HG978614.1, cover = 
98%, identity = 100%. Thus, it was concluded that the target lncRNA was successfully 
amplified. 
Similarly, primers for Sox2ot yielded a product without a BLAST hit to the 
RefSeq database or the NCBI accession used in their design. However, 
OTTMUST00000095020.1/Sox2ot gene (HG978904.1) and cDNA RIKEN 
clone:633044I21 (AK031919.1) both had a sequence cover match of 77% and identity 
match of 98%. When compared with the Sox2ot sequence used to design the primers, 
(NR_015580.1) sequence cover was 19% and sequence identity was 100%. Though 
these results were less convincing than those for Cyrano, the fact that one of the major 
hits was called “Sox2ot”, and that it is believed M. musculus Sox2ot has 16 isoforms, it 
was concluded that the primer set was specific to the target lncRNA (although 
presumably to an isoform other than that used to design the primers). 
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Unlike the rest of the primer sets, the primer pair for GM7854 yielded its highest 
cover and identity match with a transcript completely unrelated to the target. Results 
indicated a 95% sequence cover match and an 88% sequence identity match with the 
predicted M. musculus LOC102638050 noncoding RNA (XR_401556.1). In contrast, the 
sequence cover match with GM7854 (NR_028417.1) was 17% and the identity match 
was 96%. Therefore, GM7854 was not considered in subsequent experimentation. 
Percentage sequence cover and identity matches for each target transcript and associated 
primer pair are outlined in Table 6.  
 
 
 
Table 6. Sequence Cover and Identity Matches of Primer Pairs and lncRNAs 
 
Target 
 
 
Product Coverage Match (%) Product Identity Match (%) 
 
NCBI Accession Match 
 
Malat1 
 
70 
 
97 
 
NR_002847.2 
 
Cyrano 
 
92 
 
100 
 
AK147270.1 
AK030275.1 
AK029148.1 
HG978614.1 
 
Sox2ot 
 
86 
 
95 
 
AK031919.1 
HG978904.1 
 
TUNA 
 
96 
 
99 
 
NR_045047.1 
 
Emx2os 
 
98 
 
99 
 
NR_002863.2 
 
MIAT 
 
98 
 
85 
 
NR_033657.1 
NR_003718.2 
 
GM7854 
 
17 96 NR_028417.1 
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III.2  lncRNA Expression in Untreated and Ethanol-Treated Neurospheres 
 
With validated primer pairs for the majority of the lncRNAs of interest, the next 
step was to determine their baseline expression levels in NSCs and discover whether or 
not any of the transcripts exhibited ethanol sensitivity. qPCR successfully amplified the 
lncRNAs of interest in both control and EtOH-treated samples. Figure 2 shows the 
expression levels of each transcript in EtOH-treated and untreated neurospheres. 
Relative expression levels (average 2-ΔΔCt) of the six lncRNAs in untreated NSCs were 
as follows: Malat1, 1.40; Cyrano, 1.46; Sox2ot, 2.01; TUNA, 1.95; Emx2os, 1.73; 
MIAT, 2.34. Statistical analysis revealed no significant difference in expression levels of 
the six lncRNAs between untreated controls and EtOH-treated samples (Independent 
Samples T-Test: Malat1, p = 0.420; Cyrano, p = 0.633; Sox2ot, p = 0.594; TUNA, p = 
0.212; Emx2os, p = 0.660; MIAT, p = 0.859). These results indicated that none of the 
transcripts of interest were ethanol-sensitive. 
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Figure 2. Expression of lncRNAs in EtOH-Treated Neurospheres. 
 
Mean relative expression levels of the six lncRNAs of interest under two treatment conditions: 0 mg/dl 
EtOH and 320 mg/dl EtOH. *Statistical significance at α= 0.05. 
 
 
 
III.3  lncRNA Expression in Neurospheres Treated with Ethanol, Nicotine, and 
Ethanol & Nicotine in Combination 
 
Despite no effect of EtOH exposure on the expression of Malat1, Cyrano, 
Sox2ot, TUNA, Emx2os, or MIAT, research continued to assess possible effects of the 
developmental teratogen nicotine on these RNA species in NSCs. Experimentation also 
considered the effect of nicotine and EtOH exposure in combination. Significant 
differences in expression were observed for all transcripts except Sox2ot (ANOVA: 
Malat1, p = 0.032; Cyrano, p = 0.013; Sox2ot, p = 0.079; TUNA, p = 0.012; Emx2os, p 
= 0.038; MIAT, p = 0.013). Consistent with the previous experiment, no effect of 
treatment was observed for expression of these lncRNAs following EtOH exposure 
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alone (LSD: Malat1, p = 0.736; Cyrano, p = 0.553; Sox2ot, p = 0.466; TUNA, p = 0.829; 
Emx2os, p = 0.536; MIAT, p = 0.326). However, exposure to nicotine resulted in a 
significant downregulation of all the lncRNAs except Sox2ot and Emx2os (LSD: 
Malat1, p = 0.023; Cyrano, p = 0.025; Sox2ot, p = 0.107; TUNA, p = 0.015; Emx2os, p 
= 0.051; MIAT, p = 0.042). Exposure to both nicotine and EtOH in combination also 
resulted in a significant downregulation of transcript expression for Cyrano (p = 0.027), 
TUNA (p = 0.017), and MIAT (p = 0.044). This downregulation was not significantly 
different from that observed with nicotine alone for these three RNA species (Cyrano, p 
= 0.979; TUNA, p = 0.953; MIAT, p = 0.980). Despite a significant ANOVA result for 
Emx2os, the only differences observed were between EtOH treatment and treatment 
with both nicotine and nicotine and EtOH in combination (LSD: EtOH v Nic, p = 0.016; 
EtOH v EtOH+Nic, p = 0.026). These results are presented graphically in Figure 3. 
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Figure 3. Expression of lncRNAs in EtOH- and Nicotine-Treated Neurospheres. 
 
Mean expression levels of six lncRNAs of interest under four treatment conditions. * Denotes 
statistical significance at α= 0.05. 
 
 
 
III.4  Prediction of lncRNA and miRNA Interactions 
 
III.4.1  Teratogen-sensitive miRNAs 
 
Previous research in neurosphere cultures and neurodevelopmental cancer cells 
determined the existence of several EtOH-sensitive and nicotine-sensitive miRNAs 
(Sathyan et al., 2007, Huang and Li, 2009, Balaraman et al., 2012). These include miR-
140-3p, miR-153-3p, miR-21, miR-335-3p, and miR-9. Table 7 provides a brief 
overview of these five miRNAs to include their miRBase Accession numbers. 
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Table 7. Ethanol-Sensitive and Nicotine-Sensitive miRNAs. 
 
miRNA 
 
 
EtOH and Nicotine Effects in Neurospheres 
 
miRBase Accession 
 
mmu-miR-140-3p 
 
Suppressed by 320 mg/dl EtOH (Balaraman et al. 
2012), induced by 1µM nicotine (Balaraman et al. 
2012). 
 
 
 
MIMAT0000152 
mmu-miR-153-3p Suppressed by 320 mg/dl EtOH (Sathyan et al. 2007, 
Balaraman et al. 2012), induced by 1µM nicotine 
(Balaraman et al. 2012). 
 
MIMAT0000163 
 
mmu-miR-21 
 
Suppressed by 320 mg/dl EtOH (Sathyan et al. 2007, 
Balaraman et al. 2012), induced by 60 mg/dl EtOH 
(Sathyan et al. 2007), induced by 1µM nicotine 
(Balaraman et al. 2012). 
 
 
 
MIMAT0000530 
mmu-miR-335-5p Suppressed by 320 mg/dl EtOH (Sathyan et al. 2007, 
Balaraman et al. 2012), induced by 1µM nicotine 
(Balaraman et al. 2012). 
 
 
MIMAT0000766 
mmu-miR-9 
 
Suppressed by 320 mg/dl EtOH (Sathyan et al. 2007, 
Balaraman et al. 2012), induced by 1µM nicotine 
(Balaraman et al. 2012). 
 
MIMAT0000142 
 
 
 
Using the RNAhybrid in silico analysis tool, the six lncRNAs of interest were 
assessed for potential binding sites with the seed regions of these EtOH- and nicotine-
sensitive miRNAs. Of these miRNAs, miR-335-3p was the only one without any 
predicted interactions with the transcripts of interest. All of the other miRNAs had at 
least one predicted interaction. The EtOH/nicotine-sensitive miRNA with the most 
predicted interactions was miR-9. It had nine predicted interactions each with Malat1 
and MIAT, five with TUNA, and one each with Cyrano and Sox2ot. miR-140-3p was 
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the only miRNA to have predicted interactions with all six lncRNAs of interest. All 
predicted EtOH/nicotine-sensitive miRNA/lncRNA interactions are presented in Figure 
4. 
 
 
 
 
 
Figure 4. Predicted Interactions of EtOH-Sensitive miRNA and lncRNA. 
 
Heatmap depicting predicted miRNA/lncRNA interactions between the six lncRNAs of interest and 
previously discovered EtOH-sensitive miRNAs. 
 
 
 
III.4.2  Microarray Amplified miRNAs 
 
Human miRNA Array Panels were run with pooled nuclear RIP and cytoplasmic 
RIP samples. The purpose of this was two-fold: 1) to find candidates for normalization 
standards for Ago2 RIP qPCR and 2) to determine miRNA species actively associated 
with RISC that could be assessed for predicted interactions with some of the lncRNAs of 
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interest. Only TUNA, Emx2os, and MIAT interactions were considered at this phase 
because these were the only lncRNAs to be assessed during Ago2 RIP qPCR. 
Of the 52 miRNAs amplified from the nuclear RIP fraction, three were 
EtOH/nicotine-sensitive lncRNAs. These included miR-140-3p, miR-21, and miR-9. 
The only miRNAs without any predicted interactions with the three lncRNAs of interest 
were miR-21, miR-218-1*, miR-495, miR-543, and miR-598. In general, MIAT had the 
most predicted interactions. Those miRNAs exhibiting the greatest number of predicted 
interactions were let-7b (TUNA = 1, Emx2os = 3, MIAT = 12), miR-185* (TUNA = 12, 
Emx2os = 10, MIAT = 24), miR-141* (TUNA = 5, Emx2os = 2, MIAT = 6), miR-29b-
1* (TUNA = 3, Emx2os = 6, MIAT = 13), miR-30a* (TUNA = 2, Emx2os = 5, MIAT = 
13), miR-431* (TUNA = 0, Emx2os = 5, MIAT = 9), miR-760 (TUNA = 0, Emx2os = 7, 
MIAT = 18), miR-877* (TUNA = 2, Emx2os = 1, MIAT = 14), and miR-9 (TUNA = 5, 
Emx2os = 0, MIAT = 9). Full details regarding the 52 miRNAs amplified and their 
predicted interactions with TUNA, Emx2os, and MIAT can be found in Figure 5. 
A total of 89 miRNAs were amplified following analysis of the pooled 
cytoplasmic RIP fraction via Human miRNA Array Panels. Once again, the 
EtOH/nicotine-sensitive miRNAs miR-140-3p, miR-21, and miR-9 were among those 
actively associated with the RISC component Ago2. Thirteen miRNAs showed no 
predicted interactions with TUNA, Emx2os, and MIAT. These included miR-10a*, miR-
126*, miR-15b, miR-181a, miR-181b, miR-186, miR-21, miR-218-1*, miR-374b, miR-
424, miR-543, miR-598, miR-9*, and miR-98. The miRNAs with the most predicted 
interactions were let-7b (TUNA: 1, Emx2os: 3, MIAT: 12), miR-103-2* (TUNA: 7, 
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Emx2os: 6, MIAT: 26), miR-130b* (TUNA: 2, Emx2os: 2, MIAT: 14), miR-141* 
(TUNA: 5, Emx2os: 2, MIAT: 7), miR-182* (TUNA: 2, Emx2os: 4, MIAT: 10), miR-
29b-1* (TUNA: 3, Emx2os: 6, MIAT: 13), miR-30a* (TUNA: 2, Emx2os: 5, MIAT: 
13), miR-486-3p (TUNA: 4, Emx2os: 8, MIAT: 10), miR-491-5p (TUNA: 8, Emx2os: 6, 
MIAT: 11), miR-708 (TUNA: 2, Emx2os: 1, MIAT: 18), miR-877* (TUNA: 2, Emx2os: 
1, MIAT: 15), miR-9 (TUNA: 5, Emx2os: 0, MIAT: 9), and miR-93* (TUNA: 1, 
Emx2os: 3, MIAT: 9). Information on the other amplified miRNAs and their predicted 
interactions with TUNA, Emx2os, and MIAT can be found in Figure 6. 
 
 
 
 
 
Figure 5. Predicted Interactions of miRNA and lncRNA in Nuclear RIP Fractions. 
 
Heatmap depicting predicted miRNA/lncRNA interactions between TUNA, Emx2os and MIAT and the 
miRNAs amplified from a pooled nuclear RIP sample run on Human miRNA Array Panels. 
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Figure 6. Predicted Interactions of miRNA and lncRNA in Cytoplasmic RIP Fractions. 
 
Heatmap depicting predicted miRNA/lncRNA interactions between TUNA, Emx2os and MIAT and the 
miRNAs amplified from a pooled cytoplasmic RIP sample run on Human miRNA Array Panels. 
 
 
 
When considering both nuclear RIP and cytoplasmic RIP samples, miR-218-1*, 
miR-543, miR-21, and miR-598 that amplified in Human miRNA Array Panels were the 
only miRNAs without any predicted interactions with the three lncRNAs of interest. 
EtOH/nicotine-sensitive miRNAs miR-140-3p and miR-9 were amplified in both 
fractions and exhibited predicted interactions with at least two of the three lncRNAs. 
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Table 8. Human miRNA Array Panel Amplified miRNAs 
 
Amplified in Nuclear RIP 
Fraction Only 
 
Amplified in Both Nuclear and 
Cytoplasmic RIP Fractions 
 
 
Amplified in Cytoplasmic RIP 
Fraction Only 
 
 
miR-431* 
 
miR-346 
 
let-7a 
 
miR-30e* 
miR-196b* miR-29b-1* let-7d miR-324-5p 
miR-185* miR-490-3p let-7f miR-330-3p 
miR-328 let-7d* let-7g miR-340* 
miR-412 let-7b let-7i miR-342-3p 
miR-99b* miR-30a* miR-103-2* miR-34b 
miR-501-5p miR-140-3p miR-106a miR-34b* 
miR-181c* let-7c miR-10a* miR-362-3p 
miR-224* miR-543 miR-125a-5p miR-374b 
miR-222 miR-1247 miR-125b miR-409-5p 
miR-15b* miR-9 miR-126* miR-424 
miR-574-3p miR-654-3p miR-130b* miR-486-3p 
miR-302a miR-744* miR-139-5p miR-491-5p 
miR-296-5p miR-21a-5p miR-152 miR-504 
miR-103 miR-708* miR-15b miR-532-3p 
miR-495 miR-141* miR-181a miR-532-5p 
let-7c* miR-484 miR-181b miR-582-3p 
miR-760 miR-16 miR-182* miR-708 
miR-493 miR-362-5p miR-186 miR-875-3p 
 miR-1224-3p miR-187 miR-9* 
 miR-300 miR-191 miR-92a 
 miR-23b miR-195* miR-93* 
 miR-598 miR-200a* miR-98 
 miR-134 miR-20a miR-99a 
 miR-450b-3p miR-210 miR-99b 
 miR-324-3p miR-23a  
 miR-93 miR-25  
 miR-218-1* miR-27a  
 miR-19a miR-28-3p  
 miR-671-5p miR-30b  
 miR-877* miR-30c  
    
 
 
 
Thirty-one miRNAs were amplified from both the nuclear and cytoplasmic RIP 
fractions. However, the miRNAs listed in Table 8 were not the only amplified miRNAs. 
A total of 37 miRNAs in the nuclear and cytoplasmic RIPs were amplified in the Human 
miRNA Array Panels but were either dead entries in miRBase or the human miRNA did 
 57 
 
not have a mouse correlate. As such, the 52 miRNAs amplified from nuclear RIPs and 
the 89 miRNAs amplified from cytoplasmic RIPs considered were those with mouse 
correlates that closely matched the corresponding human miRNA. All miRNAs assessed 
for potential interactions with TUNA, Emx2os, and MIAT had Ct values less than 45 
with a mean Ct of 35.89 for the nuclear RIP sample and 34.94 for the cytoplasmic RIP 
sample. The miRNA with the highest Ct value for nuclear RIPs was miR-493 while the 
lowest Ct value was for miR-346. For the cytoplasmic RIPs the highest Ct value 
corresponded to miR-491-5p and the lowest Ct was associated with miR-9. 
  
III.5  Ago2 RNA Immunoprecipitation (RIP) 
  
III.5.1  miRNA Microarray Panels and Normalization Standard Selection 
 
The miRNAs amplified in the nuclear and cytoplasmic RIP fractions were 
assessed for use as possible normalization standards for the RIP fractions during Ago2 
RNA immunoprecipitation qPCR analysis. While previous research (Chi et al., 2009) 
has provided some idea of miRNA transcripts predicted to associate with Argonaute 
proteins and RISC, no experimental evidence could be found in the primary literature 
regarding such associations in nuclear or cytoplasmic fractions. As such, it was 
necessary to determine RNA species present in the RIP fractions that could serve as 
normalization standard candidates. 
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Of the 110 miRNAs amplified in the Human miRNA Array Panels from the 
nuclear and cytoplasmic fractions, five were selected as potential normalization 
standards. These included miR-346, miR-490-3p, miR-877*, miR-9*, and miR-30a*. All 
of these miRNAs were amplified in both fractions except miR-9*, which was only found 
in the cytoplasmic RIP. Ct values for these miRNAs in the composite RIP samples were 
between 32 and 36. Commercially available primer sets from Exiqon were purchased for 
each of these miRNAs and assessed via qPCR with untreated control and fractioned RIP 
samples. 
 
III.5.2  Western Blotting 
 
Following co-IP with Ago2, Western blotting was performed to verify that Ago2 
was successfully pulled down. According to the vendor of the anti-Ago2 antibody, a 
positive Western blot using their antibody yields a band at approximately 85 kDa. For 
both the nuclear and cytoplasmic RIP blots, a band was confirmed at ~85 kDa for all 
samples in which anti-Ago2 was the antibody used for pulldown (Figure 7). Further 
validating this result was the lack of such a band in lanes corresponding to RIP samples 
utilizing anti-tubulin as the antibody for pulldown. The same results were observed for 
the combined nuclear and cytoplasmic RIP gel. Blots for all three setups are presented in 
Figures 7 and 8. Based on these positive results, it was concluded that the Ago2 co-IPs 
were successful and all qPCR results could be interpreted as lncRNA expression levels 
associated with Ago2. 
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Figure 7. Nuclear and Cytoplasmic RIP Western Blotting. 
 
(a) Cytoplasmic RIP blot probed with anti-Ago2 antibody, (b) NuclearRIP blot probed with anti-Ago2 
antibody, (c) Western blot with treatment group representative samples from both nuclear and 
cytoplasmic RIPs. Colored sections showing the protein ladder are from images of the blots taken with 
a standard camera aligned with the blots. 
 
 
 
III.5.3  qPCR 
 
With strong evidence that the Ago2 RIP was successful, the remaining objectives 
were three-fold: 1) determine whether or not TUNA, Emx2os, or MIAT were present in 
the nuclear or cytoplasmic RIP fractions, 2) assess any possible effects of treatment on 
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interactions between these lncRNAs and Ago2, and 3) quantify the relative levels of 
these lncRNAs associated with Ago2 in each fraction. To these ends qPCR was 
performed on the nuclear and cytoplasmic RIPs, nuclear and cytoplasmic supernatants, 
and control samples. 
Despite consistent amplification of all three lncRNAs in the whole cell-derived 
control samples, qPCR yielded inconsistent amplification of TUNA, Emx2os, and MIAT 
in all fraction and treatment group combinations. With a cutoff Ct value for 
amplification of 35, none of the lncRNAs of interest had enough samples in each 
treatment group and fraction combination amplify. This meant that no additional 
analyses could be performed. Thus, little could be concluded about potential interactions 
between the lncRNAs and Ago2 in NSCs. Additionally, nothing could be assessed with 
regard to effect of treatment on lncRNA/Ago2 complexation or localization. 
Specifics of the amplification that was observed is detailed in Figure 8. In the 
nuclear RIPs, all three lncRNAs exhibited little to no expression. When all reactions 
were considered for the individual transcripts of interest, it was clear that TUNA had the 
greatest number of amplified wells. Yet, none of the control wells exhibited 
amplification except those for the tubulin pull-down control. Results of the cytoplasmic 
RIPs were similar with limited amplification overall and TUNA exhibiting the greatest 
number of amplified wells compared to the other two transcripts. MIAT showed 
absolutely no amplification in either of the RIP fractions. Conversely, both TUNA and 
Emx2os had at least two wells with reaction products in each of the RIP samples. 
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Figure 8. Amplification of lncRNAs in Ago2 RIP-Derived Samples. 
 
Set of tables outlining the specific amplification from the nuclear and cytoplasmic Ago2 fraction and 
treatment group combinations  for TUNA (a), Emx2os (b), and MIAT (c). All values indicate the 
number of wells. 
 
a 
b 
c 
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Amplification in the supernatants remained inconsistent for all three transcripts. 
However, the total number of amplified wells observed for each of the lncRNAs was 
greater than that seen with the RIPs. In the nuclear supernatants, amplification of TUNA 
wells for the ethanol and ethanol + nicotine treatment groups was nearly complete. 
Amplification in the controls and nicotine samples were also more consistent than in the 
RIPs. The cytoplasmic supernatant fractions also yielded greater overall amplification. 
Consistency of amplification was little improved. Once again, TUNA had more 
amplified wells than Emx2os and MIAT. Despite this, overall amplification of TUNA in 
the cytoplasmic supernatants was slightly less than that observed in the nuclear 
supernatants. Unlike in the two RIP fractions, MIAT amplification occurred. This 
amplification was mainly observed in the nuclear supernatant with at least one well 
amplified in each treatment group. 
It was unclear whether or not the limited and inconsistent amplification observed 
for TUNA, Emx2os, and MIAT was unique to these transcripts or if this was indeed a 
global effect on all RNA.. If it were observed for all RNA species it might suggest a 
general loss or degradation of RNA at some point in the experimental process. As such, 
attention was shifted to the RNA species which were chosen as normalization standards 
for each fraction. For the cytoplasmic supernatant samples, the ribosomal RNA 18S was 
to be employed. It was successfully amplified in all treatment groups including controls. 
The small nuclear RNA U6 was intended to serve as a nuclear supernatant normalization 
standard. As with 18S, U6 was expressed in all controls and supernatants. However, it 
was more highly expressed in whole cell controls than in any of the fractions. As 
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described above, several miRNAs were assessed as possible normalization standards for 
the RIP samples. After some preliminary qPCR runs, miR-490-3p was selected as the 
normalization standard for both the nuclear and cytoplasmic RIPs. In the nuclear RIPs, 
this RNA species was amplified in all whole cell controls and in all RIP samples except 
the untreated tubulin RIP control and one nicotine + EtOH-treated sample. For the 
cytoplasmic RIPs, miR-490-3p was expressed in all whole cell controls, the untreated 
tubulin RIP, and all RIP treatment groups. However, it was not amplified in two 
nicotine-treated RIPs or in one sample from both the EtOH-treated and the nicotine + 
EtOH-treated groups. These results strongly suggested that the inconsistent amplification 
seen with the three lncRNAs was not universal for all RNA. Additionally, it does not 
appear that this inconsistent amplification was due to loss of RNA species during the 
extraction, fractionation, or RIP steps. 
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CHAPTER IV  
SUMMARY AND DISCUSSION 
 
The aims of this thesis work were multifold. First, determine the expression 
levels of Malat1, Cyrano, Sox2ot, TUNA, Emx2os, MIAT, and GM7854 in developing 
NSCs. Second, assess whether or not expression levels of these lncRNAs change in 
NSCs following exposure to ethanol and/or nicotine. Third, investigate if any of the 
lncRNAs interact with Argonaute 2 (and miRNAs by proxy) and where within 
neurosphere cells these complexes localize. Finally, determine whether or not treatment 
with ethanol and/or nicotine results in changes in interactions between the lncRNAs and 
Ago2 and compartmentalization of these complexes. Discussion of the major findings 
regarding each of these aims follows. 
 
IV.1  lncRNAs in Fetal Cortical NSCs: Validated Primers and Baseline Levels of 
Expression 
 
While preparing to undertake this thesis work an initial difficulty was the lack of 
previously designed and validated primer pairs. Despite a search of the primary 
literature, few prior investigations of the seven lncRNAs of interest (Malat1, Cyrano, 
Sox2ot, TUNA, Emx2os, MIAT, and GM7854) yielded reliable primers for these 
transcripts. Reasons for this fell into one of two categories: 1) There was no previous 
research assessing expression of these lncRNAs via qPCR or 2) Provided primer pair 
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sequences were designed for non-mouse models and proved to have suboptimal 
specificity. For instance, Ulitsky et al. (2011) details expression of both Cyrano and 
TUNA in zebrafish embryos and investigates the functional roles of these two lncRNAs 
in this model organism. However, all of the expression data is based on in situ 
hybridization so no primers were provided. In Tano et al. (2010), expression of Malat1 
was assessed in human A549 lung cancer cells and primer pairs were provided in the 
supplemental information. When these primers were assessed via PrimerBLAST for 
specificity to the mouse transcript, too many non-specific matches were returned for the 
primer set to be deemed useful. In the case of GM7854, no research had been conducted 
on the transcript so finding validated primer pairs was not an option. A final issue with 
the available primer pairs was that PrimerBLAST analysis revealed that they did not 
flank conserved regions of the target transcripts. Encompassing these regions in the 
amplicon was a priority because their inclusion would likely improve specificity while 
also increasing the relevance of experimental results to other species. Therefore, it was 
necessary to design primer pairs for all of the lncRNAs of interest and to validate their 
target specificity before any other experimentation could proceed. 
Six of the seven primer pairs designed for use in this work proved to be highly 
specific to the intended targets; only GM7854 was dropped from subsequent 
experimentation. Sequencing of the amplified qPCR products of primers for Malat1, 
TUNA, Emx2os, and MIAT revealed sequence cover matches of at least 70% and 
identity matches of at least 85% when compared with the design sequences via BLAST. 
Interestingly, following BLAST analysis, the transcript sequence used to design the 
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Cyrano primers did not show any direct cover or identity matches with the qPCR 
products. However, the transcripts with the highest sequence matches to these qPCR 
products exhibited at least 96% cover and 99% identity matches with the Cyrano 
sequence used in primer design. Sox2ot qPCR primer products also showed no BLAST 
match to the design sequence. The products did exhibit a 77% cover match and a 98% 
identity match with a different transcript designated as the 
OTTMUST00000095020.1/Sox2ot gene, however. BLAST analysis of this transcript 
sequence with the design sequence resulted in a cover match of only 19%. However, this 
19% of shared sequence had a 100% identity match to the Sox2ot transcript used in 
primer design. 
As was briefly discussed in the Experimental Results chapter, the most likely 
explanation for this seeming lack of specificity is that the primers amplified a different 
isoform of Sox2ot. Evidence suggests there are 16 different Sox2ot isoforms in M. 
musculus, resulting from multiple transcription start sites spread across five exons 
(Amaral et al., 2011, Kersey et al., 2012). Since all of the primer pairs designed for this 
thesis work sought to capture a highly conserved region of the transcript of interest, it 
would make sense that the products could represent several of the 16 isoforms. With that 
being said, the isoform represented by the original design sequence may indeed have 
been among the amplified products but was not the transcript amplified by this primer 
pair. This might suggest that the various Sox2ot isoforms could be differentially 
expressed depending on cell or tissue type, developmental context, or any number of 
other factors. As such, an interesting avenue for additional research could be to assess 
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the expression levels of the individual Sox2ot isoforms instead of overall Sox2ot 
expression, as was done in these investigations. 
Regardless, a major contribution of the work presented in this thesis is the design 
and validation of these six primer pairs. There are now reliable primer sequences that 
include conserved regions of each transcript available for other investigators to use in 
their experiments. With these primer pairs others can immediately begin projects on 
Malat1, Cyrano, Sox2ot, TUNA, Emx2os, or MIAT without spending time and effort on 
the design and validation of their own original primer sets. Hopefully this will increase 
overall research on these six lncRNAs by making it easier to study them. This is 
especially important for Cyrano, TUNA, and Emx2os which have received limited 
attention to date. 
Moving past the primers and on to the major aims of this thesis, results of these 
experiments indicate that Malat1, Cyrano, Sox2ot, TUNA, Emx2os, and MIAT are all 
expressed in NSCs derived from the developing cortex of GD 12.5 mice. All six 
lncRNAs were amplified in untreated NSCs. Average relative expression levels of 
between 1.4 and 2.4 (2-ΔΔCt) were obtained for these RNA species when normalized to 
the geometric mean of HPRT1 and PPIA. Another experiment in this thesis work yielded 
slightly different relative expressions for the six lncRNAs in untreated NSCs utilized as 
controls. Not counting normal variation in expression of transcripts in each flask of 
cultured neurospheres, this discrepancy is likely owed to two factors. First, the 
normalization standards used in the two experiments were different; the subsequent 
experiment used the geometric mean of HPRT1, PPIA, and GAPDH expressions. 
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Second, the sample size used to obtain the expression levels reported above was larger 
than that used in later experiments. Therefore, it is reasonable to believe that the 
expression levels obtained in the initial experiment are a better representation of actual 
expression levels of Malat1, Cyrano, Sox2ot, TUNA, Emx2os, and MIAT in this model 
system. With that being said, the differences in relative expression levels for each 
lncRNA obtained in the two experiments was less than 1.0 (2-ΔΔCt). 
The results of these experiments do not represent the first reports of Malat1, 
Cyrano, Sox2ot, TUNA, Emx2os, or MIAT in neural tissues and stem cells. Multiple 
studies have detailed their expression in the developing mouse nervous system, mouse 
ESCs, and in the adult mouse brain (Blackshaw et al., 2004, Sone et al., 2007, Dinger et 
al., 2008, Mercer et al., 2008, Amaral et al., 2009, Bernard et al., 2010, Mercer et al., 
2010, Rapicavoli et al., 2010, Sheik Mohamed et al., 2010, Spigoni et al., 2010, 
Nakagawa et al., 2012, Onoguchi et al., 2012, Zhang et al., 2012, Aprea et al., 2013, 
Barry et al., 2013, Boraska et al., 2014). For instance, TUNA expression was observed in 
undifferentiated mouse embryonic stem cells and upregulated in these cells under a 
neural differentiation regime (Lin et al., 2014). Sheik Mohamed et al. (2010) found that 
MIAT was expressed in E14 mouse ESCs. Another study determined that Malat1 was 
present in adult mouse cortex, cerebellum, and hippocampus via in situ hybridization 
(Nakagawa et al., 2012). Additionally, Sox2ot is expressed in stem cells and 
proliferating progenitor cells from the adult mouse subventricular zone (Amaral et al., 
2009). Expression of the lncRNAs of interest has also been observed in neuroblastoma 
cell lines, the brains of patients suffering from neurological diseases, the brains of drug 
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abusers, the normal adult nervous system, and neural tissues of chicken and zebrafish 
embryos (Albertson et al., 2006, Amaral et al., 2009, Koshimizu et al., 2010, 
Michelhaugh et al., 2011, Tsuiji et al., 2011, Ulitsky et al., 2011, Clark et al., 2012, 
Kryger et al., 2012, Schor et al., 2012, Barry et al., 2013, Valdiglesias et al., 2013, Yang 
et al., 2013, Boraska et al., 2014, Ishizuka et al., 2014, Lin et al., 2014, Yan et al., 2014). 
Despite these studies reporting expression of the lncRNAs of interest in a variety 
of neural tissues and developmental contexts, only two of the transcripts have previously 
been assessed in cells of the developing cortex. Spigoni et al. (2010) observed 
expression of Emx2os in periventricular cortical precursor cells derived from the brains 
of E12.5 mouse embryos. Another study found that MIAT expression was present in 
progenitor cells derived from the lateral cortex of E14.5 mice (Aprea et al., 2013). As 
such, the findings of this thesis support the results of previous studies on MIAT and 
Emx2os expression in cortical NSCs and serve as the first direct evidence for Malat1, 
Cyrano, Sox2ot, and TUNA expression in proliferative cells of the fetal cortex. 
Yet, the studies by Aprea et al. (2013) and Spigoni et al. (2010) also observed 
differential expression of MIAT and Emx2os in proliferating vs. differentiating 
progenitors. These findings led researchers to surmise that these transcripts play roles in 
the regulation of stem cell maintenance and neural lineage specification. In particular, 
Aprea et al. (2013) observed subtle differential expression patterns for MIAT between 
proliferative progenitors, differentiating progenitors, and new neurons in E14.5 mouse 
cortex. Results indicated that MIAT is upregulated in the differentiating progenitor 
population and this upregulation is necessary for the fate determination of these cells as 
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neural progenitors. Other publications on MIAT, as well as studies of TUNA and 
Sox2ot, report similar regulatory changes in transcript expression linking transcripts to 
pluripotency maintenance, cell fate determination, and early neuron survival (Amaral et 
al., 2009, Mercer et al., 2010, Rapicavoli et al., 2010, Sheik Mohamed et al., 2010, Lin 
et al., 2014). 
Previous research in the fetal mouse cortical neurosphere model system 
employed in this thesis has determined that individual neurospheres are composed of 
several subpopulations of cells ranging from multipotent stem cells to proliferative and 
basal progenitors to differentiating progenitors specified to a neural progenitor fate 
(Santillano et al., 2005, Miranda et al., 2008). The neurosphere cultures are also easily 
differentiated into bipolar and multipolar cortical neurons when exposed to a mitogen-
withdrawal media regime (Santillano et al., 2005, Miranda et al., 2008, Camarillo and 
Miranda, 2008). Furthermore, flow cytometry-based cell sorting can be used to 
distinguish cellular subpopulations based on cell surface markers (Santillano et al., 2005, 
Tingling et al., 2013). Therefore, this model system could provide an excellent 
opportunity to further characterize differential expression patterns of the six lncRNAs of 
interest in cell types present throughout the process of cortical neurogenesis. Such 
information would be especially beneficial for the under-studied transcripts Cyrano, 
TUNA, and Emx2os. 
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IV.2  lncRNA Expression and the Effects of Ethanol and Nicotine 
 
The effect of toxic compounds on lncRNAs in a neurodevelopmental context has 
received limited investigation. Actually, relatively few researchers have considered the 
impacts of toxins on expression of lncRNAs regardless of tissue type or life stage. This 
knowledge gap is surprising given the prevalence of molecular toxicology, including a 
large body of work outlining the impacts of various compounds on miRNA expression 
(Pogribny et al., 2007, Ichi et al., 2010, Lema and Cunningham, 2010, Shookhoff and 
Gallicano, 2010, Fukushima et al., 2011, Halappanavar et al., 2011, Aluru et al., 2013, 
Yokoi and Nakajima, 2013, Taki et al., 2014, Oh et al., 2015, Lu et al., 2016). To better 
illustrate this, consider a search of the PubMed database. When the search terms “long 
non-coding RNA” and “toxicology” are entered only 57 publications are returned. In 
comparison, the same search with “microRNA” substituted for “long non-coding RNA” 
yields 524 publications. 
Despite the limited publication history, several developmental toxicology studies 
involving lncRNA. For the most part, these publications involve H19 and Xist, some of 
the first members of this ncRNA class to be studied. For example, several investigators 
have reported epigenetic effects of prenatal alcohol exposure on H19 gene methylation 
in gametes and mouse embryos (Haycock and Ramsay, 2009, Ouko et al., 2009, Stouder 
et al., 2011). A study by Kumamoto and Oshio (2013) found evidence for 
downregulation of Xist in the forebrains of female postnatal mice exposed to bisphenol 
A during fetal development. However, there was one study on an lncRNA other than 
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H19 or Xist. Nan et al. (2016) determined that lead-induced nerve injury reduces 
expression of the lncRNA Uc.173 in the hippocampus and serum of mice. Thus, the 
experiments undertaken in this thesis build on these studies and expand research on the 
developmental toxicology of lncRNAs. More specifically, this research constitutes the 
first investigation of specific toxicological effects on lncRNA expression in NSCs of the 
developing cortex. 
Ethanol and nicotine were chosen as the toxins of interest for this thesis for five 
major reasons. First, both are highly addictive neuroactive compounds commonly used 
and abused throughout the world (Kandel et al., 1997, Weiss and Porrino, 2002, 
Vengeliene et al., 2008, Fagerstrom and Furberg, 2008, Benowitz, 2009, Lingford-
Hughes et al., 2010, Dutta et al., 2014). As a result, it is not unusual for some women to 
continue their use well into pregnancy (Center for Behavioral Health Statistics and 
Quality, 2014). Second, ethanol and nicotine are often co-abused, even during pregnancy 
(Mick et al., 2002, Funk et al., 2006, Duncan et al., 2015, Center for Behavioral Health 
Statistics and Quality, 2015).  Third, previous research indicates that other noncoding 
RNA classes are differentially regulated following ethanol and nicotine exposure 
(Sathyan et al., 2007, Wang et al., 2008, Huang and Li, 2009, Wang et al., 2009, Guo et 
al., 2010, Balaraman et al., 2012, Guo et al., 2012, Tal et al., 2012, Soares et al., 2012, 
Ng et al., 2013, Takahashi et al., 2013, Qi et al., 2014, Taki et al., 2014). For example, 
one study found that Malat1 was significantly upregulated in the brains of alcoholics 
(Kryger et al., 2012). Although not a direct study on the impacts of nicotine on 
noncoding RNA, another investigation identified 12 long noncoding RNA transcripts 
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(termed long stress-induced noncoding transcripts, or LSINCTs) that were upregulated 
in normal human bronchial epithelial cells exposed to the nicotine-derived tobacco 
carcinogen NNK (Silva et al., 2010). Fourth, alcohol and nicotine are linked to 
disruptions in neuroanatomy and behavioral outcomes in exposed offspring. It is widely 
known that ethanol exposure during gestation is associated with fetal alcohol spectrum 
disorder and its suite of physical and behavioral deficits (Haycock, 2009, Alfonso-
Loeches and Guerri, 2011, Laufer et al., 2013). Additionally, some investigators have 
described specific disruptions to neural crest cells and cortical precursors due to in utero 
alcohol exposure (Miller and Dow-Edwards, 1988, Rovasio and Battiato, 2002, Tsai et 
al., 2014). Similarly, nicotine use during pregnancy is associated with a high incidence 
of ADHD and emotional problems among offspring (Slotkin, 1998, Mick et al., 2002, 
Roza et al., 2007, Cents et al., 2012). Prenatal nicotine exposure is also linked to reduced 
offspring head size, an early switch from replication to differentiation of cells in the 
developing CNS, and impairment of the autonomic nervous system resulting in a higher 
incidence of sudden infant death syndrome, or SIDS (Slotkin, 1998, Atluri et al., 2001, 
Roza et al., 2007, Takarada et al., 2012, Lee et al., 2014). The fifth and final reason for 
assessing ethanol and nicotine effects on the developing cortex is that preliminary in 
silico analysis for this thesis predicted multiple potential seed-region binding sites for 
ethanol-sensitive and nicotine-sensitive miRNAs within the sequences of Malat1, 
Cyrano, Sox2ot, TUNA, Emx2os, and MIAT. 
Despite this promising information, results of the subsequent experiments 
indicate no significant dysregulation of the six lncRNAs of interest in NSCs following 
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exposure to 320 mg/dl ethanol. This holds true for the initial assessment of ethanol 
treatment alone as well as for the secondary assessment during which effects from 
nicotine treatment and treatment with ethanol and nicotine in combination were also 
probed. Once again, the results of the initial experiment are taken to be more meaningful 
as the sample size is larger. These results suggest that ethanol does not affect expression 
of these six transcripts. Unlike ethanol, exposure to 1 µM nicotine significantly reduced 
expression of all transcripts except Sox2ot and Emx2os. As such, this research provides 
the first evidence that Malat1, Cyrano, TUNA, and MIAT are dysregulated in NSCs 
exposed to nicotine. 
The results of combined exposure to ethanol and nicotine on the transcripts of 
interests are especially interesting. Similar to the effects of nicotine exposure alone, the 
combination of 320 mg/dl ethanol and 1 µM nicotine yielded a significant 
downregulation of each lncRNA except Sox2ot, Emx2os, and Malat1. In fact, there was 
no significant difference between the effects of nicotine treatment alone and treatment 
with both ethanol and nicotine for Cyrano, TUNA, and MIAT. One previous study has 
assessed how concurrent ethanol and nicotine exposure impacts noncoding RNA 
expression during cortical development. Balaraman et al. (2012) reported that exposure 
to ethanol alone resulted in a significant downregulation of miR-9, miR-21, miR-153, 
miR-335-3p, and miR-140-3p. Conversely, nicotine exposure alone led to upregulation 
of these miRNAs. When neurosphere cultures were exposed to the two teratogens 
simultaneously, their opposing actions caused levels of these miRNAs to normalize. 
Prior to beginning the experiments described in this thesis, it seemed likely that if the 
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lncRNAs of interest mediated the expression of these ethanol- or nicotine-sensitive 
miRNAs the impacts of EtOH and nicotine on these transcripts would be opposite that 
observed by Balaraman and colleagues. Additionally, co-exposure would lead to a 
similar normalizing effect. However, it has been determined that Cyrano, TUNA, and 
MIAT levels in NSCs remain dysregulated when exposed to nicotine and ethanol in 
combination. 
Given the limited understanding of the functional means by which these two 
compounds impact lncRNA levels in this model system, there was no reason to assume 
that these lncRNAs would behave in the same fashion as miR-9, miR-21, miR-153, miR-
335-3p, and miR-140-3p. Yet, it is interesting that no recovery was observed whatsoever 
for three of the four nicotine-sensitive lncRNAs. Considering that ethanol maintained 
expression of these lncRNAs within the range observed in untreated controls, it would 
seem likely that combined exposure would at least result in an expression level 
intermediate to those observed for ethanol and nicotine individually. This would indicate 
an additive and inverse regulatory effect of these two teratogens on expression of the 
lncRNAs, similar to that observed by Balaraman et al. (2012). However, the fact that 
combined ethanol and nicotine exposure results in expression levels nearly identical to 
those observed with nicotine alone for Cyrano, TUNA, and MIAT indicates that the 
effects of ethanol and nicotine on these transcripts are completely decoupled; co-abuse 
will not counteract dysregulation of the lncRNAs of interest due to nicotine exposure. 
Interestingly, it does appear that the actions of ethanol and nicotine on Malat1 
expression could be related. The average relative expression for Malat1 obtained from 
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combined exposure to ethanol and nicotine is roughly 51% of the average relative 
expression of this transcript in untreated NSCs. Alone, ethanol does not yield any 
dysregulation while expression of Malat1 is significantly reduced by nicotine treatment. 
Based on research by Leucci et al. (2013) it is possible that this relationship is the result 
of miR-9 regulating Malat1 transcript levels. According to their report, Leucci and 
colleagues (2013) found evidence that miR-9 and Malat1 interact via the binding of 
miR-9-guided RISC complexes at two canonical sites in the Malat1 sequence. This leads 
to Malat1 degradation in the nucleus. It is possible then, that nicotine exposure increases 
miR-9 levels, as described by Balaraman et al. (2012), and this subsequently reduces 
Malat1 levels in cortical NSCs. However, when ethanol exposure occurs simultaneously, 
the downregulation of miR-9 by that compound partially ameliorates the action of 
nicotine leading to a less potent downregulation of Malat1. Clearly, more work would 
need to be done before the existence of such a relationship could be confirmed in this 
context. Regardless, it is an interesting possibility that warrants further investigation, 
especially since Leucci et al. (2013) also found that Ago2 was a component of the RISC 
complexes involved in miR-9-mediated Malat1 degradation. With that being said, future 
research should also attempt to uncover the mechanisms by which nicotine 
downregulates Cyrano, TUNA, and MIAT. 
For ethanol and nicotine treatment alone and in combination, it would be 
reasonable to investigate how other concentrations might effect lncRNA expression. Yet, 
care would need to be taken to ensure that assessments consider real-world correlates of 
exposure to developing organisms as well as ethanol and nicotine levels that could 
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realistically be achieved in pregnant females. If concentrations tested are so high that a 
person could not survive with the equivalent BAC or blood nicotine level, then such 
investigations carry little meaning. The concentration of 320 mg/dl ethanol (BAC= 
0.32%) used in this thesis falls within the range observed in alcoholics (Gottesfeld et al., 
1990, Adachi et al., 1991). Although it is possible for a woman to attain a higher 
concentration in her system, 320 mg/dl nicely approximates the BAC of individuals at 
highest risk for continuing alcohol use during pregnancy. Similarly, the 1 µM nicotine 
concentration assessed in this thesis represents a reasonable approximation of the blood 
nicotine levels attainable by smokers (Russell et al., 1980, Benowitz and Jacob, 1984, 
Williams et al., 2010, Jarvis et al., 2014). 
Since the experiments in this thesis were only performed with a single ethanol 
and nicotine concentration, it could be argued that different effects of treatment may be 
observed at either higher or lower concentrations. In preliminary analyses NSCs were 
also exposed to 120 mg/dl ethanol (BAC= 0.12%), which roughly approximates BACs 
achievable with binge drinking (Gottesfeld et al., 1990, Adachi et al., 1991). Results of 
these experiments revealed no significant effect of treatment on any of the lncRNAs. 
However, since even small amounts of alcohol consumption during pregnancy can result 
in offspring with symptoms on the fetal alcohol syndrome spectrum, it may be wise to 
assess effects of concentrations below 120 mg/dl. At this time, ethanol concentrations 
higher than 320 mg/dl have not been assessed in this model system and, thus, the 
possibility that an effect of treatment could exist at higher concentrations cannot be 
dismissed. With regard to nicotine, effects of concentrations both higher and lower than 
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1 µM have yet to be considered. Again, it is important that any future research assessing 
the effects of higher concentrations of either ethanol or nicotine consider concentrations 
that approximate physiologically relevant BACs and blood nicotine levels. 
Regardless of whether or not ethanol and/or nicotine exposure play a role in the 
expression levels of Malat1, Cyrano, Sox2ot, TUNA, Emx2os, and MIAT in mouse fetal 
NSCs, this collection of experiments is the first to investigate how these compounds 
affect lncRNAs in the developing nervous system. Ideally these findings will spur others 
to further explore the effects of nicotine and ethanol on lncRNA expression as well as 
the impacts of other toxins. 
 
IV.3  lncRNAs and Ago2 Complexation: Expression Levels, Compartmentalization, 
and the Effects of Ethanol and Nicotine 
 
The remaining aims of this thesis involve the determination of whether or not the 
lncRNAs actively associate with Ago2 in NSCs, where these lncRNA/Ago2 complexes 
localize within cells, and if ethanol and nicotine exposure disrupt normal patterns of 
association and compartmentalization. Unlike the previous studies, a subset of the six 
lncRNAs of interest were considered in this phase of experimentation. Only TUNA, 
Emx2os, and MIAT were assessed in nuclear and cytoplasmic Ago2 RIP fractions. This 
decision was in part due to the feasibility of undertaking such assessments. To 
investigate expression of a single lncRNA in each RIP-generated sample run in 
triplicate, it takes a total of 240 reactions. Therefore, assessing all six lncRNAs of 
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interest, not including potential normalization standard transcripts, would require 1440 
reactions. However, the selection of these three lncRNA as the focus of the RIP 
experiments has more to do with the results of the expression level studies involving 
ethanol and nicotine exposure. TUNA, Emx2os, and MIAT are representative of all the 
lncRNAs considered in this work with regard to three factors: effect of treatment on 
expression, prior evidence of a compartmentalization pattern, and body of research on 
the transcript. TUNA exhibits significant downregulation as a result of nicotine 
treatment and it has received little attention in the primary literature with only two 
papers published to date. However, one of these studies determined that TUNA localizes 
to both the nucleus and cytoplasm of mouse embryonic stem cells (Lin et al., 2014). Like 
TUNA, MIAT shows an effect of treatment with nicotine exposure. Yet, significantly 
more research has been published regarding MIAT (approximately 15 publications), to 
include evidence suggesting that it is enriched in the nucleus (Sone et al., 2007, 
Rapicavoli et al., 2010, Ip and Nakagawa, 2012, Ishizuka et al., 2014). Emx2os is the 
only lncRNA assessed in Ago2 RIP fractions that is not downregulated following 
nicotine exposure. While it is the subject of limited study, three investigations have dealt 
with Emx2os compared to only two for TUNA. Despite that, no localization data has 
been generated. Thus, by selecting these lncRNAs, the subsequent experiments 
considered two teratogen-sensitive lncRNAs and one unaffected “control” of sorts. 
Additionally, assessment of TUNA and Emx2os serve to further expand the knowledge 
base for these noncoding RNAs. With the compartmentalization pattern evidence 
documented by other researchers for MIAT and TUNA, their assessment in these 
 80 
 
experiments allow for the opportunity to determine agreement with the primary literature 
and potentially better assess disruptions to localization as a result of treatment. 
If evidence for complexation between the three lncRNAs of interest and Ago2 
was discovered, it would provide the preliminary evidence needed to suggest that these 
noncoding transcripts were interacting with RISC and, therefore, with miRNAs in the 
developing cortex. The impetus for such investigations stems from account in the 
primary literature detailing regulatory interactions between lncRNAs and miRNAs. 
Commonly this involves regulation of an lncRNA by a miRNA via RNA induced 
silencing. An example of this type of interaction between Malat1 and miR-9 was 
presented in the last section (Leucci et al., 2013). More recently, Wang et al. (2015) have 
also described how miR-101 and miR-217 silence Malat1 in esophageal cancer cells via 
RISC. The other lncRNA/miRNA interaction that has been gaining attention in the past 
few years involves lncRNAs acting as competing endogenous RNAs (ceRNAs), or 
miRNA sponges. In this case, the lncRNA contains at least one binding site for a 
miRNA and competitively binds and sequesters copies of the transcript; thus, reducing 
regulatory effects on the miRNA targets (Cesana et al., 2011, Cesana and Daley, 2013, 
Hansen et al., 2013, Liu et al., 2014, Zhou et al., 2014). This past year, researchers 
reported evidence of ceRNA roles for both Malat1 and MIAT. Yan et al. (2015) 
observed that MIAT overexpression partially rescued VEGF mRNA from repression by 
miR-150-5p by binding the transcript in vascular epithelial cells. Similarly, Malat1 
promotes myogenesis by easing miR-133-mediated regulation of the SRF transcription 
factor through competitively binding of this miRNA (Han et al., 2015). 
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Another reason lncRNA/Ago2 complexation was assessed as a proxy for 
lncRNA/miRNA associations in this thesis stems from the results of preliminary in silico 
analyses. RNA Hybrid was used to determine the potential for interactions between the 
six lncRNAs of interest and known ethanol- and nicotine-sensitive miRNAs. Previous 
lab members cited the existence of several ethanol-sensitive miRNAs including miR-
335-3p, miR-21, miR-153-3p, and miR-9 (Sathyan et al., 2007, Balaraman et al., 2012). 
In addition evidence from the primary literature pointed to miR-140-3p as a nicotine-
sensitive miRNA (Huang and Li, 2009). According to the in silico results, miR-335-3p 
was the only teratogen-sensitive miRNA exhibiting no predicted seed region-mediated 
interactions with TUNA, Emx2os, or MIAT. Conversely, miR-140-3p had predicted 
binding sites with all three transcripts. Thus, the potential for interactions between these 
lncRNAs and miRNAs seemed plausible. 
Unfortunately, qPCR results indicate no significant or consistent expression of 
these three transcripts in nuclear or cytoplasmic Ago2 RIP samples. This pattern is seen 
in untreated RIP controls and across each of the three treatment groups (ethanol, 
nicotine, ethanol + nicotine). All three lncRNAs are amplified consistently in whole cell 
controls, however. Thus, there is no evidence suggesting interaction between Ago2, 
TUNA, Emx2os, or MIAT in NSCs. This finding can be extended to a lack of evidence 
for interactions between these lncRNAs and miRNAs, including those exhibiting 
ethanol- and nicotine-sensitivity. However, it is important to keep in mind that only 
those interactions between these noncoding RNAs and Ago2 were probed in these 
experiments despite there being three other Argonaute proteins in mammals (Hutvagner 
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and Simard, 2008, Ender and Meister, 2010). Since RIPs targeting these other Agos were 
not performed and assessed for TUNA, Emx2os, or MIAT expression, it is still possible 
that these transcripts could mediate interactions between the lncRNAs and miRNAs. For 
that reason, a logical next step for this research would involve expanding it to consider 
the remaining Ago proteins to determine whether or not they might mediate interactions 
between TUNA, Emx2os, or MIAT and miRNAs. 
While it is possible that TUNA, Emx2os, or MIAT may interact with miRNAs 
via one of these other Ago proteins, it is also possible that they could play a role in the 
interactome of ethanol- or nicotine-sensitive miRNAs at some other level of regulation. 
Since this experimentation does not indicate a role for these lncRNAs in direct post-
transcriptional associations with RISC and miRNAs, they may instead affect miRNA 
expression via splicing of target molecules, regulation of protein and transcription factor 
activity, or genetic regulation (Hutchinson et al., 2007, Wilusz et al., 2009, Anko and 
Neugebauer, 2010, Malecova and Morris, 2010, Tsai et al., 2010, Saxena and Carninci, 
2011, Geisler and Coller, 2013, Kornienko et al., 2013, Bergmann and Spector, 2014). 
Indeed, evidence suggests that MIAT is involved in the control of splicing factors and 
that Emx2os and the transcription factor Emx2 are part of a regulatory feedback loop 
(Spigoni et al., 2010, Tsuiji et al., 2011, Aprea et al., 2013, Barry et al., 2013, Ishizuka et 
al., 2014). Future studies need to explore the whether or not the lncRNAs of interest 
exert such regulatory controls over miRNAs in NSCs. 
Instead of pulling down everything actively associated with Ago2, another 
method for this experiment would have been to use the teratogen-sensitive miRNAs 
 83 
 
themselves as RIP targets. That would require the introduction of biotinylated 
oligonucleotide miRNA mimics into the cells followed by crosslinking and pull down of 
these tagged mimics with any interacting molecules. Indeed, this would have been a 
logical next step had there been solid evidence suggesting any of these lncRNAs were 
interacting with Ago2. Realistically, results of miRNA mimic pull downs may have been 
more powerful because any lncRNA amplification in the resultant RIP fractions would 
indicate a direct relationship between a specific miRNA and a specific lncRNA. 
However, as an initial assessment for potential interactions, this option seemed 
inappropriate. 
Several pitfalls associated with miRNA mimic pull downs exist. However, for 
these experiments, the major concern was the potential for a high false positive rate. This 
often occurs in miRNA mimic pull downs because expression of the target miRNA in 
cells is altered resulting in concentrations that differ greatly from endogenous expression 
levels. Due to this effective excess of target miRNA expression in cells, associations that 
do not normally occur often or at all may be detected (Thomas et al., 2010, Thomson et 
al., 2011). Similarly, while co-immunoprecipitations always carry some risk of false 
positives due to target binding following cell lysis, this could be magnified in the case of 
miRNA mimic pull down due to the abnormal levels of transcript present; any excess 
miRNA mimics not loaded in RISC could be loaded after cell lysis (Riley et al., 2012). 
Since the goal of the RIP experiments was to assess the potential for lncRNA/miRNA 
interactions under normal cellular conditions and to observe whether or not ethanol and 
nicotine treatment changed these interactions, Ago RIP was chosen for this thesis. 
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Argonaute RIP was also deemed more appropriate as a major aim of the research was to 
expand knowledge on the lncRNAs of interest. Pull downs with miRNA mimics would 
have provided limited additional information about TUNA, Emx2os, or MIAT if they 
were not amplified in the resultant samples. 
To maintain a focus on the lncRNAs, a similar technique could be employed by 
creating oligonucleotide mimics for some of the predicted binding sites between a 
lncRNA and miRNA pair. Still, this scenario would likely suffer from many of the same 
pitfalls faced in the miRNA mimic pull down. It would also be complicated by the lack 
of commercially-available, validated mimics for these binding sites. Another challenge 
is that while it is possible to create a mimic for a full miRNA sequence, making a similar 
mimic for an entire lncRNA sequence would be extremely difficult due to the size. On a 
related note, the feasibility of instead assessing each predicted binding site for a 
lncRNA/miRNA pair using mimics for these potential binding sites would be severely 
limited by the fact that there were up to nine predicted binding sites detected for a single 
miRNA and lncRNA pair in the initial RNA Hybrid analyses. That would mean a 
minimum of nine RIPs would need to be performed in such an experiment to assess all 
potential binding sites. 
No evidence regarding compartmentalization of lncRNA/Ago2 complexes can be 
gleaned from the results of qPCR performed on the RIP-generated samples. However, 
taking care not to attribute too much significance to the limited and inconsistent 
amplification that was detected in nuclear and cytoplasmic fractions, some general 
localization patterns for the individual lncRNAs can be suggested. All three lncRNAs 
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were amplified in both the nuclear and cytoplasmic fractions. Additionally, TUNA, 
Emx2os, and MIAT were more highly amplified in the nuclear fraction than in the 
cytoplasm. Nine more wells were amplified for Emx2os in nuclear fractions while six 
and four more were amplified for TUNA and MIAT, respectively. Since there are no 
other records of cellular localization for Emx2os, no comparisons can be made to the 
prior findings. Therefore, this represents the first investigation of this and defines a new 
characteristic of the lncRNA. The general amplification pattern observed for MIAT in 
these experiments agrees with previous works mentioned above detailing MIAT 
enrichment in the nuclear compartment (Sone et al., 2007, Rapicavoli et al., 2010, Ip and 
Nakagawa, 2012, Ishizuka et al., 2014). The same is true for TUNA. Results of this 
thesis point to expression of this lncRNA in both the nucleus and the cytoplasm. 
However, given that the report by Lin et al. (2014) did not specify expression amounts in 
each compartment, it is unclear whether or not the higher amplification observed in the 
nuclear fraction in these experiments agrees with that previous work. It is also tempting 
to note that, of the three transcripts, TUNA appears to show the greatest potential for 
interactions with Ago2. Whereas MIAT was not amplified in the nuclear or cytoplasmic 
RIPs at all and amplification of Emx2os was only observed in a combined total of four 
wells, a total of 10 wells each were amplified for TUNA in RIP samples from each 
cellular compartment. Yet, given the inconsistent amplification and the inability to 
assess the results statistically, these “trends” in localization and amplification should be 
taken only as preliminary findings to inform future investigation.  
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Poor amplification of TUNA, Emx2os, and MIAT in the Ago2 RIP experiments 
warrants additional discussion. As mentioned in the Experimental Results chapter, this 
may point toward loss or degradation of RNA during the experimental process. 
Alternatively, since there were some initial issues with RNA purification following 
extraction from the Ago2 RIP samples, these results may be associated with the presence 
of contaminants in the template interfering with qPCR. For instance, it is well 
documented that the presence of proteins, salts, carbohydrates, DNA, residual guanidine-
thiocyanate, and residual phenol can lead to qPCR inhibition (Pinto, Thapper, Sontheim, 
and Lindblad, 2009; Carvalhais, Delgado-Rastrollo, Melo, and Cerca, 2013; Cleanup Of 
Trizol Reagent-Purified Total RNA Using The Pureyield RNA Midiprep System). 
Indeed, A260/A280 ratios for the RIP samples obtained following TRIzol extraction in 
these experiments were a bit lower than the 1.8-2.0 range attributed to pure RNA (Pinto, 
Thapper, Sontheim, and Lindblad, 2009; Sah, Kaur, and Kaur, 2014). Attempts were 
made to further purify the total RNA extracts via a second TRIzol extraction and spin 
columns. However, this resulted in extremely low RNA yields with little change in 
A260/A2880 ratio. For that reason, qPCR was run with the original total RNA extracts. 
While amplification was inconsistent for the lncRNAs of interest, other RNA transcripts 
assessed as potential normalization standards amplified successfully and consistently 
from nuclear and cytoplasmic RIPs and supernatants. These included 18S, U6, and miR-
490-3p. As will be discussed more fully in the following section, microarrays run using 
composite RIP samples as the template also successfully amplified 52 miRNAs from the 
nuclear compartment and 89 miRNAs from the cytoplasmic compartment. Therefore, 
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these findings do not appear to support either the RNA loss explanation or the impurity 
explanation. 
As such, the most promising explanation for this discrepancy simply appears to 
be that these transcripts were not present at a high enough concentration in the qPCR 
templates to allow for consistent detection. After all, the initial samples underwent both 
a fractionation step and a pull down that yielded four new samples for each original 
sample. Logically, if a transcript was distributed evenly across each of the four resultant 
samples, one would only expect to observe 25% of the expression present in whole cell 
extracts. For this reason, it would be wise to increase the number of cells used to 
generate the initial samples intended for fractionation and RIP. Certainly, it appears that 
a single T-75 culture flask at 80-90% confluency may not yield a high enough 
concentration of TUNA, Emx2os, and MIAT to allow for successful amplification in the 
resultant fractioned Ago2 RIP samples. For that reason, it would be wise to increase the 
number of flasks per sample in future RIP experiments. Additional optimization of each 
step of the RIP process is also advisable. 
 
IV.4  miRNAs and Ago2: Expression Levels and Compartmentalization 
 
In support of the investigations into potential lncRNA/Ago2 complexation and 
cellular compartmentalization, miRNA microarrays were run with pooled samples of 
nuclear and cytoplasmic RIP fractions in the hopes of finding normalization standards 
for these fractions. Though not part of the initial scope of this thesis, the results of these 
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microarrays also provided the opportunity to explore miRNA expression in NSCs. By 
assessing the miRNAs amplified from both nuclear and cytoplasmic Ago2 RIP fractions, 
a snapshot of miRNAs actively associated with RISC in the developing cortex was 
generated. Although there are prior reports detailing interactions between miRNAs and 
Argonaute proteins, to the author’s knowledge only one publication has reported such 
associations in the developing brain. Chi et al. (2009) performed an Ago RIP in P13 
mouse neocortex followed by high throughput sequencing and bioinformatics analyses. 
Therefore, this represents the first report of direct, in vitro associations between miRNAs 
and RISC in the prenatal brain. It is also the first report in mouse cortical NSCs to 
provide an understanding of the compartmentalization patterns of these complexes. 
Finally, the results of the microarrays allowed for an expanded in silico analysis of 
miRNAs with predicted seed-region binding sites within the sequences of TUNA, 
Emx2os, and MIAT. 
As mentioned briefly in the preceding section, a total of 52 miRNAs are 
expressed in the nuclear RIP sample and a total of 89 miRNAs are expressed in the 
cytoplasmic RIP sample. A subset of 33 miRNAs is amplified in both compartments. 
Among them are miR-140-3p, miR-21, and miR-9; three of the teratogen-sensitive 
miRNAs originally analyzed for binding sites with all six lncRNAs of interest. With 
regard to overall expression, miR-9 appears to be more actively associated with Ago2 
than either miR-21 or miR-140-3p. Actually, miR-9 was the most highly expressed 
miRNA in the cytoplasmic RIP pooled sample. 
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Figure 9. Amplification of EtOH/Nicotine-Sensitive miRNA in Ago2 RIP Samples 
 
EtOH- and nicotine-sensitive miRNAs amplified from nuclear and cytoplasmic Ago2 RIP fractions via 
qPCR..  
 
 
 
Attempts to learn more about the other miRNAs found to be actively associated 
with Ago2 in the RIP samples turned up evidence for several more ethanol- and 
nicotine-sensitive species. For example, Huang and Li (2009) observed dysregulation of 
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25 miRNAs in rat adrenal pheochromocytoma PC12 and human neuroblastoma cells 
following exposure to nicotine. In addition to miR-140-3p, ten of the other dysregulated 
miRNAs found in this study are also amplified in the nuclear or cytoplasmic RIPs. These 
include miR-328, miR-93, miR-181b, miR-125b, miR-25, miR-186, miR-152, miR-30c, 
miR-210, and miR-98. Similarly, Soares et al. (2012) reported miRNA dysregulation in 
zebrafish embryos exposed to two different concentrations of ethanol. Among the 
ethanol-sensitive transcripts observed were let-7c and miR-23a. Based on the results of 
this thesis, let-7c is expressed in both nuclear and cytoplasmic RIPs while miR-23a is 
expressed in the cytoplasmic RIP only. These studies are only two of several describing 
other nicotine- and ethanol-sensitive miRNAs amplified in the miRNA microarray 
experiments. Additionally, several more studies provide support for the ethanol 
sensitivity of miR-9 (Wang et al., 2009, Tal et al., 2012). Figure 9 outlines all nicotine- 
and ethanol-sensitive miRNAs from the primary literature that were amplified in the 
nuclear and cytoplasmic RIP fractions. In addition, Table 9 provides details about the 
publications in which these miRNAs were described as ethanol and/or nicotine sensitive. 
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Table 9. Primary Literature on EtOH- and Nicotine-Sensitive miRNAs 
 
Publication Treatment 
 
Model System Representative miRNA 
     
Balaraman, Winzer-Serhan, 
Miranda, 2012 
Ethanol/Nicotine 
Mouse fetal cortical 
neurosphere cultures 
miR-9, miR-21, miR-
140-3p, miR-153, 
miR335 
     
Guo, Chen, Carreon, and 
Qiang, 2012 
Ethanol 
Mouse fetal primary 
cortical neuron cultures 
miR-504, miR-29b, 
miR-490, miR-92a, 
miR-491 
     
Huang and Li, 2009 Nicotine 
Rat PC12 cells & Human 
neuroblastoma SH-SY5Y 
cells 
miR-140-3p, miR-125, 
miR-30c, miR-93 
     
Maccani and Knopik, 2010 Nicotine 
First trimester human 
placental cell lines 
miR-16, miR-21, miR-
146a 
     
Ng et al., 2013 Nicotine 
Human mesenchymal stem 
cells and periodontal 
ligament-derived stem cells 
miR-30b, miR-218, 
miR-15b, miR-3198, 
miR-7 
     
Sathyan, Golden, and 
Miranda, 2007 
EtOH 
Mouse fetal cortical 
neurosphere cultures 
miR-21, miR-335, miR-
153, miR-9 
     
Soares et al., 2012 EtOH Zebrafish embryos 
let-7c, miR-153, miR-
727, miR-133a 
     
Tal et al., 2012 EtOH Zebrafish embryos miR-9, miR-153 
    
Yadav et al., 2011 EtOH 
Human neuroblastoma SH-
SY5Y cells 
miR-497, miR-302b 
     
Yu et al., 2009 Nicotine 
Head and neck squamous 
cell carcinoma 
miR-101, miR-9, miR-
221, miR-135b, miR-
556-3p, miR-1259 
     
 
 
 
According to in silico analysis with RNA Hybrid, many of the miRNAs 
expressed in the Ago2 RIP samples have predicted interactions with TUNA, Emx2os, 
and MIAT. Interestingly, most of the amplified miRNAs exhibited predicted binding 
sites with MIAT. Seventy-one of the miRNAs amplified in the cytoplasmic RIP fraction 
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and 43 of the miRNAs amplified in the nuclear RIP fraction had at least one potential 
binding site with this lncRNA. In comparison, TUNA and Emx2os exhibited binding 
sites with 55 and 54 miRNAs in the cytoplasmic RIP and 33 and 32 miRNAs in the 
nuclear RIP, respectively. Across both RIP fractions only miR-218-1*, miR-543, miR-
21, and miR-598 exhibit no potential binding sites with the lncRNAs. However, miR-
140-3p and miR-9 are amplified in each RIP fraction and have predicted interactions 
with TUNA and MIAT. Of the miRNAs amplified in both of the RIP fractions those 
with the most predicted interactions with the three lncRNAs of interest are miR-141*, 
let-7b, miR-29b-1*, miR-30a*, miR-877*, and miR-9. 
 With the information these experiments generated on miRNA/Ago2 associations, 
the cellular localization of these active complexes, and potential interactions between 
amplified miRNAs and three of the lncRNAs of interest, a variety of new research topics 
arise for consideration. Perhaps the most interesting of these is the chance to explore 
how nicotine and ethanol exposure affect these associations and their 
compartmentalization. Since it was not possible to investigate such effects on 
lncRNA/Ago2 complexes, having the opportunity to do so with the miRNA data 
generated in this thesis is a nice follow on. 
  
IV.5  Conclusions and Future Research 
 
Despite research on noncoding RNAs having increased greatly in the past 
decade, a variety of unexplored topics and transcripts remain. This work represents an 
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attempt to probe some of these unknowns and better characterize several under-
investigated lncRNAs. A major outcome of these experiments is a better understanding 
of expression levels of the lncRNAs of interest in the developing brain. None of these 
RNA species were previously assessed in the mouse fetal cortical neurosphere model 
system employed in this thesis work. Results of the experiments detailed in the 
preceding chapters confirm the presence of Malat1, Cyrano, Sox2ot, TUNA, Emx2os, 
and MIAT in proliferative cells derived from the developing mouse cortex. In addition to 
gaining a better understanding of general expression patterns for the six lncRNAs of 
interest, these investigations provide the first description of how in utero exposure to 
ethanol and nicotine impacts expression of these transcripts. While ethanol exposure had 
no effect on transcripts levels in mouse fetal NSCs, several of the lncRNAs exhibited 
nicotine sensitivity. The nicotine-mediated downregulation observed for TUNA, Cyrano, 
and MIAT was unaffected by concurrent exposure to ethanol. This was in contrast to the 
normalizing effect simultaneous ethanol and nicotine treatment had on Malat1 and 
teratogen-sensitive miRNAs previously studied in this neurosphere model. 
Subsequent experiments sought to assess the potential for interactions between 
TUNA, Emx2os, MIAT, and teratogen-sensitive miRNAs by proxy of interactions with 
the RISC complex protein Ago2. Attempts were also made to determine whether or not 
such associations and their localization within cells were disrupted by ethanol and/or 
nicotine exposure. However, evidence of any such interactions between TUNA, 
Emx2os, MIAT, and Ago2 was not observed; thus, preventing further assessments of 
teratogen-mediated disruption to compartmentalization and complexation. Yet, these 
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experiments ultimately allowed for the determination of miRNAs actively associated 
with RISC in cortical progenitor cells. As such, this thesis work resulted in an expanded 
understanding of how the six lncRNAs of interest are expressed in NSCs and how these 
levels are modulated in response to ethanol and nicotine exposure. It also serves to better 
characterize Cyrano, TUNA, and Emx2os. Additionally, this work provides new insight 
on RISC activity in the developing mouse cortex by generating a set of 108 miRNAs that 
are actively primed for RNA induced silencing of targets in NSCs. 
Throughout this final chapter, details warranting future research have been 
raised. First, expression level dynamics of the six lncRNAs of interest should be probed 
in each cellular subpopulation present in NSCs. Extending this investigation to 
characterize transcript expression in newly generated cortical neurons would provide a 
complete understanding of how Malat1, Cyrano, Sox2ot, TUNA, Emx2os, and MIAT 
levels fluctuate throughout cortical neurogenesis. Second, assessment of lncRNA 
expression following exposure to ethanol and nicotine at different concentrations 
deserves exploration. Third, it would be meaningful to investigate the mechanisms by 
which nicotine downregulates Malat1, Cyrano, TUNA, and MIAT expression. A good 
starting point would be to explore whether or not the regulatory relationship between 
Malat1 and miR-9 reported in the primary literature occurs in cortical mouse NSCs; 
thus, explaining the partial amelioration of nicotine-mediated dysregulation of this 
lncRNA by concurrent ethanol exposure. A fourth area for further consideration is to 
continue research on potential interactions between the lncRNAs and miRNAs. This can 
take two paths: 1) determine whether or not the other three Argonaute proteins found in 
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mammals mediate post-transcriptional interactions between miRNAs and the long 
noncoding transcripts of interest or 2) assess possible interactions that do not occur at the 
post-transcriptional level, such as genetic regulation. Fifth, with so little information 
available on Cyrano and the fact that it is dysregulated by nicotine, this transcript should 
also be assessed in the Ago2 RIP samples. As with TUNA, even if no amplification is 
observed, it will serve to increase the limited body of knowledge on this transcript. 
Sixth, based on information from the miRNA microarrays, it would be interesting to 
investigate how nicotine and ethanol exposure might impact the loading of specific 
miRNAs into RISC as well as how these teratogens might affect compartmentalization 
of such complexes. A final topic requiring future research that was not mentioned before 
is the assessment of ethanol and nicotine effects on Malat1, Cyrano, Sox2ot, TUNA, 
Emx2os, and MIAT expression in other tissues. Special attention to expression patterns 
in other regions of the developing brain would afford the opportunity to determine if the 
actions of ethanol and nicotine on lncRNAs observed in this thesis are universal in the 
developing brain or specific to the cortex. 
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APPENDIX A 
MATERIALS AND REAGENTS 
 
General 
 
Item Manufacturer Manufacturer 
Catalog No. 
Maxymum Recovery Filter Tip Pipet 
Tips, 0.5-10 µL 
Axygen Scientific TF-300-L-R-S 
Maxymum Recovery Filter Tip Pipet 
Tips, 100 µL 
Axygen Scientific TF-100-L-R-S 
Maxymum Recovery Filter Tip Pipet 
Tips, 1000  µL 
Axygen Scientific TF-1000-L-R-S 
PCR Tubes with Caps, 0.2 mL VWR 20170-010 
MaxyClear Microcentrifuge Tubes, 0.6 
mL 
Axygen Scientific MCT-060-C-S 
Superspin Microcentrifuge Tubes, 1.5 
mL  
VWR 20170-038 
Disposable Individually Wrapped 
Serological Pipets, 5 mL 
Falcon/Corning 357543 
Disposable Individually Wrapped 
Serological Pipets, 5 mL 
VWR 89130-896 
Disposable Individually Wrapped 
Serological Pipets, 10 mL 
Falcon/Corning 357551 
Disposable Individually Wrapped 
Serological Pipets, 10 mL 
VWR 89130-898 
Disposable Individually Wrapped 
Serological Pipets, 25 mL 
Falcon/Corning 357525 
Disposable Individually Wrapped 
Serological Pipets, 25 mL 
VWR 89130-900 
Conical Centrifuge Tubes with Flat Cap, 
15 mL 
Falcon/Corning 352097 
Conical Centrifuge Tubes with Flat Cap, 
15 mL 
VWR 89039-666 
Conical Centrifuge Tubes with Flat Cap, 
50 mL 
Falcon/Corning 52098 
Conical Centrifuge Tubes with Flat Cap, 
50 mL 
VWR 89039-658 
Cryo.s Cryogenic Storage Vials, 2 mL, 
Yellow Cap 
Greiner Bio-One 122278 
Kimwipes, 4.4" x 8.4" Kimberly-Clark 34155 
Kimwipes, 11.8" x 11.8" Kimberly-Clark 34133 
Powder-free Soft Nitrile Gloves (S) VWR 89038-268 
Powder-free Soft Nitrile Gloves (M) VWR 89038-270 
Powder-free Soft Nitrile Gloves (L) VWR 89038-272 
1X DPBS, no calcium, no 
magnesium, no phenol red, 500 mL 
Life 
Technologies/Invitrogen 
14190-144 
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Item Manufacturer Manufacturer 
Catalog No. 
1X DPBS, no calcium, no 
magnesium, no phenol red, 10 x 500 
mL 
Life 
Technologies/Invitrogen 
14190-250 
UltraPure Dnase/Rnase-Free 
Distilled Water, 500 mL 
Life 
Technologies/Invitrogen 
10977-015 
UltraPure Dnase/Rnase-Free 
Distilled Water, 10 x 500 mL 
Life 
Technologies/Invitrogen 
10977-023 
Water, Dnase- and Rnase-Free, PCR 
Certified, 1 L 
Teknova W3350 
Parafilm M, 4" x 125" Alcan Packaging PM996 
Ethanol, Pure, 190 Proof (95%), 1 
gal 
KOPTEC Bio-Bio 
Stockroom 
 
Cell Culture 
 
Item Manufacturer Manufacturer 
Catalog No. 
Tissue Culture Flasks, 75 cm2, 250 mL Falcon/Corning 353135 
Tissue Culture Flasks, 25 cm2, 70 mL Falcon/Corning 353082 
AcroVac Filter Units,0.2 µm, 250 mL Pall Life Sciences AVFP02S 
AcroVac Filter Units, 0.2 µm, 500 mL Pall Life Sciences AVFP02M 
DMEM/F-12, HEPES, no phenol red, 
500 mL 
Life 
Technologies/Invitrogen 
11039-021 
DMEM/F-12, HEPES, no phenol red, 10 
x 500 mL 
Life 
Technologies/Invitrogen 
11039-047 
Human Fibroblast Growth Factor, Basic 
(bFGF), 10 x 10 µg 
Corning 356061 
Heparin, 250 mg Sigma Aldrich H4784 
Insulin-Transferrin-Selenium-X, 100X, 
10 mL 
Life 
Technologies/Invitrogen 
51500-056 
Progesterone-Water Soluble, 100 mg Sigma Aldrich P7556 
Human EGF Animal-Free, 1 mg Peprotech AF100151MG 
Penicillin/Streptomycin Life 
Technologies/Invitrogen 
15140-122 
Human LIF, 5 µg Alomone Labs L-200 
Ethanol, 200 Proof (99.5+%), ACS 
Grade 
Acros Organics Bio-Bio 
Stockroom 
 
cDNA and qPCR 
 
Item Manufacturer Manufacturer 
Catalog No. 
MicroAmp Optical 384-Well Reaction 
Plate, 50 plates 
Life 
Technologies/Invitrogen 
4309849 
MicroAmp Optical Adhesive Film, 100 
covers 
Life 
Technologies/Invitrogen 
4311971 
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Item Manufacturer Manufacturer 
Catalog No. 
RNaseZap Rnase Decontamination 
Solution, 6 x 250 mL 
Life 
Technologies/Invitrogen 
AM9782 
qScript cDNA Synthesis Kit,100 rxn Quanta Biosciences 95047-100 
PerfeCTa SYBR Green Fastmix, 1250 
rxn 
Quanta Biosciences 95073-012 
 
Western Blotting 
 
Item Manufacturer Manufacturer 
Catalog No. 
NuPAGE Novex 4-12% Bis-Tris Protein 
Gels, 1.0 mm, 17 well, 10 gels 
Life 
Technologies/Invitrogen 
NP0329BOX 
NE-PER Nuclear and Cytoplasmic 
Extraction Reagents, 15 mL kit 
Pierce/Thermo Fisher Sci 78833 
TBS 20X Liquid Concentrate, 4 L 
 
EMD Millipore 8320-4L 
iBlot Transfer Stack, PVDF, Regular 
Size, 10 sets 
Life 
Technologies/Invitrogen 
IB4010-01 
20X MOPS/SDS Running Buffer, 500 
mL 
Teknova M1089 
BLOTTO, 5% Non-Fat Dry Milk, 
Immunoanalytical Grade 
Rockland 
Immunochemicals 
B501-0500 
Western Lightning Plus ECL Kit 
 
PerkinElmer NEL103001EA  
Restore Western Blot Stripping Buffer Life 
Technologies/Invitrogen 
21059 
Goat Anti-rabbit IgG-HRP Secondary 
Antibody 
Santa Cruz sc-2004 
Kaleidoscope Prestained Standard 
Protein Ladder 
Bio-Rad 161-0324 
Anti-Ago2/eIF2C2 Rabbit Polyclonal 
Antibody-ChIP Grade 
Abcam ab32381 
Anti-Tubulin 
 
Thermo Fischer Scientific A11126 
 
RNA Extraction 
Item Manufacturer Manufacturer 
Catalog No. 
Trizol Reagent, 200 mL Life 
Technologies/Invitrogen 
15596-018 
mirVana miRNA Isolation Kit, without 
phenol 
Life 
Technologies/Invitrogen 
AM1561 
RNAqueous Total RNA Isolation Kit, 50 
preps 
Life 
Technologies/Invitrogen 
AM1912 
Isopropanol Sigma Aldrich 190764 
Chloroform Sigma Aldrich C7559 
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Immunoprecipitation 
Item Manufacturer Manufacturer 
Catalog No. 
Dynabeads Protein G, 1 mL 
 
Life 
Technologies/Invitrogen 
10003D 
Anti-Ago2/eIF2C2 Rabbit Polyclonal 
Antibody-ChIP Grade 
Abcam ab32381 
Anti-Tubulin Mouse Monoclonal 
Antibody, beta III isoform 
EMD Millipore MAB1637 
Tween 20 Sigma Aldrich P9416 
 
Crosslinking, Fractionation, Proteinase K Digestion, and Uncrosslinking 
Item Manufacturer Manufacturer 
Catalog No. 
OmniPur SDS, 500 g EMD Millipore 7910-500GM 
Proteinase K from Tritirachium album Sigma Aldrich P2308 
Halt Protease and Phosphatase Inhibitor 
Single-Use Cocktail, 100X, 24 x 100  µL 
Pierce/ThermoScientific 78442 
Paraformaldehyde 20% Solution, EM 
Grade 
Electron Microscopy 
Sciences 
15713-S 
Tween 20 Sigma Aldrich P9416 
RNaseOUT Recombinant Ribonuclease 
Inhibitor 
Life 
Technologies/Invitrogen 
10777-019 
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APPENDIX B 
NEW FUNCTIONAL HANDLE FOR USE AS A SELF-REPORTING CONTRAST 
AND DELIVERY AGENT IN NANOMEDICINE 
 
B.1  Published Article 
 
Herein is a peer reviewed article to which I have contributed.  Though not 
explicitly related to the principle subject matter of this thesis, I submit the publication as 
representative of my efforts while a student at Texas A&M University. 
 
B.2  Authorship and Contributions 
 
The authorship of this manuscript (* principle investigator, + first author) is as 
follows: 
University of Warwick; Rachel K O’Rielly*, Mathew P. Robin+, Anne B. Mabire 
Texas A&M University; Jeffery E. Raymond*, Ursula H. Winzer-Serhan, Joanne 
C. Damborsky and Elizabeth S. Raymond (née Thom). 
 
B.3  Information Related to Copyright 
 
Reprinted (adapted) with permission from: Robin, M.P.; Mabire, A.B.; 
Damborsky, J.C.; Thom, E.S.; Winzer-Serhan, U.H.; Raymond, J.E.; O’Reilly, R.K. 
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New Functional Handle for Use as a Self-Reporting Contrast and Delivery Agent in 
Nanomedicine. J. Am. Chem. Soc. 2013, 135(25), 9518. Copyright 2013 American 
Chemical Society (See Figure B1). 
This appendix has been formatted to fulfill the layout requirements of this thesis 
document with content only modified to meet this requirement. 
 
 
 
 
 
Figure B1. Permission of reproduction letter 
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B.4  Abstract 
 
The synthesis and photophysical characterization of a chromophore-bridged 
block copolymer system is presented. This system is based on a dithiomaleimide (DTM) 
functional group as a highly emissive functionality which can readily be incorporated 
into polymeric scaffolds. A key advantage of this new reporter group is its versatile 
chemistry, ease of further functionalization, and notably small size, which allows for 
ready incorporation without affecting or disrupting the self-assembly process critical to 
the formation of core−shell polymeric contrast and drug delivery agents. We 
demonstrate the potential of this functionality with a diblock system which has been 
shown to be appropriate for micellization and, when in the micellar state, does not self-
quench. The block copolymer is shown to be significantly more emissive than the lone 
dye, with a concentration-independent emission and anisotropy profile from 1.5 mM to 
0.15 μM. An emission lifetime and anisotropy decay comparison of the block copolymer 
to its micelle displays that time-domain fluorescence lifetime imaging (FLIM) is able to 
rapidly resolve differences in the supramolecular state of this block−dye−block polymer 
system. Furthermore, the ability to resolve these differences in the supramolecular state 
means that the DTM micelles are capable of self-reporting when disassembly occurs, 
simply by monitoring with FLIM. We demonstrate the great potential for in vitro 
applications that this system provides by using FLIM to observe micelle disassembly in 
different vascular components of rat hippocampal tissue. In total this system represents a 
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new class of in-chain emitter which is appropriate for application in quantitative imaging 
and the tracking of particle degradation/disassembly events in biological environments. 
 
 
 
 
 
Figure B2. Abstract figure 
 
Reprinted with permission from: Robin, M.P.; Mabire, A.B.; Damborsky, J.C.; Thom, E.S.; Winzer-
Serhan, U.H.; Raymond, J.E.; O’Reilly, R.K. New Functional Handle for Use as a Self-Reporting Contrast 
and Delivery Agent in Nanomedicine. J. Am. Chem. Soc. 2013, 135(25), 9518. Copyright 2013 American 
Chemical Society. 
 
 
 
B.5  Introduction 
 
There has been much recent interest in the use of core−shell polymeric 
nanoparticles as contrast agents1 and in-cell delivery platforms in nanomedicine.2 
Strategies for incorporating contrast and bioactive media into these systems have 
included tethering,3 cross-linking,4 and noncovalent interactions.5 These have included 
processes at all three particle regions (core,6 shell,7 and surface8), but little has been done 
at the core−shell interface. We propose this region is of particular interest given its 
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environment-shielded nature compared to the surface or shell domain and distinct 
spatially separated location from encapsulants loaded into the interior of the scaffold. 
These features are key to ensuring that the emissive properties of the reporter are 
unaffected by local changes within the scaffold or its immediate surroundings and 
instead can be reliably correlated to specific whole-system events. 
Common issues with conventionally labeled systems, in application, include the 
inability to readily observe how incubated molecules interact with the host and often no 
conclusive way to track particle degradation in vitro as it occurs. There is often 
ambiguity regarding the location of the binding molecule and its mobility in the micellar 
host, both for contrast agents and with pharmacological payloads. Another problem 
arising from encapsulation is decreased emission from loaded contrast agents, through 
either probe−polymer interactions or probe−probe self-quenching events.9 Furthermore, 
it is known that incorporation of an emissive handle, often a large hydrophobic 
molecule, can lead to changes in scaffold size, stability, and even encapsulation potential 
due to surface modification effects.2 Thus, new methods for the facile and nondisruptive 
labeling of nanostructures are required. 
One solution to these particular difficulties is the formation of a reporter group 
system which can be readily incorporated into the polymeric scaffold and used as an 
emissive reporter with a nonambiguous location in the nanostructure. For this study, we 
have selected the core−shell interface. In our previous work, we have displayed the 
versatility of dithiomaleimides (DTMs) as a new highly emissive fluorophore for protein 
and polymer labeling.10 In this study we have explored the incorporation of this new 
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system directly into a block copolymer scaffold, using the facile and well-established 
ring-opening polymerization (ROP)11 and reversible addition−fragmentation chain 
transfer (RAFT) polymerization12 methods. Indeed, we highlight how this functional 
handle can be used as a reporter group to track the micellar state and also allow for facile 
in situ particle tracking using its built-in bright fluorescence and self-reporting 
properties. This highly emissive and self-reporting system offers great potential for 
nanomedicine applications. Furthermore, given the ease of synthesis and ready 
incorporation into polymeric systems, we propose this new probe also has potential in a 
range of sensing and tracking applications. 
 
B.6  Results and Discussion 
 
B.6.1  Polymer Synthesis 
 
Our investigations have focused on the incorporation of DTM functionality and 
its exploration as a bright and emissive probe in both polymers and amphiphilic polymer 
self-assembled structures. Positioning the DTM unit at the core−shell interface required 
that the hydrophobic and hydrophilic blocks of the amphiphile were polymerized from 
either end of this functional group by two orthogonal polymerization techniques (Figure 
B3). To achieve this objective, we utilized a DTM-containing dual ROP/RAFT initiator, 
1, which we have previously shown to be highly tolerant to polymerization conditions.10 
ROP using a thiourea/(−)-sparteine organocatalyst system13 could first be initiated from 
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Figure B3. Synthesis of diblock copolymer, micelle formation and model dye. 
 
(a) Synthesis of Dual ROP/RAFT Initiator 1, (b) Synthesis of Amphiphilic Copolymer 2 by Sequential ROP 
and RAFT Polymerization, (c) Self-Assembly of 2 To Give Spherical Micelles 2M, and (d) Synthesis of 
Small-Molecule DTMs 3 and 4. Reprinted with permission from: Robin, M.P.; Mabire, A.B.; Damborsky, 
J.C.; Thom, E.S.; Winzer-Serhan, U.H.; Raymond, J.E.; O’Reilly, R.K. New Functional Handle for Use as 
a Self-Reporting Contrast and Delivery Agent in Nanomedicine. J. Am. Chem. Soc. 2013, 135(25), 9518. 
Copyright 2013 American Chemical Society. 
 
 
 
 the hydroxyl groups on the S substituents of the DTM unit to form the hydrophobic 
poly(D,L-lactide) block. Then RAFT polymerization from the trithiocarbonate attached 
through the N of the DTM unit afforded the hydrophilic triethylene glycol monomethyl 
ether acrylate (TEGA) block. The resultant Y-shaped amphiphilic block copolymer, 2, 
was subsequently characterized using 1H NMR spectroscopy and size exclusion 
chromatography (SEC) (Mn,NMR = 28.4 kg·mol
−1, ĐSEC = 1.22, Figures B9 and B11, 
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Supporting Information). To assist with the emissive characterization of the new 
materials, two further small-molecule DTMs were prepared, 3 and 4. It should be noted 
that N-Alkylation (4) had only a minor effect on the fluorescence properties (see the 
Supporting Information), so only 3 will be discussed in detail below. 
 
B.6.2  Micelle Assembly 
 
Self-assembly of polymer 2 into spherical micelles was achieved using direct 
dissolution methods to afford a solution of micelles (2M) at 1 mg/mL. The number-
average diameter was found to be 23 nm via dynamic light scattering (DLS), with a 
polydispersity index (PDI) of 0.17 (Figure B12, Supporting Information). To confirm a 
micellar structure, atomic force spectroscopy (AFM) was used to observe the micelles on 
a glass substrate. A micrograph of a typical sampling with a height profile is presented in 
Figure B4. While the micelles were not stable enough to be imaged on a high-energy 
surface (mica), which they immediately coated, the AFM images presented from 
solution-phase imaging on a lower energy surface (glass) were comparable in diameter 
to the DLS results. Furthermore, the micelles were also imaged in the dried state on a 
low-contrast graphene oxide support by transmission electron microscopy (TEM) 
without staining,14 which confirmed an average diameter of 19.1 ± 2.1 nm (Figure B13, 
Supporting Information). 
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Figure B4. Atomic force microscopy of micelles 2M. 
 
Solution-phase AFM micrographs of micelles 2M imaged on a glass substrate and cross-section 
depicting typical micelle sizes. Reprinted with permission from: Robin, M.P.; Mabire, A.B.; 
Damborsky, J.C.; Thom, E.S.; Winzer-Serhan, U.H.; Raymond, J.E.; O’Reilly, R.K. New Functional 
Handle for Use as a Self-Reporting Contrast and Delivery Agent in Nanomedicine. J. Am. Chem. Soc. 
2013, 135(25), 9518. Copyright 2013 American Chemical Society. 
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B.6.3  Steady-State Fluorescence and Emission Anisotropy 
 
Both species 2 and 3 possessed similar UV−vis and excitation spectra, with 
maxima near 403 nm. Steady-state emission spectra for 2 and 3 are presented in Figure 
B5 from 405 nm excitation. Quantum yield measurements for 2 (10 μM) in methanol 
resulted in a ΦPL of 0.343 ± 0.004. In comparison, the ca. 30-fold less emissive 3 (12 
μM) possessed a ΦPL of 0.011 ± 0.002. In particular, the micelle emission efficiency 
compares very favorably to other common fluorescent labels, ΦPL of 0.02−0.90,15 
without suffering from self-quenching, despite a dye concentration in the micelle which 
can be calculated from DLS Rh at ca. 0.05 M. The authors attribute this increased 
emission to the polymeric substituents preventing both solvent/collisional quenching 
effects and self-quenching, though a planarization effect of the polymer substituents is 
not entirely ruled out. To observe the effect of concentration on emissivity, a dilution 
study was also performed (Figure B5). It can be seen from these integrated emission 
intensities that emission from 3 scales similarly to that of most self-quenching 
fluorophores,9 while the micelle forming 2 possesses a relatively flat emission profile 
over 3 orders of magnitude of concentration. 
To confirm the supramolecular state of 2 during this relatively low dependence 
of emission on concentration, steady state anisotropy spectroscopy was performed. 
While the anisotropy for emission from 3 remained flat with regard to concentration at r 
= 0.043 ± 0.001, the anisotropy of 2 changed significantly over the same concentration 
range (Figure B5). At high concentrations, anisotropy for 2 approaches that of 3, which 
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the authors assign to a solvent-in-polymer character where 2-to-2 FRET and hopping 
events may lead to an overall less polarized emission.16 In the region of uniform 
emissivity, anisotropy is highest (0.17), typical of a polymer micelle state where a 
chromophore’s tumbling is reduced by incorporation into a structure where mass and 
volume have increased and collisional quenching with solvent is inhibited.17 At low 
concentrations, anisotropy decreases to ca. 0.12 and should be taken to represent a 
response approaching that of the isolated polymer-in-solvent state. The fact that 
anisotropy does not decrease in the intermediate concentrations where a micellar state 
exists is particularly telling. A subtly to note is that the in-micelle local dye 
concentration is significantly higher than the highest sample concentration investigated 
(1 mM). Detailed excellently in a topical review by Olaya-Castro and Scholes,18 
increased emissivity and anisotropy from chromophore- dense assemblies are an 
indication of coherent energy transfer (ET) events in supramolecular structures where 
regular or semiordered geometries exist between substituents. However, without 
proximal ordering, these effects are not observed in disordered solutions, even at high 
concentrations. In this second case, without ordered and constrained architecture, the 
more conventional ET regime dominates with all of the typical effects of increased 
concentration (such as decreased anisotropy, quenching, and/or reabsorption) 
manifesting in turn. In all, both emission and anisotropy trends provide a method for 
distinguishing between supramolecular conditions via steady-state assessment and point 
to a system where timeresolved spectra may be particularly pointed in resolving changes 
in state. 
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Figure B5. Steady-state emission, emissivity and emission anisotropy. 
 
Steady-state emission spectra, concentration-based emissivity and emission anisotropy for small-
molecule 3  and polymer 2. Reprinted with permission from: Robin, M.P.; Mabire, A.B.; Damborsky, 
J.C.; Thom, E.S.; Winzer-Serhan, U.H.; Raymond, J.E.; O’Reilly, R.K. New Functional Handle for Use 
as a Self-Reporting Contrast and Delivery Agent in Nanomedicine. J. Am. Chem. Soc. 2013, 135(25), 
9518. Copyright 2013 American Chemical Society. 
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B.6.4  Fluorescence Lifetime and Anisotropy Decay 
 
To assess the viability of this polymer system for fluorescence lifetime imaging 
microscopy (FLIM), solution-state time-correlated single-photon counting (TCSPC) was 
performed to determine emission and anisotropy decay profiles. A polymer-in-solvent 
(2S, 10 nM), polymer micelle (2M, 1 μM) and chromophore solution (3X, 1.2 μM) were 
assessed with a pulsed 405 nm diode laser (135 ps fwhm), and resultant emission decay 
and anisotropy decay spectra are presented in Figure B6 with kinetic information in 
Table B1. All species consistently displayed three components to decay after 
deconvolution. The lone chromophore 3X decays almost immediately, with two near-
ultrafast lifetimes comprising the majority of decay and one longer decay of ca. 5 ns. 
The significance of this result can be assigned and summarized as follows: (i) the 
shortest decays can reasonably be assigned to nonemissive aggregation and solvent-
collision effects19 and (ii) the longer lifetime as an intrinsic relaxation event for this 
family of emitter, observed also as the τ1 decay in the 2 series. However, the critical 
comparison, in terms of application, is of the micellar system 2M and the solvated 
polymer 2S as these differences will be key to observation of particle disassembly in 
vitro and in vivo. Perhaps easiest to implement is a direct comparison of average 
lifetimes (τav,A = 7.6−13 ns, τav,I = 15−20 ns) or emission half-lives, though any of the 
component extractions are sufficiently different to detect a change in state for this 
system. 
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Often even more sensitive to the local environment, anisotropy decay kinetics 
can also be a powerful tool for the assessment of super-, supra-, and macromolecular 
states.16,19,20 For 3X, decay from r(0) = 0.11 to r(0) = ca. 0 occurs immediately during 
the first nanosecond. Comparison of 2S and 2M provides such contrast in anisotropy 
kinetic character that all components of the fitting can be used to discriminate between 
the micellar state and the unimer. Most telling is the apparent anisotropy recovery 
observed in 2S. This rise is assigned to the emission decay of lower anisotropy states, 
which results in a greater expression of more anisotropic states, possibly quasi-micellar 
or aggregate interactions.16,21 In conjunction with a larger steady-state anisotropy in 2M 
as compared to 2S, these spectra display that the total anisotropy decay profile and all of 
the extractions are viable signaling channels for monitoring a transition from a micellar 
state to a disassembled/degraded one. 
Taking all emission and anisotropy lifetime information in total, a picture 
emerges relating kinetics to the polymer assembly state with final assignments as 
follows: (i) τ1 in the 2 series and τ3 in 3X are assigned to intrinsic lifetimes of the 
species,20,22 (ii) longer lifetimes and higher amplitudes for τ2 and τ3 for 2M are the result 
of better fluorophore protection when compared to 2S,16 (iii) fast anisotropy decay in 
2M suggests the possibility of coherent effects from localized, similarly oriented dye 
bridges at the core−shell interface,19,20 and (iv) the long anisotropy decay in 2M informs 
as to the time scale at which micellar tumbling occurs. For a detailed discussion of the 
emission lifetime and anisotropy decay for 2P see the Supporting Information. 
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Figure B6. Fluorescence lifetimes and anisotropy decays  
 
Fluorescence lifetime (top) and anisotropy decay spectra (bottom) for 2M, 2S and 3X with residuals. 
Reprinted with permission from: Robin, M.P.; Mabire, A.B.; Damborsky, J.C.; Thom, E.S.; Winzer-
Serhan, U.H.; Raymond, J.E.; O’Reilly, R.K. New Functional Handle for Use as a Self-Reporting 
Contrast and Delivery Agent in Nanomedicine. J. Am. Chem. Soc. 2013, 135(25), 9518. Copyright 
2013 American Chemical Society. 
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Table B1. Emission lifetime and anisotropy kinetics for solution- and solid-state 
systems. 
 
ar(0) is the anisotropy fit value after 95% of instrument response function (IRF), with the difference 
between r(0) and 0.4 taken as the ultrafast decay amplitude. br(inf) is the asymptotic anisotropy 
reached by 95% of decay intensity. c⟨r⟩ is the steady-state anisotropy at emission maxima with 405 nm 
excitation. Reprinted with permission from: Robin, M.P.; Mabire, A.B.; Damborsky, J.C.; Thom, E.S.; 
Winzer-Serhan, U.H.; Raymond, J.E.; O’Reilly, R.K. New Functional Handle for Use as a Self-
Reporting Contrast and Delivery Agent in Nanomedicine. J. Am. Chem. Soc. 2013, 135(25), 9518. 
Copyright 2013 American Chemical Society. 
 
 
 
B.6.5  FLIM 
 
To display the viability of self-assembled nanoparticles as self-reporting agents 
for nanomedicine applications, 2S and 2M were cast onto glass and the films (2S′ and 
2M′) inspected by FLIM (excitation 405 nm, 450 nm long-pass collection). The 
resulting images and spectral data are presented in Figure B7. FLIM images indicate that 
both systems possess extensive micellization in the solid state. However, polymer 
scarcity on deposition of 2S, and a lack of micelle structure predeposition, results in 
large droplet-like structures and a film background of unassembled polymer. While 
resolution limits preclude observation of nanoscale micelles in these systems, it is 
reasonable that the majority of the nanoscale micelles remain in the casting of 2M 
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despite some larger (1 μm) structures. Direct lifetime tail fittings of the entire field of 
view are presented in Table B1. Again, observing the contrast in signals, a poignant 
difference in contributions to signal for the short lifetime and longer two lifetimes exist, 
with 2M′ possessing a significantly larger contribution to signal from longer lived states. 
Component lifetimes are also longer for 2M′ in all cases, as is the half-life. Comparing 
the average arrival time of emission and the lifetime extraction histograms (fast-FLIM 
signal) for both systems reveals that, even without formal emission fitting, total photon 
arrival times per pixel are readily capable of resolving the difference in average 
supramolecular state of each system (Figure B7). This ability to differentiate between 
states is of particular importance in terms of end-use application in translational and 
pharmacological studies. To summarize, the results we detail here mean that in future 
work with DTM functional nanoparticles it will not be necessary for expert care to be 
given to spectral analysis. Rather, it should be possible to readily generate biological 
protocols for the use of this system in a fashion that does not require extensive and 
overtly time consuming analysis of the decay spectra. As a demonstration of the great 
potential these self-reporting micellar contrast agents possess, we investigated FLIM of 
the particles in rat hippocampal tissue. 
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Figure B7. Fluorescence lifetime imaging microscopy of 2M′ and 2S′. 
 
FLIM of cast 2M′ (left) and 2S′ (middle) with droplet-like microstructures indicated by arrows and 
fast-FLIM lifetime extraction histograms (right) from average photon arrival times. Reprinted with 
permission from: Robin, M.P.; Mabire, A.B.; Damborsky, J.C.; Thom, E.S.; Winzer-Serhan, U.H.; 
Raymond, J.E.; O’Reilly, R.K. New Functional Handle for Use as a Self-Reporting Contrast and 
Delivery Agent in Nanomedicine. J. Am. Chem. Soc. 2013, 135(25), 9518. Copyright 2013 American 
Chemical Society. 
 
 
 
B.6.6  FLIM in Rat Hippocampal Tissue 
 
It is known that polymeric nanoparticles which have not been tailored to 
penetrate the blood−brain barrier tend to have a variety of interactions with vascular 
tissues and fluids which inhibit transport into neuronal tissue.2,23 To provide a proof-of 
principle test in vitro, a cross-section of living rat hippocampal tissue was subjected to 
ca. 0.1 mL of 10 mg/mL polymer micelles in phosphate-buffered solution for 1 h, fixed 
with ethanol, and then imaged via FLIM. It was found that the micelles and degradation 
products could be found in three forms in the tissue, identified by their respective 
fluorescence lifetimes, with all states associated with vascular tissue components (Figure 
B8). In clotted regions (A), it could be observed that micellar (2M) emission was 
retained, while on the vascular wall (B), a shorter lifetime non-micellar polymer (2S) 
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emission can be observed. Emission from blood cells exposed to the micelles (C) 
displayed the shortest lifetimes. While this may be the result of heme-group emission,24 
the longer lifetime components of the emission profile do not support this theory and 
suggest instead that degraded polymer may have bound to the cells, resulting in emission 
similar to that of the solution-phase dye (3X). Indeed, emission decay for the C region 
overlays almost exactly with that of 3X, with τav = 1.1 and 1.0 ns, respectively (Figure 
B19, Supporting Information). 
 
 
 
 
 
Figure B8. Fluorescence lifetime imaging microscopy in vitro. 
 
FLIM of 2M in rat hippocampal tissue with fast-FLIM emission lifetime extractions for the clotting 
region (A), vascular tissue (B), and blood cells (C). Reprinted with permission from: Robin, M.P.; 
Mabire, A.B.; Damborsky, J.C.; Thom, E.S.; Winzer-Serhan, U.H.; Raymond, J.E.; O’Reilly, R.K. New 
Functional Handle for Use as a Self-Reporting Contrast and Delivery Agent in Nanomedicine. J. Am. 
Chem. Soc. 2013, 135(25), 9518. Copyright 2013 American Chemical Society. 
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B.6.7  Application of Block-Dye-Block Emitters as Quantitative Contrast Agents and 
Self-Reporters 
 
The advantage of being able to use a concentration-independent emitter as part of 
a diblock micelle or cross-linked nanoparticle relates to the generation of a venue for 
quantitative microscopic techniques in assessing nanomedicine delivery platforms. In 
short, without ambiguities regarding the state/location of the emitter, it becomes possible 
to perform cellular imaging where emission intensity is truly an indication of particle 
density. Similarly, for the determination of small-molecule location and 
loading/unloading kinetics in a polymeric nanoparticle, it becomes possible to use the 
FRET signal to or from the built-in chromophore to track molecules moving across the 
core−shell interface. Given the differences in emission anisotropy and lifetime, these 
materials may be ideal candidates for FLIM, anisotropy or anisotropy decay imaging of 
particle incorporation, and degradation both in vitro and in vivo. Lastly, noting the 
various gross differences in total and component decay parameters (Table B1), an array 
of possibilities exist for developing biological protocols that provide unambiguous 
answers regarding micelle location and its supramolecular state (micellar polymer, non-
micellar polymer, or degraded). In practice, we suggest use of the fast-FLIM signal, fast-
FLIM component signal, or a gating technique25 for analysis when using FLIM for 
degradation/disassembly studies in these venues. By gating, the authors refer to selecting 
the temporal region where 2M emission intensities have the highest ratio of difference 
for analysis. This bypasses the arduous assessment of similar fast-lifetime emission 
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components and allows one to look at trends in specific temporal regions where micelle 
emission and free polymer emission are distinctly different. 
 
B.7  Conclusion 
 
We present the full synthesis and photophysical properties of a polymeric emitter 
capable of self-assembly into bright self-reporting nanoparticles. The block−dye−block 
strategy presented here is the first of a new platform chemistry for generating self-
reporting materials for nanomedicine through the incorporation of a specific 
dithiomaleimide functional group. Spectral analysis of the concentration dependence of 
the fluorescent polymer shows that supramolecular structuring controls emissivity, 
emission polarization, and lifetime. This new probe with self-reporting capabilities can 
be readily incorporated into polymeric nanostructures and, given its small size, can be 
considered non-invasive. Application methods are both shown and discussed throughout 
this work to best utilize the unique signaling capabilities of this system. In addition to 
being shown as a viable self-reporting system for solid-state applications and in-tissue 
studies, the “at the core−shell interface” strategy provides a route to potentially tracking 
explicit loading and unloading kinetics from changes in the spectral signature of the 
DTM from transient species crossing to and from the core. 
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B.11  Supporting Information for New Functional Handle for Use as a Self-
reporting Contrast and Delivery Agent in Nanomedicine 
 
B.11.1  Experimental 
 
B.11.1.1  Materials and Apparatus 
 
Chemicals were used as received from Aldrich, Fluka and Acros. Dry solvents 
were obtained by passing over a column of activated alumina using an Innovative 
technologies solvent purification system. ROP reagents were purified according to 
literature procedures.1 TEGA was synthesized as previously reported and stored below 4 
°C.2 
1H and 13C NMR spectra were recorded on a Bruker DPX-400 spectrometer in 
CDCl3. Chemical shifts are given in ppm downfield from the internal standard 
tetramethylsilane. Size exclusion chromatography (SEC) measurements were conducted 
using a Varian 390-LC-Multi detector suite fitted with differential refractive index 
(DRI), light scattering (LS) and photodiode array (PDA) detectors equipped with a guard 
column (Varian Polymer Laboratories PLGel 5 µm, 50×7.5 mm) and two mixed D 
columns (Varian Polymer Laboratories PLGel 5 µm, 300×7.5 mm). The mobile phase 
was tetrahydrofuran with 2% triethylamine eluent at a flow rate of 1.0 ml·min-1 and data 
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was analyzed using Cirrus v3.3 with calibration curves produced using Varian Polymer 
laboratories Easi-Vials linear poly(styrene) standards (162-2.4×105 g·mol-1). Dynamic 
light scattering (DLS) was conducted using a Malvern Zetasizer NanoS instrument 
operating at 25 °C with a 4 mW He-Ne 633 nm laser module and a detection angle of 
173°, with data analysed using Malvern DTS 5.02 software. Transmission electron 
microscopy (TEM) imaging was performed on a Jeol 2011 200 kV LaB6 instrument 
fitted with a Gatan UltraScan™ 1000 camera. Samples were prepared according to 
literature procedure.3 UV-Vis spectra were determined with the use of Shimadzu UV-
2550 spectrophotometer. All steady state emission, excitation and anisotropy spectra 
were obtained with a Horiba FluoroMax4 with automatic polarizers. Quantum yield 
calculations were performed against a tris(2-2’-pispyridyl)dichlororuthenium(II) 
hexahydrate standard,4 (8 µL in 0.2 µm filtered deionized water) following the IUPAC 
standard method.5 Time correlated single photon counting was employed to obtain all 
fluorescence lifetime spectra. This was done with a Fluorotime 100 fluorometer and 405 
nm solid state ps diode laser source (PicoQuant) in matched quartz 0.7 mL cells (Starna 
Cell). Instrument response functions (IRF) were determined from scatter signal solution 
of Ludox HS-40 colloidal silica (0.01% particles in water wt/wt). The phosphate 
buffered saline was 1X 0.0067 M PO4 without calcium or magnesium while methanol 
was anhydrous Atomic force microscopy was performed using a Multimode 8 system 
(Bruker) with a SA Fluid+ probe (k 0.7 N/ 150 kHz, Bruker). Fluorescence lifetime 
imaging was performed using a FLIM LSM upgrade kit for the FV1000 (PicoQuant) 
mounted on a FV1000 (Olympus) confocal microscope on a IX-81 inverted base 
 153 
 
(Olympus). A PlanApo N 60x oil lens (NA 1.42, Olympus) was used for all imaging. 
The FV1000 system was driven with the FV10-ASW v3.1a software platform 
(Olympus) with scan rates of 4 us/pixel at 256 by 256 pixels. FLIM images and spectra 
were collected using bins of 16 ps with a 405 nm (LDH-P-C-405B, PicoQuant) driven at 
2.5 MHz. FWHM for the 405 nm laser head was 59 ps and maximum power was 0.21 
mW (attenuated by variable neutral density filters to prevent count pile up and maintain 
counting rates below 1% bin occupancy). Steady-state spectra were analyzed in 
FluoreEssence (Horiba) and in Origin 8.6 Pro (Origin Labs). TCSPC analysis was 
performed on Fluorofit (PicoQuant) software and confirmed by tail-fitting in Origin 8.6 
Pro. AFM images were assessed with Nanoscope Analysis (Bruker). SymphoTime 64 
(Picoquant) software was used for collection and analysis of FLIM images and spectra, 
with spectra confirmed by tail-fitting in Origin 8.6 Pro. All IRF deconvolved exponential 
fits were performed with the number of exponents selected for completeness of fit as 
determined by boot-strap chi-squared analysis in Fluorofit, typically three. 
 
B.11.1.2  Animal Tissue Studies 
 
Fresh 300 µm thick adult rat hippocampi slices maintained in artificial 
cerebrospinal fluid, as outlined in detail elsewhere,6 were incubated with 0.1 mL of a 10 
µM (PBS, Hyclone, Thermo Scientific) solution of 2 immediately after dissection. The 
rat used was not killed for the purposes of this experiment and all tissues used were 
excess from an unrelated study. In brief, an adult female Sprague-Dawley rat was 
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decapitated under isoflurane anesthesia, and its brain was quickly removed and 
submerged in an ice-cold cutting solution containing (in mM) 0.3 Kynurenic acid, 120 
NaCl, 11 D-Glucose, 26 NaHCO3, 6 MgCl2, 3 KCl, 0.5 CaCl2, and 5 HEPES. While still 
in the cutting solution, 300 µM coronal slices were taken through brain using a 
Vibratome 3000 Sectioning System. The hippocampi were dissected from the slices, and 
transferred to artificial cerebrospinal fluid containing (in mM) 124 NaCl, 3 KCl, 1.5 
MgSO47H2O, 1.2 NaH2PO4, 2.4 CaCl2, 26 NaHCO3, and 10 D-Glucose bubbled with 
95%O2 /5%CO2. The solution of micellar 2 was directly applied to the surface of the 
slices and allowed to incubate for 1 hour, then fixed with ethanol and mounted before 
imaging. 
 
B.11.1.3  Synthetic Protocols 
 
Compounds 1, 3, and poly(D,L-lactide) were prepared as previously reported.7 
 
B.11.1.3.1  3µ-[poly(triethyleneglycol monomethyl ether methacrylate)]-b-[poly(D,L-
lactide)]2 Star Block Copolymer (2) 
 
A solution of poly(D,L-lactide) (25 mg, 3.71 µmol), TEGA (80.0 µL, 0.408 
mmol), and AIBN (0.152 mg, 0.926 µmol) in CHCl3 (240 µL) was added to a 
polymerization ampoule. The solution was degassed by three freeze-pump-thaw cycles 
and sealed under N2. The reaction was stirred at 60°C for 16 hours to a monomer 
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conversion of 95 %, at which point the reaction was quenched by rapid cooling. The 
solvent was removed in vacuo, and the residue was purified by dialysis (MWCO 6-8000 
Da) against distilled water. The product was obtained as a fluorescent yellow waxy solid 
by lyophilization. Mn,NMR = 28.4 kg·mol-1, Mn,SEC = 20.1 kg·mol-1, ÐSEC = 1.22. 
1H 
NMR (400 MHz, CDCl3) δ 5.25-5.11 (2H PLA, m, OCH(CH3)CO2), 4.30-4.04 (2H 
PTEGA, br, CO2CH2CH2), 3.72-3.52 (10H PTEGA, br m, CO2CH2CH2O[CH2CH2O]2), 
3.39-3.35 (3H PTEGA, br, [CH2CH2O]3CH3), 2.48-2.20 (1H PTEGA, br, CH(CO2)CH2), 
1.53-1.33 (2H PTEGA, br, CH(CO2)CH2) and (6H PLA, m, OCH(CH3)CO2); FTIR 
(neat) νmax / cm-13511 (alcohol), 1732 (C=O ester of PLA and PTEGA), 1453 
(aromatic); Fluorescence (CHCl3) λem = 520 nm, λex = 410 and 270 nm 
 
B.11.1.3.2  3,4-bis(butylsulfanyl)-1-methyl-2,5-dihydro-1H-pyrrole-2,5-dione (4) 
 
2,3-Dibromo-N-methylmaleimide (0.956 g, 3.56 mmol) was dissolved in diethyl 
ether (40 mL). To the solution was added dropwise triethylamine (0.756 g, 7.47 mmol) 
and butanethiol (0.674 g, 7.47 mmol), whereby an immediate yellow colour was 
observed and a white precipitate. Upon complete addition, the solution was stirred at 
room temperature for 24 hours. The solution was filtered and concentrated in vacuo and 
the crude mixture purified by column chromatography (SiO2, petroleum ether: ethyl 
acetate = 97:3) to yield the product as a yellow oil (0.35 g, 34 %). Rf = 0.21. 
1H NMR 
(400 MHz, CDCl3) δ 3.28 (4H, t, J = 7.5 Hz, SCH2), 3.01 (3H s, NCH3), 1.63 (4H quin, J 
= 7.5 Hz, SCH2CH2), 1.45 (4H, sex, J = 7.5 Hz, CH3CH2), 0.93, (3H, t, J = 7.5 Hz, CH3); 
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13C NMR (100 MHz, CDCl3) δ 166.8(C=O), 135.9 (C=C), 32.5 (SCH2CH2), 31.6 
(SCH2), 24.4 (NCH3), 21.7 (CH3CH2), 13.6 (CH3); FTIR (neat) νmax / cm
-1 1768 and 
1697 (C=O of maleimide); HR-MS (MaXis) m/z found 310.0903, calc. 310.0906 
([M+Na]+, 100 %). 
 
B.11.2  Characterization 
 
 
 
 
 
Figure B9. 1H NMR (400 MHz, CDCl3) spectrum of 2. 
 
Reprinted with permission from: Robin, M.P.; Mabire, A.B.; Damborsky, J.C.; Thom, E.S.; Winzer-
Serhan, U.H.; Raymond, J.E.; O’Reilly, R.K. New Functional Handle for Use as a Self-Reporting Contrast 
and Delivery Agent in Nanomedicine. J. Am. Chem. Soc. 2013, 135(25), 9518. Copyright 2013 American 
Chemical Society. 
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Figure B10. a) 1H NMR (400 MHz, CDCl3) spectrum and b) 
13C NMR (100 MHz, 
CDCl3) spectrum of 4.  
 
Reprinted with permission from: Robin, M.P.; Mabire, A.B.; Damborsky, J.C.; Thom, E.S.; Winzer-
Serhan, U.H.; Raymond, J.E.; O’Reilly, R.K. New Functional Handle for Use as a Self-Reporting Contrast 
and Delivery Agent in Nanomedicine. J. Am. Chem. Soc. 2013, 135(25), 9518. Copyright 2013 American 
Chemical Society. 
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Figure B11. Molecular weight distributions obtained by SEC, with a polystyrene 
calibration and THF as the eluent for poly(D,L-lactide) and poly(TEGA)-b-poly(D,L-
lactide), 2.  
 
Reprinted with permission from: Robin, M.P.; Mabire, A.B.; Damborsky, J.C.; Thom, E.S.; Winzer-
Serhan, U.H.; Raymond, J.E.; O’Reilly, R.K. New Functional Handle for Use as a Self-Reporting Contrast 
and Delivery Agent in Nanomedicine. J. Am. Chem. Soc. 2013, 135(25), 9518. Copyright 2013 American 
Chemical Society. 
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Figure B12. Intensity, Volume and number-weighted micelle size distribution obtained 
by DLS for 2M, with average diameters (Dav).  
 
Reprinted with permission from: Robin, M.P.; Mabire, A.B.; Damborsky, J.C.; Thom, E.S.; Winzer-
Serhan, U.H.; Raymond, J.E.; O’Reilly, R.K. New Functional Handle for Use as a Self-Reporting Contrast 
and Delivery Agent in Nanomedicine. J. Am. Chem. Soc. 2013, 135(25), 9518. Copyright 2013 American 
Chemical Society. 
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Figure B13. TEM Image of micelles 2M, dried to a graphene oxide substrate (scale bar 
= 50 nm).  
 
Reprinted with permission from: Robin, M.P.; Mabire, A.B.; Damborsky, J.C.; Thom, E.S.; Winzer-
Serhan, U.H.; Raymond, J.E.; O’Reilly, R.K. New Functional Handle for Use as a Self-Reporting Contrast 
and Delivery Agent in Nanomedicine. J. Am. Chem. Soc. 2013, 135(25), 9518. Copyright 2013 American 
Chemical Society. 
 
 
 
B.11.3  Effect of N-H Substitution to N-CH3 
 
In order to confirm that polymeric block-dye-block topology is responsible for 
the gross change in emission character when comparing 2 and 3, and not merely the 
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result of aliphatic substitution of the maleimide N, a second small molecule dye 4 was 
synthesized (see above for synthetic protocol and characterization).  
4 emission was then characterized at 100 μM in methanol and contrasted to 3 
emission at 100 μM in methanol, as well as to the emission of 2M. Steady state UV-
Vis/fluorescence spectra are presented in Figure B14 and fluorescence lifetime traces for 
the two samples are presented in Figure B15, along with a reproduction of 2M solution 
spectra for comparison in both figures. 
 
 
 
 
 
Figure B14. Emission spectra of 4, 3 and 2M.  
 
Reprinted with permission from: Robin, M.P.; Mabire, A.B.; Damborsky, J.C.; Thom, E.S.; Winzer-
Serhan, U.H.; Raymond, J.E.; O’Reilly, R.K. New Functional Handle for Use as a Self-Reporting Contrast 
and Delivery Agent in Nanomedicine. J. Am. Chem. Soc. 2013, 135(25), 9518. Copyright 2013 American 
Chemical Society. 
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Figure B15. Emission lifetime spectra of 4, 3 and 2M.  
 
Reprinted with permission from: Robin, M.P.; Mabire, A.B.; Damborsky, J.C.; Thom, E.S.; Winzer-
Serhan, U.H.; Raymond, J.E.; O’Reilly, R.K. New Functional Handle for Use as a Self-Reporting Contrast 
and Delivery Agent in Nanomedicine. J. Am. Chem. Soc. 2013, 135(25), 9518. Copyright 2013 American 
Chemical Society. 
 
 
 
It can be observed in the steady state emission spectra that incorporation of the 
dithiomaleimide into the polymer structure results in blue shifted emission (544 
nm522 nm) while the change from a non N-functional DTM (3) to an N-alkyl 
functional DTM (4) results in a red shifted emission (544 nm562 nm). Steady state 
anisotropy measurements of emission at 550 nm for both 3 and 4 with 405 nm excitation 
were also made, providing <r> = 0.04 for 3 and <r> = 0.01 for 4. Corrected for 
absorption at 405 nm for both solutions, the integrated intensities for emission showed 4 
to be ca. 2 times more emissive than 3. The N-methyl 4 displayed an intensity average 
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lifetime of 1.8 ns compared to 0.6 ns in 3. Anisotropy decay rates for both were not 
significantly different (ca. 0.4 ns). Together, these measurements support the assertion 
that the differences in emissive character between 2 and 3 cannot be taken to be the 
result of N-substitution as the primary mode of ‘on-switching’ in 2. Of note, these results 
suggest that the N-substitution alone provides a very different effect on emission (red 
shift, decreased anisotropy, nominal increase in emission lifetime and emission 
efficiency) and that the ultimate blue shift in 2 is primarily a function of the 
supermolecular architecture and supramolecular state. 
 
B.11.4  Fluorescence of High Concentrations of 2 and 3 
 
The block-dye-block strategy was designed to in part avoid the often laborious, 
low yield dye conjugation strategies employed in modern core-shell nanotheranostics. 
Given this target application, it is reasonable to investigate the response of this system at 
high concentrations, as may be found in application (leukocytes, lymphatic tissue, 
targeted cell types, etc.). A study of the neat 2 solid and the neat 3 liquid using FLIM 
was performed on the systems individually and together to be certain that the polymers 
degradation state at high concentrations can be elucidated. FLIM images for these 
systems can be found in Figure B16. Emission decay spectra, fittings and intensity 
average lifetimes are provided in Figure B17. 
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Figure B16. FLIM TCSPC spectral imaging of 2, 3 and a 2/3 blend. 
 
(a) FLIM of neat polymer 2 smeared as a film onto a glass slide; (b) FLIM of neat liquid dye 3 between a 
glass slide and glass cover slip; (c1-c3) neat polymer 2 pressed between a glass slide and glass cover slip 
with neat liquid dye allowed to intercalate and interact with some regions of the polymer, (c1) confocal 
fluorescence image of the blend at the dye advancement front, (c2) DIC image of the same region, (c3) 
FLIM of the same region. Fast-FLIM lifetime color scale applies to all FLIM images. Intensity (Events) 
scale in grey indicates emission intensity (a.u.) for c3. Reprinted with permission from: Robin, M.P.; 
Mabire, A.B.; Damborsky, J.C.; Thom, E.S.; Winzer-Serhan, U.H.; Raymond, J.E.; O’Reilly, R.K. New 
Functional Handle for Use as a Self-Reporting Contrast and Delivery Agent in Nanomedicine. J. Am. 
Chem. Soc. 2013, 135(25), 9518. Copyright 2013 American Chemical Society. 
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Figure B17. Full-frame emission spectra extracted from FLIM of neat 2, 3 and 2/3 
blend. 
 
Raw extracted lifetime spectra for all three systems with fitting (line). Reported average fluorescence 
lifetime τ from (Σanτn2) / (Σ anτn) and multi-exponential decay fitting. Reprinted with permission from: 
Robin, M.P.; Mabire, A.B.; Damborsky, J.C.; Thom, E.S.; Winzer-Serhan, U.H.; Raymond, J.E.; O’Reilly, 
R.K. New Functional Handle for Use as a Self-Reporting Contrast and Delivery Agent in Nanomedicine. 
J. Am. Chem. Soc. 2013, 135(25), 9518. Copyright 2013 American Chemical Society. 
 
 
 
While it is unlikely that concentrations approaching a neat sample would occur in 
an in vitro or in vivo environment, the differences between states in Figure B16 (c3) 
indicates that high concentrations of either can be rapidly determined by fast-FLIM 
lifetime contrast. In this figure the solvent front has advanced from the upper left (blue, 
low intensity) to the center of the field of view, leaving a region of untouched polymer 
(red, high intensity) that maintains pure neat 2 signal. For studies, like theranostic 
clearance studies, where disassembled nanoparticle materials need to be resolved in 
terms of extent of chain degradation, this contrast will be extremely useful. Additional 
examples of this contrast can be seen in other blend configurations/regions as presented 
in Figure B18. 
 166 
 
 
 
Figure B18. FLIM time domain contrast imaging of 2/3 blends. 
 
Top: fluorescence, DIC and FLIM images of a region where liquid 3 has advanced to the edge of solid 2. 
Middle: fluorescence, DIC and FLIM images polymer 2 with advancing liquid 3 on both the left and right 
and pure neat polymer signal from the untouched region in the center. Bottom: fluorescence, DIC and 
FLIM images of isolated polymer regions at the dye 2 liquid front, with signal from regions outside of the 
front possessing longer lifetimes and those within expressing a convolution of 2 and 3 signal. Raw 
extracted lifetime spectra for all three systems with fitting (line). Reprinted with permission from: Robin, 
M.P.; Mabire, A.B.; Damborsky, J.C.; Thom, E.S.; Winzer-Serhan, U.H.; Raymond, J.E.; O’Reilly, R.K. 
New Functional Handle for Use as a Self-Reporting Contrast and Delivery Agent in Nanomedicine. J. Am. 
Chem. Soc. 2013, 135(25), 9518. Copyright 2013 American Chemical Society. 
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A final comparison between the raw decay data for the FLIM signal of the C 
extracts region (as denoted in Figure B8) to the emission decay of 3X by solution 
TCSPC is presented in Figure B19. From this comparison of decays, it is clear that the 
signal of the C extract region is virtually indistinguishable from the solvated 3X. This 
further reinforces the application readiness of our block-dye-block architecture as a self-
reporting system where the dye regions are capable of reporting on its degradation state. 
 
 
 
 
 
Figure B19. Comparison of raw spectral data from region C in rat hippocampal tissue 
and 3X solution. 
  
Reprinted with permission from: Robin, M.P.; Mabire, A.B.; Damborsky, J.C.; Thom, E.S.; Winzer-
Serhan, U.H.; Raymond, J.E.; O’Reilly, R.K. New Functional Handle for Use as a Self-Reporting Contrast 
and Delivery Agent in Nanomedicine. J. Am. Chem. Soc. 2013, 135(25), 9518. Copyright 2013 American 
Chemical Society. 
 
 
 
In order to determine the emission character for disordered, high concentration 
solutions of 2 in contrast to micellar 2, a 1 mM (2P) solution in methanol was assessed 
by steady state anisotropy, lifetime and anisotropy decay fluorescence spectroscopies. 
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Steady state anisotropy from 405 nm excitation and 550 nm emission provided <r> = 
0.06. Emission lifetime measurements provided a τavg,I of 19.7 ns and τavg,A of 12.2 ns 
and τ1/2 of 6.2 ns. Component lifetimes (amplitude | component lifetime) were 0.54 | 4.8 
ns, 0.42 | 18.4 ns and 0.04 | 46 ns. Fluorescence anisotropy decay studies resulted in a 
fast decay (0.09 | 0.1 ns) and a longer decay (0.05 | 16 ns) with residuals of rinf = 0.13.  
When compared to the micellar 2M solution, the largest differentiation between 
the two systems can be observed in <r>, the longest component lifetime, the longest 
anisotropy decay and the amplitude contributions of anisotropy decay. In application, 
these metrics will be important for distinguishing between micellar emission and high 
concentrations of non-micellar polymer. Table B2 highlights the key differences in the 
emissive character of the two systems. Of note (in terms of ease of experimental 
implementation) the stark contrast in steady state emission anisotropy between the 2M 
and 2P samples emerges as a metric for discrimination that could be readily utilized in 
wide field collection, without resorting to more costly and time consuming experimental 
configurations. 
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Table B2. Key differences in 2M and 2P emission profiles  
 
Reprinted with permission from: Robin, M.P.; Mabire, A.B.; Damborsky, J.C.; Thom, E.S.; Winzer-
Serhan, U.H.; Raymond, J.E.; O’Reilly, R.K. New Functional Handle for Use as a Self-Reporting Contrast 
and Delivery Agent in Nanomedicine. J. Am. Chem. Soc. 2013, 135(25), 9518. Copyright 2013 American 
Chemical Society. 
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APPENDIX C 
ENHANCING THE PROTEIN RESISTANCE OF SILICONE VIA SURFACE-
RESTRUCTURING PEO-SILANE AMPHIPHILES WITH VARIABLE PEO 
LENGTH 
 
C.1  Published Article 
 
Herein is a peer reviewed article to which I have contributed. Though not 
explicitly related to the principle subject matter of this thesis, I submit the publication as 
representative of my efforts while a student at Texas A&M University. 
 
C.2  Authorship and Contributions 
 
The authorship of this manuscript (* principle investigator, + first author) is as 
follows: 
Texas A&M University; Marc A. Rufin+, Melissa A. Grunlan*, Jeffery E. 
Raymond*, John A. Gruetzner, Matthew J. Hurley, Melissa L. Hawkins, and 
Elizabeth S. Raymond. 
 
C.3  Information Related to Copyright 
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To access the original article, please use the following link: 
http://pubs.rsc.org/en/content/articlelanding/2015/tb/c4tb02042a#!divAbstract. 
This appendix has been formatted to fulfill the layout requirements of this thesis 
document with content only modified to meet this requirement. 
 
 
 
 
 
Figure C1. Permission of reproduction letter 
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Figure C1. Continued 
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Figure C1. Continued 
 
 
 
C.4  Abstract 
 
Silicones with superior protein resistance were produced by bulk-modification 
with poly(ethylene oxide) (PEO)–silane amphiphiles that demonstrated a higher capacity 
to restructure to the surface–water interface versus conventional non-amphiphilic PEO–
silanes. The PEO–silane amphiphiles were prepared with a single siloxane tether length 
but variable PEO segment lengths: α-(EtO)3Si(CH2)2-oligodimethylsiloxane13-block-
poly(ethylene oxide)n-OCH3 (n = 3, 8, and 16). Conventional PEO–silane analogues (n 
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¼ 3, 8, and 16) as well as a siloxane tether-silane (i.e. no PEO segment) were prepared 
as controls. When surface-grafted onto silicon wafer, PEO–silane amphiphiles produced 
surfaces that were more hydrophobic and thus more adherent towards fibrinogen versus 
the corresponding PEO–silane. However, when blended into a silicone, PEO–silane 
amphiphiles exhibited rapid restructuring to the surface–water interface and excellent 
protein resistance whereas the PEO–silanes did not. Silicones modified with PEO–silane 
amphiphiles of PEO segment lengths n = 8 and 16 achieved the highest protein 
resistance. 
 
C.5  Introduction 
 
Silicones, particularly silica-reinforced, crosslinked poly-dimethylsiloxane 
(PDMS), are widely used for medical, marine and industrial applications. These include 
blood-contacting devices (e.g. hemodialysis catheters, catheter balloons and cardiac 
pacing leads)1–3 and marine coatings.4 Unfortunately, as a result of their extreme 
hydrophobicity, the performance of silicones is severely limited by poor resistance to 
biomolecules such as proteins.5,6 For example, in the case of blood-contacting devices, 
the non-specific adsorption of plasma proteins is considered the first step of thrombosis 
and even infection.7–9 Various modifications have been utilized to hydrophilize silicones 
in order to reduce protein adsorption, including physical, chemical and combined 
approaches.10–14 
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Silicone modification with poly(ethylene oxide) (PEO; or poly(ethylene glycol) 
(PEG)) represents arguably the most widely utilized method for enhancing 
hydrophilicity and protein resistance.15–19 The exceptional protein resistance of PEO is 
attributed to its hydrophilicity and hydration, as well as its configurational mobility.20–23 
The biocompatibility24 and recently demonstrated in vivo oxidative stability25 of PEO 
contributes to its widespread use. Notably, the protein resistance of PEO has largely 
been assessed for chains surface-grafted onto physically stable substrates such as gold,26–
28 silicon29–31 and glass.32,33 For these “model PEO surfaces,” PEO chains are maintained 
at the surface irrespective of the environment (i.e. air versus water). In contrast, PEO 
chains incorporated into silicones are subject to surface reorganization upon exposure to 
a different environment.34 This process has been studied mainly in terms of hydrophobic 
recovery (i.e. loss of hydrophilicity with exposure to air) such as that observed for 
plasma treated silicones.35 This behavior is attributed to the low surface energy of 
silicones,36,37 coupled with their high chain flexibility.38,39 For example, hydrophobic 
recovery has been observed for PEO-modified silicones formed by bulk crosslinking 
with triethoxysilylpropyl PEO monomethyl ether [(EtO)3Si(CH2)3-(OCH2CH2)x-
OCH3]
40,41 as well as allyl PEO monomethyl ether [CH2═CHCH2-(OCH2CH2)x-
OCH3].
42 Hydrophobic recovery is also observed for surface-grafted PEO chains such as 
those prepared with allyl PEO monomethyl ether.42,43 However, since biofouling events 
such as protein adsorption occur in an aqueous environment, the rapid and substantial 
surface restructuring of PEO to the surface–water interface is of critical importance. 
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Towards the goal of enhancing the protein resistance of silicones, we sought to 
improve the capacity of PEO to migrate to the surface–water interface by altering its 
molecular structure. Previously, we reported PEO–silane amphiphiles prepared with a 
siloxane tether of varying lengths (m) separating the PEO segment from the 
crosslinkable ethoxy silane groups [α(EtO)3-Si(CH2)2-oligodimethylsiloxanem-
(OCH2CH2)8-OCH3; m = 0, 4, and 13].
44 The siloxane tether distinguishes the PEO–
silane amphiphiles from the analogous conventional PEO–silanes noted above which 
contain a short alkane (e.g. propyl) spacer.40–43 The siloxane tether is characterized by 
high flexibility resulting from the wide bond angle (~145°) and low barrier to 
linearization (~0.3 kcal mol-1) of Si–O–Si dimethylsiloxane bonds, features that give rise 
to low glass transition temperatures (e.g. PDMS, Tg = -125 °C).38,39 Like a silicone 
elastomer, the siloxane tether is also hydrophobic, imparting an amphiphilic character to 
these PEO–silanes. We anticipated that the flexibility and similarly hydrophobic nature 
of the siloxane tether would facilitate water-driven migration to the surface of a bulk-
modified silicone thereby reducing protein adsorption. Indeed, when the PEO–silane 
amphiphiles (m = 0, 4, and 13) were bulk crosslinked with α,ω-bis(Si–OH) PDMS (Mn = 
3000 g mol-1), protein resistance,44 as well as bacteria and diatom resistance,45 increased 
with siloxane tether length. Furthermore, extensive atomic force microscopy (AFM) 
analysis has confirmed the water-driven migration of PEO to these silicone coating 
surfaces to form nanocomplex surfaces.46 Herein, we evaluated the impact of PEO 
segment length by bulk crosslinking a medical grade RTV silicone with three PEO–
silane amphiphiles of different PEO segment lengths (n = 3, 8, and 16) and a single 
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siloxane tether length (m = 13) (Fig. C2). Given the protein resistance of PEO oligomers 
when surface-grafted onto a model substrate,26 the PEO–silane amphiphile (n = 8) was 
selected for our previous work to enhance the protein resistance of bulk-modified 
silicones.44,46–49 Thus, for this study, values of “n” (3, 8, and 16) were chosen as they are 
“substantially” different from one another (by a factor of approximately two) and thus 
were predicted to have different restructuring potentials. Analogous conventional PEO–
silanes or “PEO-controls” (i.e. no siloxane tether, n = 3, 8, and 16) as well as a 
“siloxanecontrol” (i.e. no PEO segment, m = 13) were likewise evaluated to highlight the 
effect of the siloxane tether. Water-driven surface restructuring was quantified by 
temporal static contact angle analysis of water droplets, and resistance to fibrinogen was 
also measured. In addition, PEO–silane amphiphiles, PEOcontrols and the siloxane-control 
were each surface-grafted onto silicon wafers in order to evaluate their protein resistance 
in the absence of surface restructuring. This study therefore represents an effort to better 
understand the influence of the siloxane tether and PEO segment length on the protein 
resistance and surface restructuring of PEO–silanes through systematic comparisons 
versus controls. 
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Figure D2. Structures of PEO-silane amphiphiles, PEO-silane controls and siloxane 
control 
 
Reproduced by permission of The Royal Society of Chemistry.  To access the original article, please use 
the following link: http://pubs.rsc.org/en/content/articlelanding/2015/tb/c4tb02042a#!divAbstract. 
 
 
 
C.6  Results and Discussion 
 
C.6.1  Surface-Grafted Coatings on Silicon Wafers 
 
The protein resistance of PEO–silane amphiphiles (n = 3, 8, and 16) in the 
absence of water-driven restructuring to the surface was evaluated with surface-grafted 
coatings prepared on silicon wafers. PEO-controls (n = 3, 8, and 16) and the siloxane-
control were likewise evaluated to elucidate the impact of the siloxane tether. 
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C.6.1.1  X-ray Photoelectron Spectroscopy (XPS) 
 
The surface-grafting of conventional PEO–silanes onto silicon wafers has been 
widely reported.29–31 Likewise, the successful surface-grafting of PEO–silane 
amphiphiles (n = 3, 8, and 16) was confirmed via XPS with the PEO-control (n = 8) and 
siloxane-control serving as controls. Surface elemental atomic percent compositions are 
reported in Table 1. For the oxidized silicon wafer, the 1s and Si 2p peaks correspond to 
the wafer composition whereas the carbon (C 1s) is attributed to adsorbed 
contaminants.50,51 Following surface-grafting, a decrease in Si 2p and increase in C 1s 
content was observed as expected. To further confirm surface-grafting, the C 1s peak 
was deconvoluted into two peaks of different binding energies and normalized to the 
peak centered at 284.5 eV (Fig. C3). These peaks correspond to the C–C/C–Si (at 284.5 
eV) and C–O (at 286.4 eV) of PEO.43 The areas of the C–C/C–Si and C–O peaks are 
reported in Table C1. When surfaces were grafted with PEO–silane amphiphiles, C–O 
content increased with PEO-segment length (n) and a concomitant decrease in C–C/C–Si 
content was also observed. As expected, the relative quantity of C–O on the surface 
grafted with the PEO-control was greatest due to the absence of C–Si associated with the 
siloxane tether that was present on all other samples. Finally, for the surface-grafted 
siloxane-control, C–O content was very low and may be attributed to residual unreacted 
ethoxy groups. Together, these results confirm the successful grafting of PEO–silane 
amphiphiles to silicon wafers. 
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Table C1. Surface atomic % composition by XPS  
 
Reproduced by permission of The Royal Society of Chemistry.  To access the original article, please use 
the following link: http://pubs.rsc.org/en/content/articlelanding/2015/tb/c4tb02042a#!divAbstract. 
 
 
 
 
 
Figure C3. HR C 1s XPS spectra of silicon wafers grafted with PEO–Silane 
amphiphiles (n = 3, 8, and 16) as well as the PEO-control (n = 8) and Siloxane-control  
 
Reproduced by permission of The Royal Society of Chemistry.  To access the original article, please use 
the following link: http://pubs.rsc.org/en/content/articlelanding/2015/tb/c4tb02042a#!divAbstract. 
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C.6.1.2  Ellipsometry 
 
As chain spacing is known to influence the protein resistance of grafted PEO 
coatings,52,53 it was important to ensure that the graft density was similar for all samples 
using ellipsometry. Dry thickness values (h) of grafted PEO–silane amphiphiles, PEO-
controls, and siloxane-control were measured and the obtained values of h were then 
used to estimate the chain density (σ) (Table D2):54–56  
 
σ = (hρNA)/Mn     (1) 
 
where ρ is the density of the dry grafted layer, NA is Avogadro's number and Mn is the 
number average molecular weight of the chain. The chain distance or “spacing” (D, nm) 
(i.e. distance between grafting sites) was also calculated (Table C2):56 
 
D = (4/πσ)1/2      (2) 
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Table C2. Surface atomic % composition by XPS  
 
Reproduced by permission of The Royal Society of Chemistry.  To access the original article, please use 
the following link: http://pubs.rsc.org/en/content/articlelanding/2015/tb/c4tb02042a#!divAbstract. 
 
 
 
Utilizing the described grafting conditions, all grafted layers were found to have 
similar chain spacing (D) (1.0–1.5 nm) except for the PEO-control (n = 8). Initially, this 
particular composition yielded high values of h (~4.3 nm) which are significantly higher 
than the fully extended chain length of the PEO segment (~2.8 nm),57 indicative of 
substantial multilayer formation. To prevent multilayer formation and increase D, the 
grafting conditions for the PEO-control (n = 8) were adjusted as follows: grafting 
solution concentration = 0.006 M, exclusion of water droplet from grafting solution, and 
cure under vacuum at RT. 
For all compositions of surface-grafted chains to be in the brush regime, D must 
be less than twice the Flory radius (2Rf).
53 For each chain composition, Rf was calculated 
on the basis of the length of one monomer (a) and the degree of polymerization (N) as 
follows:53,58,59 (i) for the siloxane-control in a poor solvent (water): Rf = aN
1/3, where a = 
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0.5 nm and N = 13 and (ii) for the PEO-controls in a good solvent (water): Rf = aN
3/5, 
where a = 0.35 nm and N = n. For all of these controls, D < 2Rf. Calculation of Rf for the 
PEO–silane amphiphiles is complicated by the fact that these contain two “blocks” (i.e. 
siloxane tether and PEO segment) of differing solubility in water. Thus, Rf was 
individually calculated on the basis of both the siloxane tether and the PEO segment47 
using the aforementioned equations. For all grafted PEO–silane amphiphiles, D < 2Rf, 
even when considering the lower of the two calculated Rf values. Thus, for all grafted 
chains, a brush regime was obtained. 
 
C.6.1.3  Water Contact Angle Analysis 
 
An oxidized silicon wafer provides a physically stable surface such that the 
concentration of grafted chains is maintained at the surface, irrespective of an air or 
water environment. Thus, the impact of PEO–silane amphiphile structure, including PEO 
segment length, on surface wettability (i.e. θstatic) may be elucidated by comparing these 
grafted surfaces to those prepared with the PEO-controls and the siloxane-control. θstatic 
was measured immediately after water droplet deposition (0 s) and at 2 min (Fig. C4; 
Table C9). For all grafted surfaces, θstatic (0 s) was very similar to θstatic (2 min) due to the 
expected lack of surface restructuring. For the siloxane-control grafted surface, the 
hydrophobicity of the siloxane tether (and the absence of a hydrophilic PEO segment) 
led to a hydrophobic surface as characterized by θstatic > 90°.
60 In the case of PEO-
control grafted surfaces, surface hydrophilicity increased (i.e. θstatic decreased) with 
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increased PEO-segment length (n). This trend was likewise observed for PEO–silane 
amphiphile grafted surfaces. However, due to the contributions of the PEO–silane 
amphiphiles' hydrophobic siloxane tethers, these surfaces were substantially more 
hydrophobic versus the corresponding PEO-controls (i.e. same n). 
 
 
 
 
 
Figure C4.  Static contact angle (θstatic) of surface-grafted silicon wafers at 0 s (dark) and 
2 min (Light) following placement of water droplet 
 
Each bar represents the average and standard deviation of measurements performed in triplicate on four 
identically prepared samples. Reproduced by permission of The Royal Society of Chemistry.  To access the 
original article, please use the following link: 
http://pubs.rsc.org/en/content/articlelanding/2015/tb/c4tb02042a#!divAbstract. 
 
 
 
C.6.1.4  Protein Adsorption 
 
Human fibrinogen (HF) was chosen as the protein for these adsorption studies 
due to its well-established influence in surface-induced thrombosis by causing platelet 
adhesion and activation.61–66 Its use in evaluating the thromboresistance of materials in 
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vitro has also been well established.26,40,46–49,53,54,63,67–71 Adsorption of HF onto surface-
grafted silicon wafers was measured by quartz crystal microbalance with dissipation 
monitoring (QCM-D) (Fig. C5). QCM-D has been widely used for measuring adsorption 
of proteins on low-fouling grafted monolayers and thin films.70,72–74 The Sauerbrey 
model was used to approximate the mass of fibrinogen due to the relatively low 
dissipation of the adsorbed protein.68 Furthermore, the changes in frequency and 
dissipation for the most protein-resistant surfaces were too small for the software to 
accurately calculate the mass using a viscoelastic (Voigt) model. Mass was calculated 
from the seventh overtone of frequency. 
 
 
 
 
 
Figure C5.  QCM-D-measured adsorption of human fibrinogen (HF) onto silica-coated 
sensors grafted with the siloxane-control [blue solid line], PEO–Silane mphiphiles (n = 
3, 8, and 16) [dashed lines] and PEO-Controls (n = 3, 8, and 16) [solid lines] 
 
After equilibration for 5 min with PBS, the sensors were exposed to HF for 20 min and then to PBS for 5 
min. Reproduced by permission of The Royal Society of Chemistry.  To access the original article, please 
use the following link: http://pubs.rsc.org/en/content/articlelanding/2015/tb/c4tb02042a#!divAbstract. 
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Proteins, including HF, are known to adsorb more onto hydrophobic versus 
hydrophilic surfaces.75,76 Indeed, the degree of hydrophobicity of the grafted surfaces (as 
indicated by θstatic reported in Fig. C4) correlates well with the observed amounts of HF 
adsorbed (Fig. C5). For instance, the siloxane-control produced the most hydrophobic 
grafted surface which led to the highest level of HF adsorption. Due to increasing 
hydrophilicity, the protein resistance of grafted surfaces with PEO–silane amphiphiles as 
well as PEO-controls increased with PEOsegment length (n). Notably, for a given PEO-
segment length (n), the PEO–silane amphiphile adsorbed more HF than the PEO control 
which is consistent with the higher hydrophobicity of the former. These results agree 
with the exceptionally low fouling nature observed for PEO chains grafted onto stable 
surfaces.26,28–30,32,33 
 
C.6.2  Bulk-Modified Silicone Coatings 
 
In order to evaluate the capacity of the silanes to undergo waterdriven surface 
reorganization and reduce protein adsorption, a medical-grade RTV silicone was bulk-
modified with PEO–silane amphiphiles (n = 3, 8, and 16), PEO-controls (n = 3, 8, and 
16) and the siloxane-control. Each silane was introduced at a constant level (50 µmol of 
silane per 1.0 g silicone) and the solvent-cast films were cured on glass slides (Fig. C6). 
The thicknesses of all films were measured by an electronic caliper and found to be 0.14 
± 0.01 mm. When modified with the hydrophobic siloxane-control, the coating 
appearance resembled that of the unmodified silicone. The lack of increased opacity of 
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these films was attributed to the solubility of the siloxane-control in the silicone matrix. 
In contrast, silicones modified with PEO-controls were substantially more opaque and 
notably so when compared to those prepared with the corresponding PEO–silane 
amphiphiles. Opacity increased, particularly for the PEO-controls, as the PEO-segment 
length (n) increased. The lesser increase in opacity of silicones modified with PEO–
silane amphiphiles may be attributed to reduced phase separation stemming from the 
solubility of the hydrophobic siloxane tether in the silicone matrix. 
 
 
 
 
 
Figure C6.  Unmodified silicone and silicones bulk-modified with PEO–silane 
amphiphiles (n = 3, 8, and 16), PEO-controls (n = 3, 8, and 16) and the Siloxane-control  
 
Reproduced by permission of The Royal Society of Chemistry.  To access the original article, please use 
the following link: http://pubs.rsc.org/en/content/articlelanding/2015/tb/c4tb02042a#!divAbstract. 
 
 
 
C.6.2.1  Water Contact Angle Analysis 
 
As noted, AFM was previously used to confirm the water-driven formation of a 
PEO-enriched surface for silicone modified with the PEO–silane amphiphile (n = 8).46 
Water-driven surface restructuring of bulk-modified silicones was evaluated by 
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temporally measuring qstatic of a water droplet placed on the surface over a 3 min 
period (Fig. C7, Table C10). As expected, the unmodified silicone was very hydrophobic 
and the θstatic value did not change significantly during the 3 min measurement. The 
siloxane-control produced a modified silicone that was also very hydrophobic but 
displayed a slight decrease in θstatic over 3 min (Δ = ~12°). However, at 3 min, θstatic was 
still >90° and therefore hydrophobic.60 Notably, silicones modified with PEO-controls 
also remained hydrophobic after 3 min (θstatic,3min > 90°), similarly exhibiting only a 
moderate decrease in θstatic 3 min after droplet deposition (n = 3, Δ = ~19°; n = 8, Δ = 
~15°; n = 16, Δ = ~12°). Thus, the PEO-controls demonstrated a limited capacity to 
migrate to the surface–water interface and hydrophobicity was only slightly diminished 
with decreased PEO length. In contrast, when modified with PEO–silane amphiphiles, 
silicone surfaces underwent extensive and rapid water-driven surface reorganization as 
noted by large decreases in θstatic over a 3 min period (n = 3, Δ = ~33°; n = 8, Δ = ~88°; n 
= 16, Δ = ~59°). Thus, the siloxane tether critically facilitates the migration of PEO 
segments to the surface–water interface. Due to this enhanced surface reorganization, 
initially hydrophobic surfaces quickly became more hydrophilic, with hydrophilicity 
increasing in the order: n = 3 (θstatic,3min = ~84°) < n = 16 (θstatic,3min = ~57°) < n = 8 
(θstatic,3min = ~29°). Thus, the PEO segment length of PEO–silane amphiphiles produced 
an obvious impact. For n = 8, modified silicones displayed the greatest decrease in θstatic 
over 3 min (i.e. Δ) and also achieved the highest hydrophilicity (i.e. θstatic,3min). For n = 
16, the longer PEO segment length likely imparts a greater steric challenge for water-
driven surface reorganization. In contrast, for n = 3, while short PEO segments may 
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more readily move to the surface–water interface, the reduced number of PEO repeating 
units diminishes the relative potential to increase hydrophilicity. 
 
 
 
 
 
Figure C7.  Static water contact angles measured over three minutes on bulk-modified 
silicone films. Bars are organized as the time after initial drop placement from dark color 
to light as follows: 0 s, 15 s, 30 s, 1 min, 2 min and 3 min. Each bar represents the 
average of three contact angles measured at the same time point on the same sample and 
the error bar is the standard deviation  
 
Reproduced by permission of The Royal Society of Chemistry.  To access the original article, please use 
the following link: http://pubs.rsc.org/en/content/articlelanding/2015/tb/c4tb02042a#!divAbstract. 
 
 
 
C.6.2.2  Protein Adsorption 
 
Protein resistance of the bulk-modified silicone “thick” films was determined via 
confocal microscopy.44,46,48,49 Adsorption of fluorescently-labeled HF (100 µg mL-1) was 
measured on silicone in terms of absolute fluorescence intensity (Table C11) and that 
normalized to unmodified silicone (Fig. C8). The unmodified silicone, due to its high 
hydrophobicity, resulted in characteristically high protein adsorption. Due to its 
hydrophobic nature, the siloxane-tether produced modified silicones with similarly high 
 191 
 
protein adsorption. Despite modification of silicones with PEO-controls (n = 3, 8, and 
16), protein adsorption was also high. This is notably contrary to the high protein 
repellency of PEO-controls when grafted onto silicon wafers (Fig. C5). This can be 
explained by the contact angle analysis that demonstrates that the PEO segments 
comprising the PEO-controls are severely inhibited in their migration to the surface–
water interface where protein adsorption occurs (Fig. C7). The PEO–silane amphiphile 
(n = 3), due to its short PEO segment length and corresponding inability to effectively 
hydrophilize the surface–water interface (Fig. C7), also produced modified silicones that 
adsorbed high levels of protein. However, distinctively low protein adsorption was 
observed for silicones modified with PEO–silane amphiphiles (n = 8 and 16), with the 
PEO–silane amphiphile (n = 8) yielding the lowest of the two. This agrees with the 
contact angle analysis that shows the rapid transition from a hydrophobic to hydrophilic 
surface, indicative of highly efficient water-driven PEO surface migration (Fig. C7). 
Thus, while these PEO–silane amphiphiles demonstrated reduced protein repellency 
versus the corresponding PEO-controls when surface-grafted onto silicon wafers (Fig. 
C5), they are superior and highly effective in reducing protein adsorption onto bulk-
modified silicones. 
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Figure C8.  Fibrinogen adsorption on bulk-modified silicones as measured by 
fluorescence intensity with confocal microscopy. Each bar represents the average and 
standard deviation of pixel intensity for three images normalized to unmodified silicone. 
Statistical significance was determined for low-fouling samples by one-way analysis of 
variance (Holm–Sidak method where * indicates p < 0.05)  
 
Reproduced by permission of The Royal Society of Chemistry.  To access the original article, please use 
the following link: http://pubs.rsc.org/en/content/articlelanding/2015/tb/c4tb02042a#!divAbstract. 
 
 
 
C.7  Experimental 
 
C.7.1  Materials 
 
Vinyltriethoxysilane (VTEOS), triethoxysilane, α,ω-bis-
(SiH)oligodimethylsiloxane [Mn = 1000–1100 g mol
-1 per manufacturer's specifications; 
Mn = 1096 g mol
-1 per 1H NMR end group analysis; 1H NMR (δ, ppm): 0.05–0.10 (m, 
78H, SiCH3), 0.19 (δ, J = 2.7 Hz, 12H, OSi[CH3]2H) and 4.67–4.73 (m, 2H, SiH)] and 
allyl methyl PEO3 [Mn = 204 g mol
-1 per manufacturer's specifications; Mn = 204 g mol
-1 
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per 1H NMR end group analysis; 1H NMR (δ, ppm): 3.35 (s, 3H, OCH3), 3.50–3.67 (m, 
12H, OCH2CH2), 4.00 (dt, J = 6.0 and 1.5 Hz, 2H, CH2═CHCH2O), 5.13–5.28 (m, 2H, 
CH2═CHCH2O) and 5.82–5.96 (m, 1H, CH2═CHCH2O)] were purchased from Gelest. 
Allyl methyl PEO [Polyglykol AM 450, Mn = 292–644 g mol
-1 per manufacturer's 
specifications; Mn = 424 g mol
-1 per 1H NMR end group analysis; 1H NMR (δ, ppm): 
3.35 (s, 3H, OCH3), 3.51–3.66 (m, 32H, OCH2CH2), 4.00 (δ, J = 5.4 Hz, 2H, 
CH2═CHCH2O), 5.13–5.28 (m, 2H, CH2═CHCH2O) and 5.82–5.96 (m, 1H, CH2] 
CHCH2O)] was graciously provided by Clariant. Anhydrous magnesium sulfate 
(MgSO4), hydrogen peroxide (H2O2) solution (30%), glass microscope slides (75 mm x 
25 mm x 1 mm), and phosphate buffer solution (PBS, without calcium and magnesium, 
pH = 7.4) were purchased from Fisher. Sulfuric acid (H2SO4, 95–98%), PEO methyl 
ether [Mn = 750 g mol
-1 per manufacturer's specifications, Mn = 736 g mol
-1 per 1H NMR 
end group analysis; 1H NMR (δ, ppm): 3.37 (s, 3H, OCH3) and 3.53–3.73 (m, 64H, 
OCH2CH2)], sodium hydride (NaH; 60 wt% dispersion in mineral oil), allyl bromide, 
RhCl(Ph3P)3 (Wilkinson's catalyst), Pt-divinyltetramethyl–disiloxane complex 
(Karstedt's catalyst), and human fibrinogen (HF; Mw = 340 kDa; lyophilized powder; 
≥90% clottable protein) were purchased from Sigma-Aldrich and were used as received. 
Organic solvents were also purchased from Sigma-Aldrich and were dried over 4 Ǻ 
molecular sieves prior to use. Silicon wafers (111) were obtained from University 
Wafer, Inc. Silica-coated QCM-D sensor crystals (QSX-303) were purchased from Q-
Sense. Medical-grade RTV silicone (MED-1137) was purchased from NuSil. Per 
manufacturer specifications, MED-1137 is comprised of α,ω-bis(Si–OH)PDMS, silica 
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(11–21%), methyltriacetoxysilane (<5%), ethyltriacetoxysilane (<5%), and trace 
amounts of acetic acid. The Alexa Fluor 546-dye conjugate of HF (AF-546 HF; Mw = 
340 kDa; lyophilized) was obtained from Invitrogen. 
 
C.7.2  Synthetic Approach 
 
All reactions were run under a N2 atmosphere with a Teflon-covered stir bar to 
agitate the reaction mixture. Chemical structures were confirmed with nuclear magnetic 
resonance (NMR) spectroscopy using a Mercury 300 MHz spectrometer operating in the 
Fourier transform mode and with CDCl3 as the standard. 
 
C.7.2.1  Synthesis of Allyl Methyl PEO16 
 
Allyl methyl PEO16 was prepared using a procedure adapted from literature.
77,78 
PEO methyl ether (Mn = 736 g mol
-1, 13.98 g, 19 mmol) was dissolved in 90 mL 
tetrahydrofuran (THF) and added dropwise to a chilled (0 °C) NaH dispersion (6.24 g, 
156 mmol) in 120 mL THF. The reaction was then warmed to room temperature (RT) 
and stirred for 6 h. Next, the PEO solution was chilled, allyl bromide (19.32 g, 160 
mmol) in 120 mL THF was added dropwise, and the mixture was warmed to RT and 
stirred for 16 h. The reaction was then filtered to remove precipitates and volatiles 
removed under reduced pressure. The resulting orange oil was dissolved in 75 mL de-
ionized (DI) water and washed three times with 75 mL toluene. The product was 
 195 
 
extracted three times with 50 mL chloroform. The chloroform solution was then dried 
with anhydrous MgSO4, filtered, and volatiles removed under reduced pressure to yield 
the final product (8.32 g, 56% yield) as a white, waxy solid. 1H NMR (δ, ppm): 3.36 (s, 
3H, OCH3), 3.51–3.68 (m, 64H, OCH2CH2), 4.00 (dt, J = 5.7 and 1.5 Hz, 2H, 
CH2═CHCH2O), 5.14–5.28 (m, 2H, CH2═CHCH2O) and 5.83–5.96 (m, 1H, 
CH2═CHCH2O). 
 
C.7.2.2  Synthesis of PEO–Silane Amphiphiles (n = 3, 8, and 16) 
 
PEO–silane amphiphiles (Fig. C2) were prepared as previously reported for n = 
8.44 Wilkinson's-catalyzed regioselective hydrosilylation of VTEOS and α,ω-bis-
(SiH)oligodimethylsiloxane13 produced “1” which was then subjected to 
Karstedt'scatalyzed hydrosilylation with the designated allyl methyl PEOn. PEO–silane 
amphiphile (n = 3). 1 (22.11 g, 17.2 mmol), allyl methyl PEO3 (3.50 g, 17.2 mmol) and 
Karstedt's catalyst were reacted together. In this way, the product (25.76 g, 94% yield) 
was obtained. 1H NMR (δ, ppm): 0.00–0.15 (m, 90H, SiCH3), 0.48–0.55 (m, 2H, 
SiCH2CH2CH2), 0.56 (s, 3H, SiCH2CH2), 1.09 (d, J = 7.8 Hz, 1H, SiCH2CH2), 1.22 (t, J 
=7.1 Hz, 9H, SiOCH2-CH3), 1.54–1.66 (m, 2H, SiCH2CH2CH2), 3.38 (s, 3H, OCH3), 
3.41 (t, J =7.2 Hz, 2H, SiCH2CH2CH2), 3.52–3.69 (m, 12H, CH2CH2O) and 3.82 (q, J = 
7.0 Hz, 6H, SiOCH2CH3). 
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C.7.2.3  PEO–Silane Amphiphile (n = 8) 
 
1 (20.02 g, 15.57 mmol), allyl methyl PEO8 (6.60 g, 15.57 mmol) and Karstedt's 
catalyst were reacted together.44 In this way, the product (22.68 g, 85% yield) was 
obtained. 1H NMR (δ, ppm): -0.02–0.14 (m, 90H, SiCH3), 0.47–0.53 (m, 2H, 
SiCH2CH2CH2), 0.55 (s, 3H, SiCH2CH2), 1.08 (d, J =7.5 Hz, 1H, SiCH2CH2), 1.22 (t, J 
= 7.1 Hz, 9H, SiOCH2-CH3), 1.52–1.66 (m, 2H, SiCH2CH2CH2), 3.37 (s, 3H, OCH3), 
3.40 (t, J = 7.2 Hz, 2H, SiCH2CH2CH2), 3.51–3.68 (m, 32H, CH2CH2O) and 3.81 (q, J = 
7.0 Hz, 6H, SiOCH2CH3). 
 
C.7.2.4  PEO–Silane Amphiphile (n = 16) 
 
1 (17.98 g, 13.98 mmol), allyl methyl PEO16 (10.85 g, 13.98 mmol) and 
Karstedt's catalyst were reacted together.44 In this way, the product (23.55 g, 82% yield) 
was obtained. 1H NMR (δ, ppm): -0.01–0.15 (m, 90H, SiCH3), 0.47–0.54 (m, 2H, 
SiCH2CH2CH2), 0.55 (s, 3H, SiCH2CH2), 1.09 (d, J = 7.5 Hz, 1H, SiCH2CH2), 1.22 (t, J 
= 6.9 Hz, 9H, SiOCH2-CH3), 1.52–1.66 (m, 2H, SiCH2CH2CH2), 3.37 (s, 3H, OCH3), 
3.41 (t, J ¼ 7.2 Hz, 2H, SiCH2CH2CH2), 3.52–3.72 (m, 64H, CH2CH2O) and 3.82 (q, J = 
6.9 Hz, 6H, SiOCH2CH3). 
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C.7.3  Synthesis of Siloxane- and PEO-Controls (n ¼ 3, 8, and 16) 
 
PEO-controls (i.e. no siloxane tethers) (Fig. C2) were prepared as previously 
reported for n = 8 by the Karstedt's-catalyzed hydrosilylation of triethoxysilane and the 
designated allyl methyl PEOn (1.1 : 1.0 molar ratio).
44 
 
C.7.3.1  PEO-Control (n = 3) 
 
Triethoxysilane (5.43 g, 33.1 mmol), allyl methyl PEO3 (6.14 g, 30.1 mmol) and 
Karstedt's catalyst were reacted together. In this way, the product (7.53 g, 65% yield) 
was obtained. 1H NMR (δ, ppm): 0.57–0.65 (m, 2H, SiCH2CH2CH2), 1.20 (t, J = 6.9 Hz, 
9H, SiOCH2CH3), 1.62–1.74 (m, 2H, SiCH2-CH2CH2), 3.36 (s, 3H, OCH3), 3.41 (t, J = 
6.9 Hz, 2H, SiCH2-CH2CH2), 3.51–3.68 (m, 12H, CH2CH2O) and 3.80 (q, J = 7.1 Hz, 
6H, SiOCH2CH3). 
 
C.7.3.2  PEO-Control (n = 8) 
 
Triethoxysilane (4.24 g, 25.8 mmol), allyl methyl PEO8 (9.94 g, 23.4 mmol) and 
Karstedt's catalyst were reacted together.44 In this way, the product (9.32 g, 68% yield) 
was obtained. 1H NMR (δ, ppm): 0.57–0.64 (m, 2H, SiCH2CH2-CH2), 1.20 (t, J = 7.1 
Hz, 9H, SiOCH2CH3), 1.62–1.74 (m, 2H, SiCH2CH2CH2), 3.36 (s, 3H, OCH3), 3.41 (t, J 
= 6.8 Hz, 2H, SiCH2CH2CH2), 3.50–3.66 (m, 32H, CH2CH2O) and 3.79 (q, J = 7.0 Hz, 
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6H, SiOCH2CH3). PEO-control (n = 16). Triethoxysilane (1.57 g, 9.57 mmol), allyl 
methyl PEO16 (6.74 g, 8.69 mmol) and Karstedt's catalyst were reacted together. In this 
way, the product (4.17 g, 50% yield) was obtained. 1H NMR (δ, ppm): 0.57–0.65 (m, 
2H, SiCH2CH2CH2), 1.20 (t, J = 6.9 Hz, 9H, SiOCH2CH3), 1.62–1.74 (m, 2H, SiCH2-
CH2CH2), 3.36 (s, 3H, OCH3), 3.41 (t, J = 6.9 Hz, 2H, SiCH2-CH2CH2), 3.50–3.71 (m, 
64H, CH2CH2O) and 3.80 (q, J = 7.0 Hz, 6H, SiOCH2CH3). 
 
C.7.3.3  Siloxane-Control (1) 
 
1 served as the siloxane-control and was prepared as noted above for the  rst 
step of the synthesis of the PEO–silane amphiphiles. VTEOS (3.53 g, 18.6 mmol) and 
a,ubis-(SiH)oligodimethylsiloxane (20.37 g, 18.6 mmol) were reacted together.44 In this 
way, the product (23.65 g, 99% yield) was obtained 1H NMR (δ, ppm): 0.003–0.177 (m, 
84H, SiCH3), 0.19 (d, J = 2.7 Hz, 6H, OSi[CH3]2H), 0.56 (s, 3H, SiCH2CH2), 1.09 (d, J 
= 7.5 Hz, 1H, SiCH2CH2), 1.23 (t, J = 7.1 Hz, 9H, SiOCH2CH3), 3.83 (q, J = 7.0 Hz, 6H, 
SiOCH2CH3) and 4.67–4.73 (m, 1H, SiH). 
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C.7.4  Coating Preparation 
 
C.7.4.1  Preparation of Surface-Grafted Coatings on Silicon Wafers 
 
Silicon wafers (1” x 1”) were cleaned by sequentially sonicating in (10 min) and 
rinsing with acetone, repeating with DI water and then drying in a 120 °C oven 
overnight. Next, the surfaces of the wafers were oxidized by submerging in a 7 x 3 v/v 
concentrated H2SO4/30% H2O2 (Piranha) solution for 30 min (warning: Piranha solution 
must be handled with extreme caution), removed, rinsed thoroughly with DI water and 
dried under a stream of air. In a typical procedure, grafting solutions comprised of each 
of the PEO–silane amphiphiles, PEOcontrols and the siloxane-control were prepared at a 
concentration of 0.012 M in isopropanol (IPA) (30 mL). Following the addition of 1 
drop of DI water, the grafting solutions were mixed in sealed jars for 1 h on a shaker 
table. Next, an oxidized wafer was placed into a jar and remained on a shaker table for 
12 h. Afterwards, the wafers were removed, air dried, and cured under vacuum (36 mm 
Hg) at 150 °C for 12 h. To remove unbound chains, the wafers were sequentially soaked 
(1 h), sonicated (3 min) and rinsed with ethanol, the sequence repeated with DI water 
and then lastly dried under a stream of air. 
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C.7.4.2  Preparation of Modified Silicone Coatings 
 
Glass microscope slides were sequentially rinsed with dichloromethane (DCM) 
and acetone followed by drying in a 120 °C oven overnight. Casting solutions were 
prepared by combining 2.0 g MED-1137 silicone in 6 g (9 mL) hexane and mixing with 
a vortexer until a homogenous solution was obtained. The PEO–silane amphiphiles, 
PEO-controls and siloxane-control were each added to individual casting solutions at 50 
mmol of silane per 1.0 g silicone and mixed thoroughly. Solutions were solvent-cast 
onto leveled glass microscope slides (1.5 mL per slide) and a polystyrene Petri dish 
cover placed on top of each so as to slow solvent evaporation and prevent bubble 
formation. The films were allowed to cure for one week at RT and immediately used for 
designated analyses. 
 
C.7.5  Surface Characterization 
 
C.7.5.1  XPS 
 
Surface composition analysis of surface-grafted coatings on silicon wafers was 
performed with a KRATO AXIS Ultra Imaging X-ray Photoelectron Spectrometer with 
a monochromatized Mg Kα source and operating at a base pressure of ~2% x 10
-9 mbar. 
The area of analysis was 7 x 3 mm. Elemental atomic percent compositions were 
determined from three survey spectra sweeps performed from 0 to 1100 eV. High 
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resolution (HR) analyses with a pass energy of 40 eV were performed with a take-off 
angle of 90°. HR scans (180 s sweeps) were performed at 526 to 536 eV for O 1s, 280 to 
295 eV for C 1s, and 96 to 106 eV for Si 2p. Raw data was quantified and analyzed 
using XPS Peak Processing software. 
 
C.7.5.2  Ellipsometry 
 
The thickness of surface-grafted coatings on silicon wafers was measured via 
ellipsometry (Alpha-SE, J.A. Woollam) with an incident angle of 70° in the spectral 
range of 380–900 nm and in the high-precision mode (30 s data acquisition time). The 
average thickness of the oxide layer of an oxidized silicon wafer was determined at three 
regions of a wafer specimen (taken from a wafer designated for grafting with a particular 
composition) using a standard two-layer (silica–silicon) optical model included in the 
manufacturer's software. To measure the thickness of the grafted chains, the previously 
determined oxide layer thickness was utilized in a second optical model that included the 
third “Cauchy layer” (polymer–silica–silicon). The index of refraction (n) was set to 
1.450 which is that of crystalline PEO.47,53 The average thickness (h) of the grafted 
layers was based on four individual wafers, each measured at three different regions. 
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C.7.5.3  Water Contact Angle Analysis 
 
Static contact angles (θstatic) of DI water droplets were measured at RT using a 
CAM-200 goniometer (KSV Instruments) equipped with an autodispenser, video 
camera, and drop-shape analysis software (Attension Theta). Following deposition, a 5 
mL sessile drop of water was iteratively measured over a 2 min (surface-grafted wafers) 
and 3 min (silicone-based coatings) period. The reported qstatic values of the surface-
grafted wafers were based on four individual wafers, each measured at three different 
areas (12 measurements total). The θstatic for the silicone-based coatings was an 
average of three measurements from different areas of the same film surface. 
 
C.7.5.4  Protein Adsorption 
 
Protein adsorption onto surface-grafted coatings was measured by QCM-D (Q-
Sense E4). Silicon dioxide coated sensors (50 nm thickness; Q-Sense) were 
ultrasonically cleaned with acetone and DI water as described above for silicon wafers. 
Following exposure to oxygen plasma for 2 min (Harrick Plasma, PDC-001), the sensors 
were surface-grafted with the designated PEO–silane amphiphile, PEO-control or 
siloxane-control as described above for silicon wafers. Contact angle analysis was used 
to verify grafting. Grafted sensors were subjected to the following sequence: (1) 150 µL 
min-1 flow of PBS until the frequency and dissipation values remained constant for >5 
min, (2) 150 µL min-1 flow of 100 µg mL-1 HF in PBS for 20 min and (3) 150 µL min-1 
 203 
 
flow of PBS for 5 min to remove loosely bound protein. The manufacturer's software 
was used to process the raw data and determine the mass of HF adsorbed to each sensor. 
The adsorption of AF-546 HF onto silicone coatings was measured via 
fluorescence microscopy. A silicone isolator well (20 mm well diameter, 2 mm depth; 
McMaster-Carr) was pressed against silicone films thereby creating a seal which 
prevented leakage of solution from the well. Fibrinogen solution (100 µg mL-1 in PBS, 
0.7 mL) was added to each well. (Note: per manufacturer specifications, the AF-546 was 
first dissolved in 0.1 M NaHCO3 to obtain a 1.5 µg mL-1solution and was further diluted 
in PBS to obtain a final concentration of 0.1 mg mL-1.) After 3 h at RT (protected from 
light), the solution was removed and 0.7 mL of fresh PBS was then added to each well 
and removed after 5 min. This process was repeated five times with fresh PBS and lastly 
one time with DI water. The samples were dried under a stream of air and protected from 
light until imaged. For each coating, an additional specimen was prepared and likewise 
rinsed with PBS and DI water, but without exposure to AF-546 (i.e. soaked 3 h in PBS) 
in order to correct for the background intensity. 
A FV1000 (Olympus) laser scanning confocal microscope was used for 
quantification of protein adsorption onto all films. Imaging conditions, both in excitation 
and collection, were identical for all samples: objective (SPLSAPO 10x objective, NA 
0.40), laser excitation type and intensity (HeNe 543 nm source), field of view and 
resolution (256 x 256 pixels, 317 x 317 micron field of view), depth (40 slices at 1 mm 
per slice), slice averaging, and collection (150 mm pinhole, 560 nm long-pass filter 
followed by a 560–660 nm band-pass filter, identical photomultiplier 
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voltages/sensitivities). Data analysis was performed on the FV10-ASW v3.1 software 
suite (Olympus). Each surface was imaged in three locations and aggregate intensities 
computed. These were compared to three images obtained from the analogous surface 
that had similar treatment without protein exposure. Changes in intensity from exposure 
to protein were then obtained and compared, with errors reported as the standard 
deviation of three measurements. 
 
C.8  Conclusions 
 
While the exceptional protein resistance of PEO (e.g. conventional PEO–silanes) 
is well described, these observations have largely been made when PEO is grafted to a 
physically stable substrate (e.g. silicon wafer). In this way, migration of the PEO to the 
surface–water interface (where protein and other biological adhesion occurs) is not 
required. However, when PEO is used to bulk-modify a silicone elastomer, rapid water-
driven restructuring is essential in order to affect protein resistance. In this work, both 
surface-grafted silicon and bulk-modified silicones were prepared with PEO–silane 
amphiphiles comprised of a siloxane tether (m = 13) and a PEO segment of variable 
lengths (n = 3, 8, and 16) as well as the corresponding PEO controls (i.e. no siloxane 
tether). Surface-grafted PEO-controls, due to their greater hydrophilicity, demonstrated 
superior resistance to fibrinogen versus the PEO–silane amphiphiles. However, when 
used to bulk-modify a silicone, PEO-controls produced surfaces that remained 
hydrophobic after 3 min of exposure to water. As a result, these surfaces exhibited poor 
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resistance to protein adsorption. In contrast, PEO–silane amphiphiles (n = 8 and 16) 
demonstrated dramatic and rapid water-driven surface restructuring, becoming extremely 
hydrophilic after exposure to water for only 3 min. As a result, these surfaces displayed 
exceptionally high resistance to fibrinogen. While the PEO–silane amphiphile (n = 3) 
also exhibited water driven restructuring, the achieved hydrophilicity and resistance to 
protein was diminished by its low PEO content. The enhanced potential of PEO–silane 
amphiphiles to migrate to the surface–water interface and reduce protein adsorption may 
be attributed to the hydrophobic nature as well as flexibility of the siloxane tether which 
allows movement of the tether and attached PEO segment through the silicone network. 
Furthermore, these results point to the limitations of predicting PEO's protein resistance 
using model substrates. 
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C.11  Supplementary Material 
 
 
 
Table C9.  Static water contact angles (°) measured on surface-grafted silicon wafers. 
Each value reported is the average and standard deviation of measurements performed in 
triplicate on four identically prepared samples (12 measurements total)  
 
Reproduced by permission of The Royal Society of Chemistry.  To access the original article, please use 
the following link: http://pubs.rsc.org/en/content/articlelanding/2015/tb/c4tb02042a#!divAbstract. 
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Table C10.  Static water contact angles (°) measured on bulk-modified silicone films. 
Each value reported is the average and standard deviation of three water droplets 
measured on the same film  
 
Reproduced by permission of The Royal Society of Chemistry.  To access the original article, please use 
the following link: http://pubs.rsc.org/en/content/articlelanding/2015/tb/c4tb02042a#!divAbstract. 
 
 
 
 
 
Table C11.  Fluorescence intensity measured on bulk-modified silicone films before 
(absolute) and after normalizing all values to the signal measured on unmodified silicone  
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